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Abstract
1. The present study examined whether primary cultured rat A2B5^ cerebrocortical 
oligodendrocyte progenitor cells (OPC) were susceptible to Zn^^- and excitotoxin-induced 
cell death.
2. Initial pharmacological studies demonstrated the selective ionotropic glutamate 
receptor agonists’ kainate and (S)-5-Iodowillardiine induced OPC death after 24-hour 
exposure. (S)-AMPA and L-glutamate only induced cell death in the presence of lOOpM 
cyclothiazide (a selective AMP A receptor desensitisation blocker). The selective AMPA- 
receptor antagonists, GYKI 52466 and Evans’ Blue, attenuated 300pM kainate-induced 
toxicity and therefore suggested OPC excitotoxic insult was via AMP A receptor activation.
3. Metabotropic glutamate receptor (mGluR) involvement was also established as (S)- 
DHPG (lOOpM), a selective group I mGluR agonist, afforded significant (p<0.05) protection 
against 300pM kainate-induced toxicity. The selective mGIuR antagonist (S)-MCPG 
reversed the effects of (S)-DHPG protection.
4. OPC death was partially prevented by the broad-spectrum caspase inhibitor Z-VAD- 
fmk (lOOpM) at 6-hour and 24-hour paradigms. Hoechst 33342 staining revealed the 
presence o f pyknotic nuclei following 6-hour kainate (300pM) exposure and Western 
Blotting using anti-caspase-3 antibody and anti-a-fodrin antibody indicated potential 
activation of the apoptotic executioner caspase-3. 300pM Kainate-induced OPC death did 
not appear to result in the activation of reactive oxygen species (ROS).
5. Zn^  ^ exposure over 24-hours resulted in OPC death (pECso 4.1+0.1). lOOpM Zn^^- 
induced OPC death was not potentiated by 300pM kainate and Evans Blue afforded no 
protection. Nicardipine also failed to influence OPC viability. The lack of effect of kainate 
and nicardipine was confirmed by ^^Zn^  ^uptake studies.
6. lOOpM and 300pM Zn^^-induced OPC death did not appear to result in activation of 
ROS. Hoechst 33342 staining revealed the presence of chromatin condensation with 300pM 
Zn^ (6-hour exposure). lOOpM and 300pM Zn^  ^ (24-hour exposure) was not influenced by 
Z-VAD-fmk or PD 150606.
7. Zn^^-induced OPC toxicity resulted in significant ATP depletion 6-hours following 
300pM Zn^  ^exposure (p<0.05) and was attenuated in the presence of 5mM pyruvate. These 
data therefore suggest the mechanisms of Zn^^ toxicity may involve disraption of the 
glycolytic cascade.
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Chapter 1
Glutamate. Excitotoxicity and Oligodendrocytes
1.1 Glutamate. Excitotoxicitv and Oligodendrocytes.
The excitatoiy amino acid L-glutamate occurs in high concentrations (8-13 
jimol/g total human brain content (Perry et a l, 1971)) throughout the mammalian 
brain whereby it functions in metabolism, such as in the detoxification of ammonia in 
the brain and also as a precursor for the inhibitory amino acid y-aminobutyric acid 
(GABA). However the main function of L-glutamate is to seive as a neurotransmitter 
whereby it is the main neurotransmitter in the mammalian CNS responsible for 80- 
90% of excitatory synaptic transmission (De Felipe et a l, 1997) exerting its effects 
via glutamate receptors.
1.1.1 Glutamate in the CNS
L-Glutamate is synthesised in nerve terminals and from glutamine in 
neighbouring glial cells. In neuronal terminals L-glutamate is synthesised from 
glucose via the Krebs cycle and also by transamination of a-ketoglutarate as 
illustrated in Figure 1.1. The sources of nitrogen and carbon atoms for the de novo 
synthesis of glutamate remain unclear in neurones, however the amino acid lysine, 
which is present at high concentrations within the brain (Smith, 2000), has been 
suggested as a candidate providing the e-amino group to form a-ketoglutarate which 
is then metabolised to form glutamate (Papes et a l, 2001). Short-term precursors for 
glutamate, such as glutamine, alanine and aspartate have also been suggested. It is 
mainly glial cells which synthesise glutamate, for example 25% of glutamate 
produced in the brain comes from leucine, isoleucine and valine via branched-chain
2
aminotransferase in astrocytes utilizing glucose as the main precursor of the carbon 
skeleton of glutamate.
GlutamineGlucose Alanine
I T  ATP 
L-GlutamatePyruvate
y-aminobutyric acidAcetyl CoA
Isocitrate
a-ketoglutarateCitrate
KREBS
CYCLE
Succinyi CoAOxaloacetate
Malate Succinate
Fumarate
Figure 1.1. Metabolism of glutamate from glucose and a-ketoglutarate.
The second source of glutamate is provided by the glutamate-glutamine cycle, 
whereby excess glutamate in the synapse (normally provided by vesicular glutamate 
release) is taken up mainly by astrocytes, but also to some extent oligodendrocytes, 
via sodium-dependent transporters (e.g. the excitatoiy amino acid transporters 
(EAATl-5)). Glial glutamate is converted to glutamine via glutamine synthetase and 
is either oxidised to a-ketoglutarate or transported via a low-affinity process back into 
neurones where it is hydrolysed to glutamate by mitochondrial glutaminase (Nicholls
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& Coffey, 1994). A very small percentage of glutamate can also be supplied via 
transport across the blood-brain barrier, via the amino acid transport system x‘. 
System x mediates sodium-independent, high affinity uptake of amino acids with 
anionic side chains, namely L-glutamate and L-aspartate. This uptake of glutamate is 
very small (influx rate of 0.67nmol/(min-g) in rat brain) since the brain is capable 
already of synthesising L-glutamate (Hawkins et a i, 1995). Indeed L-glutamate 
uptake rates are 5- to 10-fold less than that of most of the large neutral (e.g. leucine, 
tyrosine, valine) and basic (arginine and lysine) amino acids (Smith, 2000).
Vesicular glutamate release is by a Ca^^ dependent mechanism. Briefly, 
following neuronal depolarisation influx of Na^ ions occurs and results in Ca^^ influx, 
which then promotes vesicular glutamate release pre-synaptically. The transmitter 
then difluses across the synaptic cleft to exert it’s actions on glutamate receptors 
located post- and also pre-synaptically. Removal o f glutamate from the synaptic cleft 
occurs via sodium-dependant glutamate transporters localised at the pre- and 
postsynaptic terminals of neurons and alternatively at glial cell membranes after 
glutamate has diffused out of the synapse (Rothstein et a l, 1994). This process is 
important as it can firstly end the excitatory signal, recycle glutamate via the 
glutamate-glutamine cycle and also, more importantly, remove excess glutamate, 
which can be neurotoxic. Uptake of L-glutamate is achieved by utilizing 
transmembrane ion gradients, whereby stoichiometric studies suggest that the 
intracellular translocation of one molecule of L-glutamate is coupled to the inward 
movement of 3 Na^ ions and 1 ion and the outward movement of 1 ion 
(Zerangue & Kavanaugh, 1996; ) There are at least five major glutamate transporters, 
GLAST (EAATl), GLT-1 (EAAT2), EAACl (EAAT3), EAAT4 and EAAT5 each 
displaying eight membrane-spanning a-helices and two pore-loop structures (one
outward and one inward facing) (Slotboom et a l, 2001). EAACl is viewed as the 
major neuronal glutamate transporter, whereas as GLAST and GLT-1 are considered 
to be the principle glial transporters (Domercq et a l, 1999).
In vivo, basal glutamate has been suggested to be present at low micromolar 
concentrations (1.3-1.8pM) in the extracellular space outside of the synaptic cleft 
(Perry et a l, 1975; Stover et a l, 1997). This non-vesicular glutamate release is 
considered to be the result of a cystine-glutamate antiporter (Warr et a l, 1999; Baker 
et a l, 2002). The antiporter is a Na^-independent anionic amino acid transporter that 
exchanges extracellular cystine, a precursor for the antioxidant glutathione, for 
intracellular glutamate. During periods of synaptic transmission it is considered that 
this antiporter shifts into reverse direction, thereby removing extracellular glutamate 
and replacing with cystine, as high concentrations of glutamate are know to be toxic 
to neurons (Piani & Fontana, 1994). Interestingly glutamate release via the cystine- 
glutamate antiporter has also been shown to be negatively regulated by metabotropic 
glutamate receptors (mGluR) 2 and 3 (Baker et a l, 2002). A schematic representation 
of synaptic glutamate release, action and uptake at a neuronal synapse is illustrated in 
Figure 1.2.
Released vesicular glutamate can activate not only post-synaptic glutamate 
receptors in a point-to-point manner, it is also able to diffuse out of the synaptic cleft 
and activate receptors located further afield in the perisynaptic environment. For 
example activation of mGluRs located outside the synaptic cleft (Min et a l, 1998) or 
activation of kainate and mGluRs located on the GABA-releasing axons of 
interneurones (Semyanov & Kullmami, 2000; Semyanov & Kullmann, 2001).
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Figure 1.2. Schematic representation of synaptic glutamate release, action and uptake at a 
neuronal synapse. Depolarisation results following an action potential and causes influx of Na" 
ions and results in Ca^  ^ influx. Ca^-mediated vesicular release of glutamate ( , Glu) leads to 
activation of glutamate receptors (NMDA, AMPA, Kainate and metabotropic (mOluR)). Synaptic 
glutamate release is regulated by a negative feedback mechanism via group II metabotropic 
glutamate receptors (mGluR 2/3). Clearance of glutamate from the synapse is via excitatory amino 
acid transporters (EAAT) and during synaptic transmission the glutamate/cystine antiporter. 
Following uptake into glial cells, glutamate is metabolised to glutamine (Gin) and transported back 
into the pre-synaptic cell where it is converted into glutamate. It is considered that glutamate is 
packaged into synaptic vesicles via a glutamate transporter (vGLUTl) by an ATP dependent 
mechanism (Bellocchio et a l, 2000).
Glutamate via activation of glutamate receptors regulates a host of functions in 
the CNS. lonotropic glutamate receptors underlie fast excitatory transmission at 
many central synapses, for example the NMDA receptors are cmcial for the induction 
of specific forms of synaptic plasticity and play important roles in several 
neuropsychiatrie disorders, such as schizoplirenia following ‘under’ excitation of the 
NMDA receptor (Hollmann & Heinemann, 1994; Dingledine et ah, 1999; Hasimoto 
et a l, 2003). AMPA receptors main function is to mediate fast excitatoiy synaptic 
transmission and may also be involved in synaptic plasticity (cognitive learning and 
memory processes) such as long-term potentiation (long lasting increase in synaptic 
transmission) (Franciosi, 2001; Song & Huganir, 2002), where GluRl subunit 
expression is considered to be crucial to this process (Zamanillo et a l, 1999). Indeed 
LTP requires the combination of AMPA receptor-mediated components and pure 
NMDA receptor-mediated responses (Liao et a l, 1995; Isaac et a l, 1995). Kainate 
receptors contribute to the postsynaptic responses at excitatory synapses and can also 
modulate presynaptic neurotransmitter release at some synapses (Lerma et a l, 1997; 
Bortolotto et a l, 1999). Recently they have been linked to the transmission of pain 
(Ruscheweyh & Sandkühler, 2002). For example in animal models of hyperalgesia 
caused by inflammation, AMPA/kainate antagonists reduced central sensitisation 
(Schwarcz, 2001). Furthermore glutamate receptors in the spinal cord appear to be 
involved in the development of neuronal plasticity that accompanies sensitisation to 
pain (Dray et a l,  1994). AMPA, kainate and NMDA receptors have also been linked 
to epilepsy; studies using antagonists of these receptor subtypes have been shown to 
be anti-convulsive (Smith et a l ,  1991). Indeed it is suggested that kainate receptors 
may in fact have a role in the pathogenesis of epileptiform activity (Lerma, 1997). 
lonotropic glutamate receptors have been implicated in several neuronal pathologies.
such as epilepsy as mentioned above. In patients with Rett Syndrome, a genetic, 
developmental disorder that begins in infancy, AMPA receptors showed a 
developmental change in receptor number such that AMPA receptor number 
decreased markedly with age in the putameii-and basal ganglia compared with age- 
matched controls. Moreover NMDA receptor number was also shown to be 
decreased. The findings suggest that the manifestations observed with this syndrome 
such as seizure activity, abnormal movements and hyperventilation might in fact be 
due to a disturbance in glutamate transmission (Blue et a l, 1999). AMPA receptors 
have also been implicated in Alzheimer’s disease and other dementia-related disorders 
where differences in AMPA receptor localisation has been observed when compared 
to age-matched controls. For example Aronica et a l  (1998) reported in patients with 
Alzheimer’s disease GluR2 subunit expression was increased in the inner portion of 
the molecular layer of the dentate gyrus compared to age, sex and post mortem 
inteiwal matched controls. Whereas GluRl and GluR2 subunit expression was 
decreased in the hippocampal CAl region, but this finding may have been due to 
neuronal cell loss associated with the disease.
Glutamate via the activation of glutamate receptors in glial cells also functions 
to regulate gene expression, cell proliferation and differentiation. For example 
activation of AMPA receptors, in cultured Bergmann glial cells, increased expression 
of the activator protein 1 (AP-1) family of transcription factors, whereas in astrocytes 
glutamate receptor activation caused rapid induction of a set of immediate-early 
genes, such as Fos and Jun (Steinhauser & Gallo, 1996). Glutamate regulation of 
oligodendrocyte cell growth will be discussed later in detail.
The roles of mGluRs in synaptic transmission are to modulate rapid synaptic 
lonotropic (glutamatergic or GABAergic) transmission and the generation of slow
postsynaptic currents. Group I mGluRs have been shown to be located 
presynapticaily and activation of these receptors potentiates glutamate release from 
cortical synaptosomes (Moroni et a l, 1998; Reid et a l, 1999) and GAB A release 
front hippocampal intemeurones (Poncer et a l, 1995). Interestingly group I mGluRs 
inhibit glutamate release at the Schaeffer collateral-CAl and GAB A release at 
interneurons-CAl synapses in adult rats (Gereau & Conn, 1995; Poncer et a l, 1995). 
Group II and III mGluRs located presynapticaily have been shown to inhibit 
glutamatergic transmission in many synapses (Conn & Pin, 1997). Additionally 
mGluRl has been implicated in long term depression (LTD) (Conn & Pin, 1997). 
Since mGluRs appear to have mainly regulatory roles at glutamate neurotransmission, 
it indicates that they may also have many roles in neuropathologies (e.g. 
neurodegeneration, nociception, Parkinson’s Disease, addiction, sehizoplirenia and 
epilepsy) whereby therapeutic intervention with mGluR agonists/antagonists may 
prove to be useful.
1.1.2 Glutamate Receptors.
Glutamate receptors ai e widely distributed throughout the CNS, and have been 
classified into two main groups, the ionotropic and metabotropic receptors. The 
lonotropic receptors (iGluR), as detailed in table 1.1, are split into three receptor 
types, a-amino-3 -hydroxy-5 -methyl-4-isoxazole propionate (AMPA), kainate and N- 
methyl-D-aspartate (NMDA), originally named after the ligand that was considered 
selective for the receptor sub-type. These receptors are all ligand-gated ion channels 
produced by the homo- and/or heteromeric combination of different glutamate
receptor subunits, which when activated allow the influx of cations. AMPA and 
kainate receptors conduct Na^ ions, and also depending on subunit composition, 
permit the influx of Ca^ "^  ions. The NMDA receptor displays high Ca^^ permeability 
with lower Na^ conductance.
Receptor Family Functional role Subunit
Composition
Gene
lonotropic
(ion-channel linked)
AMPA NaV (Ca^’^  ion GluRl GRIAl
influx GluR2 GRIA2
K^ efflux GluR3 GRIA3
GluR4 GRIA4
Kainate NaV (Ca^+) ion GluR5 GRIKl
influx GluR6 GRIK2
K^ efflux GluR7 GRHC3
KAl GRIK4
KA2 GRIK5
NMDA Na^ ion influx NRl GRINl
K^ efflux NR2A GRIN2A
NR2B GRIN2B
NR2C GRIN2C
NR2D GRIN2D
NR3A GRIN3A
NR3B GRIN3B
Metabotropic
(G-protein coupled)
Group I TPI hydrolysis via mGlul mGluRl
PLC mGlu5 mGluR5
Group II \LCyclic AMP via mGlu2 mGluR2
iA C mGlu3 mGluR3
Group III \LCyclic AMP via mGlu4 mGluR4
iA C mGlu6
mGlu7
mGlu8
Table 1.1. The glutamate receptor family. Where PLC is phospholipase Cp and AC 
is adenylyl cyclase.
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These receptors share the same overall transmembrane receptor topology but 
have different electrophysiological characteristics, permeabilities, developmental 
expression patterns and trafficking profiles. They are higlily conserved between 
mammals for example rat, mouse and human GluRl show 96-97% similarity at the 
amino acid level (Hollmann & Heinemann, 1994). The ionotropic glutamate receptor 
stmcture is believed to consist of a tetrameric subunit composition, where each of the 
subunits consists of three trans-membrane domains (M l, M3 and M4) and one 
cytoplasmic-facing re-enterant loop within the membrane (M2) (Figure 1.3) 
(Dingledine et a i ,  1999). It is believed that the M2 loop plays a role in the formation 
of the ion channel pore (Wo & Oswald, 1994; Bennett & Dingledine, 1995) and the 
150 amino acid sequences SI and S2, which are separated by the M l-M3 domains, 
appear to represent the agonist recognition sites (Armstrong ei a l, 1998). 
Glycosylation sites in the N-terminal domain and also in the loop between M3 and 
M4 are considered to be important in desensitisation profiles by preventing the 
agonist-induced conformational change in receptor structure, for example, 
Concanavalin A, a lectin, prevents kainate receptor desensitisation by binding to 
glycosylation sites (Partin et a l, 1993; Everts et a l, 1999; Lerma et a l, 2001). The 
role of the caiboxyl terminus is speculated to contribute to the targeting and 
trafficking of receptors, possibly by interacting with trafficking, motor and 
scaffolding proteins to promote proper receptor localisation and regulation (Ban-y et 
al, 2002). This cytosolic ‘tail’ has been suggested to interact with proteins 
expressing PDZ (PSD95/DLG/ZO-1) peptide-binding domains (Hata et a l, 1998). 
Research with AMPA receptors suggests that PDZ domain containing proteins 
provide a mechanism for clustering ion chamiels and receptors in the plasma
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membrane (O’Brien et al., 1998), however much of this research is at present unclear, 
examples of proteins containing PDZ domains are AMPA receptor binding protein 
(ABP) and glutamate receptor interactive protein (GRIP) (Braithwaite et a i, 2000).
Glycosylation sites
Glu
Flip/flop
M 2
membrane
intracellular
COOH
Figure 1.3. Schematic illustration showing the structure of a typical AMPA/kainate 
receptor subunit. The transmembrane topology is shown along with the flip/flop 
alternatively spliced exon. Glycosylation sites are depicted in the N-terminal region. 
* Represents the mRNA edited Q/R site. (Dingledine et al., 1999; Braithwaite et a i, 
2000; Madden, 2002; Ruscheweyh & Sandkühler, 2002))
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Growing research, at present, indicates that activation of a glutamate receptor 
requires the binding of four agonists (one for each subunit). Most of this knowledge 
has been gained from studies of GluR2 constructs of the S1S2 domain core utilizing 
X-ray crystallography. Upon binding of L-glutamate or agonist to the S1S2 binding 
domain or cleft (Figure 1.4 side views: left-hand side and middle), the cleft closes and 
traps the ligand within it, similar to that of a Venus-fly trap, however the mechanism 
for tills cleft closure is not yet understood (Madden, 2002). It should be noted that not 
all glutamate receptor subunit binding domains are closed when ligand-bound, it has 
been suggested that the mGluR 1 consists of a mixture of open and closed 
conformations in the presence of glutamate (Kunishima et a l, 2000). Figure 1.4 
illustrates the series of events that are considered to result following L-glutamate 
binding to the iGluR.
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Figure 1.4. A model for iGluR activation and desensitisation. Upper row: 
Hypothetical iGluR channel physiology in response to glutamate application in mouse 
embryonic hippocampal neurones. Top and Side view left-hand-side shows a 
schematic representation of an iOluR receptor in resting state, ligand-free. Following 
glutamate binding to the S1S2 domains (top and side views, middle panel), cleft 
closure in a given subunits pulls the transmembrane domains of that subunit away 
from the pore axis resulting in ion pore opening (orange arrow). Desensitisation (top 
and side views, right-hand-side) is considered to occur as a result of ‘slippage’ 
between subunits allows the gate to close again, while the subunits remain in the 
agonist-bound conformation. Adapted from Armstrong & Gouaux (2000) and 
Madden (2002).
14
1.1.2.1 NMDA receptors
Oligodendrocytes do not express functional NMDA receptors (Patneau et a i, 
1994) and therefore NMDA receptors will not be extensively discussed in this 
document. NMDA receptors consist of four heteromers comprising of both NRl and 
NR2 subunits and allow the influx of Na^^ and Ca^^ ions. NRl has a large N-terminal 
with 10 N-glycosylation sites and can exist in seven splice variants, whereas there are 
four different genes encoding NR2, namely NR2A, B, C and D. An NR3 subunit 
family has also been identified comprising of isoforms NR3A and NR3B. Recent 
experiments have demonstrated that NR3A may play a regulatory role as they can co- 
assemble with certain NR1/NR2 subunit complexes (Perez-Otana et a l, 2001). The 
NMDA receptor is a complex molecule that has multiple recognition sites for 
endogenous and exogenous ligands, each with discrete binding domains (Figure 1.5), 
The receptor requires co-agonism with either glycine or D-serine, which bind to the 
NRl subunits, whereas L-glutamate binds to the NR2 subunits. At resting membrane 
potentials extracellular Mg^^ blocks the membrane channel. It is only when 
depolarisation of the membrane occurs that this ion is relieved of its position. There 
is also an inhibitory divalent cation site that binds Zn^^ to produce a voltage- 
independent block, although this is much weaker than for Mg^^ (Chiistine & Choi, 
1990; Legendre & Westbrook 1990; Paoletti et a l, 1997).
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Figure 1.5. Schematic illustration of the NMDA receptor and the sites of action 
of different agents on the receptor. NMDA channel is shown with only two of the 
four subunits required for ion channel formation. The NMDA receptor gates a cation 
channel that is permeable to Na^^ and Ca^ and is gated voltage-dependently by Mg^  ^
PCP, phencyclidine.
1.1.2.2 AMPA receptors, mRNA editing and alternate splicing.
Functional AMPA receptors consist of four homo- or heteromeric receptor 
subunits named GluRl-4. The individual AMPA receptor subunits are approximately 
900 amino acids in length and show approximately 68-73% sequence similarity 
between the subunits (Hollmann & Heinemann, 1994). AMPA receptors were 
originally considered to be similar in structure to other ligand-gated ion channels such
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as the nicotinic acetylcholine receptor, however the overall amino acid sequence 
identity of GluRl-4 to these receptors is only 20%, which is not considered 
significantly higher than for two random sequences (Hollmann & Heinemann, 1994). 
It is thought that AMPA receptors now show a related receptor structure to that of 
potassium channels in that a re-entrant loop is present.
AMPA receptor function and structure is further increased by greater subunit 
diversity due to post-transcriptional modifications such as alternative splicing and 
RNA editing. Studies have shown with recombinant AMPA receptors lacking the 
GluR2 subunit there is an increased permeability to Ca^^ ions, whereas AMPA 
receptors expressing edited GluR2(R) subunits have low calcium permeability 
(Sommer et a l, 1990). This finding can be explained in terms of single amino acid 
changes occurring post-transcriptionally. With AMPA receptors expressing the 
GluR2 subunit, the M2 segment of the channel protein has a positively charge 
arginine (R) residing in position 586 (see Figure 1.3, position indicated by *). GluRl, 
GluR3 and GluR4 all express a neutral glutamine (Q) in the 586 position and 
therefore an AMPA receptor lacking the GluR2(R) subunit will be more permeable to 
divalent cations. The GluR2 subunit is the most highly edited of all the subunits, for 
all species, especially in rats and humans where it is reported to be virtually complete 
in the adult brain (Sommer a/., 1991; Paschen <?/., 1994).
AMPA receptor subunits aie subject to further change post-transcriptionally 
via alternate splicing of exons positioned before the M4 domain (for GluR2, exons 14 
and 15) and result in flip/flop subunit variations (Figure 1.3). Flip isoforms tend to be 
dominant before birth, possibly contributing to prenatal synapse formation. They also 
continue to be expressed during adult life, whereas the flop isoform is expressed in 
relatively low abundance at birth. Expression increases with maturity until adulthood
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when flop form levels are similar to flip isoforms. The importance of these subunit 
variations at different maturation states is unknown, however it is known that flip and 
flop isoforms differ in desensitisation time course profiles whereby the flip isoforms 
generate rapidly decaying currents, wliich fade to steady-state level in the presence of 
glutamate whereas flop isoforms desensitise more rapidly (Sommer et ah 1990).
1.1.2.3 Kainate receptors, mRNA editing and alternate splicing.
Like AMPA receptors, kainate receptors are composed of different subunit 
compositions and are also subject to post-transcriptional modifications. Kainate 
receptors can form homo- or heteromeric receptor stmctures. These receptors are 
tetrameric in structure (as shown in Figure 1.3) comprising of either K A l-2 or GluR5- 
7 subunits (see Table 1.1). Kainate receptors are flirther split in terms of low- 
(GluR5-7) and high- (KAl & KA2) affinity subunit compositions based on their 
affinity for [^H]-kainate (Bettler et a l, 1992).
Like the AMPA receptor subunits, kainate receptor subunits are -900 amino 
acids in length but only share —40% sequence similarity to GluRl-4. Between the 
kainate receptor subunit family the sequence homology is higher. KAl and KA2 
share 68% homology, whilst GluR5- GluR7 have a sequence similarity of 75%. The 
homology between GluR5-GluR7 and KA1/KA2 is similar to that observed with 
AMPA subunits at -45%  (Hollmann & Heinemann, 1994).
Alternate splice variants also exist within the kainite receptor family, GluR5 
exists as 2 splice variants GluR5-l and GluR5-2, whereby the former has an 
additional 15 amino acids in the extracellular N-terminal region (Bettler et a l, 1990).
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A fijrther three splice variants exist within GluR5-2, which have alternate C-terminal 
sequences, namely GluR5-2b (originally GluR5-2), GluR5-2a and GluR5-2c. GluR7 
also has two alternative splice variants in the C-terminal domain (7a and 7b), No 
alternate splicing has been reported for GluR6 and KA1/KA2,
Kainate receptors are subject to post-transcriptional mRNA editing at two 
distinct sites, the M l and M2 region of the receptor subunit (Figure 1.3). RNA 
editing in the M2 region of GluR5 (residue 591) and GluR6 (residue 590) is similar to 
the editing in GluR2, where a neutral glutamine (Q) is replaced with a positive 
arginine (R). This editing is not as efficient as editing of the GluR2 subunit, only 50- 
60% of GluR5 and 70-96% of GluR6 are edited in adult populations (Chittajallu et al.,
1999). Editing of GluR5 and 6, also like GluR2, results in functional changes in 
homomeric kainate receptors such that GluR5(R) and GIuR6(R) also display a 
reduced Ca^^ permeability (Kohler et a l, 1993), a linear or slightly outwardly 
rectifying current-voltage relationship instead of the inward or double rectifying 
properties shown by homomeric GluR5 (Q) and GluR6 (Q) (Burnashev et a l, 1995) 
and a highly significant increase in Cl' permeability (Burnashev et a l, 1996). In 
addition to the functional changes occumng with edited homomeric GluR5 and 6, 
functional changes can also occur in edited or unedited GluR5 and 6 heteromeric 
receptors (Chittajallu et a l ,  1999). These qualities are considered to be due to the 
ring of positively charged arginine residues within the pore lining and therefore 
display an energy barrier to the movement of cations such as Ca^ .^ Furthermore these 
residues would electrostatically prevent polyamines (considered to be responsible for 
inward or double rectification properties) from entering the pore (Kamboj et a l, 1995; 
Bowie et a l, 1995). The mechanism of this editing remains unclear at present.
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however what is understood is that this Q/R editing appears to be developmentaliy 
regulated.
1.1.2.4 Metabotropic glutamate receptors.
The second group of glutamate receptors are the seven transmembrane 
spanning G-protein-coupled metabotropic glutamate receptors which comprise of 
three receptor families, groups I, II & III (Table 1.1) as determined by their 
similarities in coupling mechanisms, molecular structure and pharmacology. 
Metabotropic glutamate receptors are thought to exist as homodimers linked by a 
disulphide bridge as has been reported to occur in group I mGluRl and mGluR5 
(Romano et a l, 1996, Kunishima et a l, 2000; Tsuchiya et a l, 2002) and the proposed 
structure is illustrated in Figure 1.6. Metabotropic glutamate receptors are members 
of family 3 G-protein coupled receptors (GPCRs) and also include the Ca^^-sensing 
receptors in charge of sensing Ca^ "^  located in parathyroid glands, kidney and brain 
(Ruat et a l, 1996). The binding site is considered to be located in the N-terminal 
region, whereby binding of the ligand either results in a “Venus-fly trap” closure of 
the binding cleft followed by the transduction of structural changes possibly involving 
the transmembrane domain and leads to the coupling and activation of G-proteins or 
alternatively, binding of the ligand to the N-terminal domain modifies the structural 
relationship between the two dimers in such a way as to cause activation of G-proteins 
(Romano e/a/., 1996).
Group I (Gq-coupled) comprise of inGluRl and mGluRS and stimulate the 
production of inositol (1, 4, 5)-trisphosphate and diacylglycerol via phospholipase cp
2 0
2 +(PLC), which leads to the activation of protein kinase C (PKC) and release of Ca 
from intracellular stores respectively. The sequence homology between mGluRl and 
mGluRS are very similar and C-terminal splice variants of mGluRl and mGluRS have 
been shown to exist, namely mGluRla-d and mGluRSa and 5b.
N-terminal
domain
~y- 7-TM G protein coupling domain
C-terminal
domain
Figure 1.6. Proposed homodimer formation of the G-protein coupled metabotropic 
glutamate receptor-5. TM, transmembrane. (Romano a/. 1996).
The splice variants do not alter receptor pharmacology from mGluRl, however they 
do appear to produce longer lasting, delayed [Ca^^Ji oscillations that may generate 
different Ca^  ^ responses (Hollmann & Heinemann, 1994; Bockaert et a i, 2002). This 
observation may be due to the later finding of Homer proteins. MGluR la and 
mGluR5 have been shown to interact via a specific Homer binding sequence 
(PPXXFR) in their long C-terminal domain with a domain of a series of Homer 
proteins (Brakeman et a l, 1997). Homer proteins (lb, Ic, 2 and 3) can all form 
dimers or multimers via coiled-coil interactions of their C-terminal domains, whereas
2 1
Homer la  is a C-terminal truncated form of Homer which does not form coiled-coil 
interactions with other Homer proteins but does interact with mGluRla and mGluRS 
(Ango et a l, 2000). Therefore raising the possibility that Homer la  can disrupt the 
bridge foimed between mGluRla and 1P3 receptors assembled via Homer dimers, 
resulting in a reduction of the speed of mGluR-induced Ca^^ release from intracellular 
stores (Tu et a l, 1998; Xiao et a l, 1998). Recently Homer proteins have also been 
implicated to cause agonist-independent activation of group I mGluRs when they are 
over-expressed in the cell line Human Embryonic Kidney (HEK) 293 cells (Ango et 
a l, 2001), however as yet this effect has not been obseiwed in native receptors. 
Group I receptors are present in many areas of CNS such as the hippocampus, cortex, 
thalamus and cerebellum (not mGluR5) (Bordi & Ugolini, 1999).
Group II (mGluR2-3) and group HI (mGluR4, 6-8 and their splice variants 
mGluR4a, 4b, 7a, 7b, 8a and 8b) are negatively coupled to adenylyl cyclase, and will 
therefore inhibit forskolin-stimulated cyclic AMP formation (Cartmell & Schoepp,
2000). However most of groups II and III mGluR fonctions do not require inhibition 
of adenylyl cyclase, for example they can inhibit the L, N and P/Q type Ca^^ channels 
(depending on the type of neurone) by the direct interaction between Gpy released 
from Gi/Go with the channels (Herlitze et a l, 1997).
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1.1.3 Glutamate Receptor Pharmacology
1.1.3.1 AMPA and Kainate Receptor Pharmacology.
Distinguishing between kainate and AMPA receptors in the past has been 
difficult due to the fact that both these receptors respond to many of the same 
agonists. For example AMPA receptors can be activated by kainate (Boutler et al., 
1990), and functional heteromeric kainate receptors can be activated by (S)-AMPA. 
However, with the development of new compounds, distinction between the two 
receptor groups has been achieved.
AMPA Receptor agonists
(S)-AMPA is the agonist of choice at AMPA receptors, however due to rapid 
desensitisation of this receptor by this agonist, kainate is often used as an agonist for 
AMPA receptor studies even though is has a much lower affinity for AMPA receptors 
compared with (S)-AMPA. Other classical agonists include quisqualate (used prior to 
(S)-AMPA), domoate, L-glutamate and kainate (Figure 1.7). Displacement studies of 
[^H]AMPA binding to recombinant receptors for GluRl, GluR2 and GluR3 follow the 
rank order quisqualate> AMPA = domoate> L-glutamate> kainate (Fletcher & Lodge, 
1996). AMPA receptor agonist development has focused mainly around two classes 
o f chemical compounds, those derived from (S)-AMPA and the willardiine (l-(2- 
amino-2-carboxyethyl)pyrimidme-2,4-dione) series. It should be noted again that 
many of these compounds can also activate kainate receptors, such as (S)-5- 
fluorowillardiine, however this compound has a 46-fold selectivity for AMPA
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receptors located in dorsal root ganglia neurones over kainate receptors (Wong et al., 
1994). Agonist rank orders of potencies can vary for AMPA receptors due to AMPA 
receptor subunit composition, cell type and localisation within the CNS. Another 
contributing factor to AMPA receptor pharmacology is the ability of some agonists to 
cause fast desensitising currents in the receptor, for instance, (S)-AMPA, L-glutamate 
and quisqualate can all desensitise the AMPA receptor, whereas kainate is considered 
a non-desensitising agonist (Bleakman & Lodge, 1998).
CO,H
H O ,C ^
COgH
HN
COjH
HjN “  \  NHj
L-Glutamate (S)-AMPA Kainate
HN Ny/O NH HN N NHO F
Quisqualic acid (S)-5 -Fluorowillardiine
Figure 1.7. Stmcture of AMPA receptor agonists.
AMPA Receptor Allosteric Modulators
Positive allosteric AMPA receptor modulators are a group of compounds that 
can interact with the AMPA receptor and act in such a way as to slow the rates of
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desensitisation and/or deactivation. These compounds are split into two groups, the 
pyrrolidones (such as aniracetam, 1-BCP ( 1 -( 1,3 -benzodioxol-5 -ylcarbonyl)- 
piperidine) and CX516 (BDP12) (l-(quinoxalin-6-yIcarbonyl)piperidine) (Tsuzuki et 
al, 1992; Arai et a l, 1994) and the benzothiadiazides (such as diazoxide, 
cyclothiazide and 7-chloro-3-3methyl-3-4-dihydro-2H-l, 2, 4 benzothiadiazide 
(IDRA-21)) (Vyklicky et a l ,  1991; Partin et a l, 1993) (Figure 1.8). There are also 
other compounds such as PEPA (4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro- 
phenoxyacetamine) and S I8986 (a pyrolo-benzothiadiazide derivative) that have been 
shown to potentiate AMPA receptor responses (Sekiguchi et a l ,  1998; Desos et a l,  
1996). PEPA is a useftil tool as it displays a selectivity profile for the AMPA receptor 
subunits of GluR3>GluR4>GluRl and flop>flip variants (Sekiguchi et a l, 1998).
OMe
N .0
NCN
Aniracetam CX516
NH
N CH3
Cyclothiazide IDRA-21
2 5
HgNOC
F
-SO. Cl
PEPA
S ^ oNH
S18986
Figure 1.8. Structure of AMPA receptor modulators.
AMPA receptor antagonists
Competitive AMPA receptor antagonists reportedly selective for this receptor 
type are generally from the quinoxalinedione series, which includes 6-cyano-7- 
nitroquinoxaline-2,3-dione (CNQX), and 2,3-dihydroxy-6-nitro-7-suIfamoylbenzo(/)- 
quinoxaline (NBQX) (Figure 1.9). There is also an AMPA derivative, (R,S)-2-amino- 
3-[5-/e/7-butyl-3-phosphonomethoxy)-4-isoxazoly]propionic acid (ATPO), which has 
been shown to be a competitive inhibitor of recombinant AMPA receptors (Wahl et 
a i,  1998). The above mentioned antagonists may be selective for the AMPA 
receptor, however they will also show activity at kainate receptor subtypes and this 
therefore limits their use as agents able to discriminate between the receptor 
subclasses. For example the selectivity of quinoxalinediones for AMPA receptor 
antagonism vs. kainate receptors is only approximately 3-10 fold (Wilding & 
Heuttner, 1996).
Non-competitive AMPA receptor antagonists, also known as negative 
allosteric modulators, are structured around the 2,3-benzodiazepine series. The most 
commonly used are l-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-
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benzodiazepine (GYKI 52466) and l-(4-aminophenyl)-3-methylcarbamyl-4-methyl“ 
7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine (LY 300168) (GYKI 53655) 
(Wilding & Heuttner, 1995). GYKI 52466, which was originally developed as a 
muscle relaxant (Tamawa et al., 1989), is considered to act as an allosteric modulator 
wliich down-modulates AMPA receptor function as it appears not to interact with the 
agonist/antagonist site to which glutamate and the quinoxalinedione inhibitors bind. It 
is also not reported to act as a channel blocker (Arai, 2001).
CN
CNQX
HOX
O — /
ATPO
PO.H3 '  '2
NBQX
CH
— H
GYKI 52466
O
<O
CH.
0
NHCH.
LY 300168 (GYKI 53655) 
Figure 1.9. Structure of AMPA receptor antagonists.
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Another compound of interest is the 1,3-naphthalene disulphonic acid derivative 
Evans Blue (Figure 1.10), has been shown to reduce recombinant AMP A receptor 
mediated responses respectively (Keller et a/., 1993). With the synthesis of these new 
antagonists it has become possible to pharmacologically separate AMPA and kainate 
receptor-mediated events, however it should be noted that although these compounds 
are, to a high degree, selective for the AMPA receptor, they are not specific to this 
receptor and will show some activity at kainate receptors and also other glutamate 
receptors .
SOgNa
NaOgS
NH2 OH
NaOgS
Evans Blue
Figure U 0« Structure of the AMPA receptor antagonist Evans Blue.
Also of interest as a pharmacological tool is Joro Spider Toxin, which is able 
to discriminate against receptor populations expressing the GluR2 (R) subunit 
(decreased Ca^^ peimeabilities). In studies using recombinant AMPA receptor 
subunits, Joro Spider Toxin displayed affinities for GluRl,3 and 4 (IC50 of 30nM) but
28
had no effect on GluR2 (R), and exerted its effect by acting as an open channel 
blocker (Priestley et a l, 1989; Blaschke et a l, 1993).
Kainate receptor agonists.
Development of selective kainate receptor agonists is somewhat more 
advanced for discriminating between the receptor subclasses and also receptor subunit 
composition when compared to AMPA receptors. Rank order of potencies of 
compounds selective for the kainate receptor show different pharmacological profiles 
depending on the subunit composition located within a brain region and some of these 
selective compounds also show subunit selectivity. Studies have shown the following 
compounds to be selective for the kainate receptor, ATPA {tertAmXyX AMPA 
derivative), (S)-5-iodowillardiine, 5-iodo-6-azawillardiine, (S)-trifluoromethyl- 
willardiine and (2S,4R)-4-methylglutamate (SYM2081) (Jones et a l, 1997; Zhou et 
a l, 1997; Swanson et a l, 1998) (Figure 1.11). ATPA, a compound developed to be 
an AMPA receptor agonist, has been shown to display a liigh affinity for the GluRS 
subunit when using human recombinant kainate receptors (Clarke et a l,  1997). Of 
the willardiine series, (S)-5-iodowillardiine also shows subunit selectivity for GluRS 
(Swanson et a l,  1998), with an E C 5 0  value of 0.14pM (kainate receptor mediated) in 
dorsal root ganglia. However this compound also displays activity at the AMPA 
receptor with an E C 5 0  value of 19pM in hippocampal neurones (Wong et a l ,  1994). 
The relatively new compound (2S,4R)-4-methyIglutamate has been shown by Toms et 
a l  (1997) and Bailey et a l  (2001) to show selectivity for kamate receptor subunits 
GluRS and GluR6.
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CF. NH
HO,
NH,'2
(S)-5-Iodowillardiine
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(S)-5-trifluoromethylwillardiine LY 339434
Figure 1.11. Structure of kainate receptor agonists.
Kainate Receptor Antagonists.
Development of selective kainate receptor antagonists is somewhat limited.
There are a few candidates that were originally reported to be selective, however they
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can all function as AMPA receptor antagonists. A competitive inhibitor, NS102, 
shows preference for recombinant GluR6 over the other kainate receptor subunits, 
however it is reported to have only a 20-fold selectivity for kainate vs. AMPA- 
receptor mediated responses (Wilding & Huettner, 1996). The 
decahydroisoquinolines, such as LY3 82884 ((3S,4aR,6S,8aR)-6-(4-
carboxyphenyl)methyl-l,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic 
acid), LY294486 ((3SR,4aSR,6SR,8aRS)-6-((lH-tetrazol-5-yl)methyloxy- 
l,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid), and LY293558 
((3S,4aR,6R,8aR)-6-[2-(lH-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic 
acid), show selectivity towards the GluRS over GluR6 subunits, and are therefore 
useful in discriminating kainate receptor-mediated response (Clarke et ah, 1997; 
O’Neill e ta l, 1998) (Figure 1.12).
N.\ \N •N
O
NH
H
NS-102 LY 294 486
H H COgH
H
LY 377 770 LY382 884
31
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H
LY 293 558
Figure 1,12. Structure of kainate receptor antagonists.
1.1.3.2 Metabotropic group I glutamate receptor pharmacology.
The group I mGluR receptors are well-characterised thanks to selective 
agonists and antagonists for this group. Agonists selective for group I mGluRs are 
(S)-3,5-dihydroxyphenylglycine (DHPG) and ^?w?5'-azetidine-2,4-dicarboxylate (t- 
ADA) (Figure 1.13). These agonists show little activity at other mGluR groups, and 
are therefore extremely useful in identifying this receptor group. However, although 
these compounds are very selective for group I, they are not the most potent. Rank 
order of potencies for group I mGluRs aie as follows: quisqualate > DHPG = 
glutamate > IS, 3R-1 -amino-1,3-cyclopentanedicarboxylate (ACPD) = ibotenate > 
(2S, 1 ’ 8,2 ’ S)-2-(carboxycycloproyl)glycine (L-CCG-I) > AaM^-azetidine-2,4- 
dicarboxylic acid (/-ADA) (Bordi & Ugolini, 1999). A derivate of the phenylglycine 
series, (RS)-2-cliloro-5-hydroxyphenylglycine (CHPG), has been shown to activate 
mGluR5 and not mGluRl, however although useful as a pharmacological tool, it has 
relatively low potency for group I receptors (Doherty et a l,  1997).
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Figure 1.13. Stmcture of group I metabotropic glutamate receptor agonists.
(S)-a-methyl-4-carboxyphenylglycme (MCPG) was the hrst selective mGluR 
antagonist, however it does not display selectivity between the gi'oups (Hayashi et al., 
1994) (Figure 1.14). Derivatives of the phenylglycine series such as (S)-4- 
carboxyphenylglycine (4CPG) and (S)-4-carboxy-3-hydroxyphenylglycine ((S)- 
4C3HPG) have since been synthesised and found to be selective antagonists for the 
group I receptors, with 4CHPG being the most potent. (S)-4C3HPG has also been 
shown to be an agonist at mGluR2 with equipotent action of (S)-4C3HPG to mGluRl 
(Hayashi et a l, 1994). Other antagonists claiming to have improved potency to group 
1 have also been synthesised, these include: (RS)-1 -aminoindan-1,5-dicarboxylic acid 
(AIDA), (S)-(+)-2-3’-carboxybicyclo[l.l.l]penty-glycine (CBPG) and ethyl-7-
33
(hydroxyiimno)cyclo-propan[b]cliromen-la-carboxylate (EtCCC), some of which 
show selectivity for mGluRl over mGluR5 (Bordi & Ugoliiii, 1999).
CO2H
,vMe 
HgN COgH
(S)-MCPG (S)-4-CPG
HO
(S)-4C3HPG
AIDA CBPG
Figure 1.14, Structure of group I metabotropic receptor antagonists.
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1.1.4 Excitotoxicitv
Although glutamate is essential for normal CNS neurophysiology, excess 
glutamate is toxic to both neuronal and glial cells. Excitotoxicity is a term used to 
describe the prolonged activation of glutamate receptors expressed by cells in the 
CNS and was first described in the late 1950s in retinal ganglion neurones exposed to 
sustained levels of glutamate (Lucas & Newhouse, 1957). Later research by Olney 
and Sharpe (1969) demonstrated in infant Rhesus monkey central neurones, which 
contained glutamate receptors, were damaged following treatment with monosodium 
glutamate. Acute CNS injuries, such as stroke, lead to ischaemia with subsequent 
cellular ATP depletion, cellular depolarisation and consequent excessive release of 
glutamate (initially by vesicular release fi*om nerve terminals and later by reverse 
transport from astrocytes). Glutamate under these conditions can reach near- 
millimolar concentrations in the extracellular space and so result in over-stimulation 
o f glutamate receptors (NMDA, AMPA and Kainate) and subsequent excessive Na^ 
and Ca^^ influx which can propagate the response and lead to Ca^  ^ overload and 
eventual cell death, a summary of these events is illustrated in Figure 1.15 (Choi,
1988).
Excitotoxicity can fall into two categories, rapidly triggered- and slowly 
triggered excitotoxicity. Rapidly triggered excitotoxicity can be used to describe the 
over-activation of NMD A receptors. 3-5 minutes exposure to NMD A has been 
shown to trigger widespread cortical neuronal death, probably due to the higher rate 
of Ca^^ influx observed with NMDA receptor-gated channels. NMDA receptor 
antagonists have been shown to be neuroprotective in animal models of focal brain 
ischaemia, though not transient focal ischaemia (Albers et a l, 1989).
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Figure 1.15. Diagrammatic representation of neuronal excitotoxicity. Abbreviations: 
- PLC, phospholipase CP; VDCC, voltage-dependent Ca^ channel; IP3, inositol 
1,4,5-trisphosphate; DAG, diacylglycerol; ROS, reactive oxygen species; NOS, nitric 
oxide synthase.
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Slowly triggered excitotoxicity could be mediated by the activation of 
AMPA/Kainate receptors and account for the damage occurring in transient global 
ischaemia (Lee et a l, 2000). Non-NMDA receptor mediated excitotoxicity has been 
proposed to contribute to neuronal loss in a broad range of neurodegenerative 
conditions such as hypoxia, hypoglycaemia, ischaemia, epilepsy, trauma, amyotrophic 
lateral sclerosis, Huntington’s Disease and Alzheimer’s Disease (Choi, 1988; Choi,
1989). A plethora of experimental treatment strategies, many of which involve the 
blockade of glutamate receptors, have so far failed or are ongoing in investigation in 
the effective treatment of stroke. The answer may not lie within one effective 
treatment but in combination with other therapies as in stroke (or some of the 
neuropathologies described above) excitotoxicity may not be the only mechanism of 
cellular damage.
1.1.5 Oligodendrocytes
The CNS comprises a complex network of glial cells; oligodendrocytes, 
astrocytes and microglia for example, which are ubiquitously expressed throughout 
the CNS and have very specific functional roles. Oligodendrocytes are responsible 
for the synthesis and maintenance of myelin in the CNS, where myelin is the compact, 
multilamellar, lipid-rich sheath that envelops axons. As a result of this membrane 
insulation, the rate of axonal conduction is maximised while energy and space 
demands within the CNS are minimised.
Oligodendrocyte progenitor cells (OPCs) arise from neuroepithelial precursors 
that line the lumen of the spinal cord and the ventricles of the brain, namely the
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subdomain of the ventral ventricular zones (Yu et a l, 1994). Oligodendrogenesis in 
the forebrain has not been as extensively studied as spinal cord OPC origins, however 
there are strong analogies to spinal cord oligodendrogenesis. It is suggested that 
OPCs here originate in the ventral forebrain and later migrate dorsally into the 
cerebral cortex. OPCs are observed approximately around mid to late gestation where 
they proliferate in CNS germinal zones, migrate to the developing white matter and 
further proliferate and differentiate into mature oligodendrocytes capable of foraiing 
elaborate myelin sheaths around neuronal axons. The different stages of cell lineage 
in vitro are defined by expression of specific cell surface receptors and responses to 
distinct growth factors and are outlined in Figure 1.16.
Protein trophic factors, such as platelet-derived growth factor (PDGF), insulin­
like growth factor 1 (IGF-1), basic fibroblast growth factor (bFGF), ciliary 
neurotrophic factor (CNTF) and neurotrophin-3 (NT-3), are required for OPC 
differentiation, proliferation and survival both in vivo and in vitro (Raff, 1989; Barres, 
1993a; Barres et a l, 1993b; Barres et a l, 1994b; Gard et a l, 1995;). PDGF is 
mitogenic for 0-2A progenitors and OPCs have been shown to express the PDGF 
receptor early on (E13 in rat; E7-E9 in chick) (Hall et a l, 1996). This factor is not 
only mitogenic for 0-2A cells but also plays a role in determining cell morphology by 
acting to keep these cells in a bipolar, migratory state (McKinnon et a l, 1993). Once 
OPCs start to differentiate into oligodendrocytes they rapidly loose PDGF receptors 
and so PDGF no longer has a mitogenic role (BaiTes et a l, 1993b). However, PDGF 
is considered to play a role in oligodendrocyte survival for pro- oligodendrocytes and 
oligodendrocytes but not for fully differentiated oligodendrocytes long term (up to 14 
days in vitro culture).
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Figure 1.16. Oligodendrocyte maturation occurs in a number of discrete stages
The sequential appearance of stage-specific antigens, cell morphology and major 
proliferative response are outlined. Cell surface markers/antigens; NG2 proteoglycan 
(NG2 chondroitin sulfate); A2B5 monoclonal antibody (recognises ganglioside 
antigens); 04  (04 giycolipid antigen); GalC (galactocerebroside); MBP (myelin basic 
protein); PLP (proteolipid protein). Protein trophic factors controlling cell 
proliferation and survival at specific lineage stages; platelet-derived growth factor 
(PDGF), basic fibroblast growth factor (bFGF), ciliary neurotrophic factor (CNTF) 
and neurotrophin-3 (NT-3). Adapted from Miller (1996) and Levine ei al. (2001).
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Oligodendrocyte lineage cells respond to FGF in a developmental stage-
specific way. bFGF is a mitogen for OPCs by preventing maturation into
oligodendrocytes (GalC^), but will however push 0-2A  cells from a bipolar state to a
non-migratoiy multipolar state (OPC stage) therefore displaying both stimulatory and
inhibitory roles for bFGF depending on cell lineage stage (Gard & Pfeiffer, 1990;
McKinnon et a l, 1993). It is also stated the bFGF up-regulates the PDGFa receptor
in early progenitor cells, therefore modulating the effect of PDGF, whereby when
PDGF and bFGF are used in culture of OPCs {in viti^o) the result is prolonged
proliferation and inhibition of differentiation (Bogler et a l, 1990). However, in vitro
OPCs will not divide indefinitely to these mitogens as they have an intrinsic clock that
limits their number of divisions to approximately eight. After this stage cells become
unresponsive to mitogens, withdraw from cell cycle and differentiate into
oligodendrocytes (Barres et al^ 1994a). IGF or insulin at high concentrations
promotes cell proliferation and survival in vitro and is considered to play an important
role in regulating oligodendrocyte development and synthesis of myelin in vivo
(Barres et a l, 1993b). The biological effects of IGF or insulin are mediated via type I
IGF receptors expressed in OPCs and GalC^ oligodendrocytes (McMorris & Dubois-
Dalcq, 1988). NT-3 in vivo is considered not to have a critical role in OPC
proliferation, however it is expressed by neurons neighbouring oligodendrocytes in
the CNS and oligodendrocytes fi"om rat brain have been shown to express TrkA and
TrkC, high affinity receptors for NT-3 (Barres et a l, 1994c). In vitro NT-3 promotes
survival of GalC*" oligodendrocytes and is also considered to be a potent mitogen for
OPCs. Moreover the cytokine CNTF in vitro and in vivo has also been attributed to
promoting cell survival of oligodendrocytes though not working alone. IGF (insulin),
NT-3 and CNTF alone only promote cell survival for approximately 3 days in culture,
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whereas if oligodendrocytes are cultured with each of the extracellular signals 
described survival is prolonged (Barres et a l, 1993b). In vivo, these soluble factors 
are considered to arise fiom neighbouring astroglial cells with bFGF and PDGF also 
being provided by neurons (Belachew et a l ,  1999). Oligodendrocyte differentiation 
is thought to depend on an intrinsic clock, briefly described above, whereby the 
number of divisions that occur at each lineage stage is restricted and is considered to 
be controlled by thyroid hormones such as thyroxine (T4) and triiodothyronine (T3). 
Although they are not required for survival, proliferation or differentiation of 
oligodendrocyte lineage cells, their function is in the timing of the cell and so 
promotes differentiation. In culture, oligodendrocytes in the presence of mitogens, 
such as PDGF and in the absence of T3 from the medium does not result in indefinite 
proliferation. Proliferation is extended but the cell will eventually stop dividing and 
differentiate (Barres et a l, 1994a).
Oligodendrocytes synthesise a diverse repertoire of membrane ion channels 
and neurotransmitter receptors and are detailed in Table 1.2. The physiological 
relevance of these receptors and ion channels in oligodendrocytes for some remains to 
an extent unknown, however the levels of expression change during development and 
therefore suggests involvement in regulation of proliferation, migration, 
differentiation and myelination (see review by Belachew et a l, 1999).
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Receptor/Ion channel OPC Pro­
oligodendrocyte
Mature
Oligodendrocyte
GABA + ± -
AMPA/kainate + ± ±
5 - H T 3 ± + +
Glycine + ± -
Nicotinic + ± -
Muscarinic (Mi) + + 4-
Dopamine ( D 3 ) + ± -
Ca^^VDCC(H&L) + - -
k V 4- + -
K i^r - ± 4-
Na+ (V A C.) + - -
p2-Adrenergic + + +
Substance P (NKl) 
Somatostatin
±
db
Table 1.2. Developmental regulation of neuroligand receptors and membrane 
channels in cultured oligodendroglia +: high expression; ±: intermediate 
expression; very low or absent expression; Ca^ "^  VDCC (H & L) = voltage-
dependent Ca^^ channels (high and low); IC^dr = delayed rectifier potassium channels; 
K ^r == inwardly rectifier potassium channels; Na^ (V.A.C.) = voltage-activated 
sodium currents (Belachew et a l, 1999).
OPCs have been shown to express functional AMPA (GluRl-4) and kainate 
(KAl, KA2, GIuR6-7) receptors (as illustrated in Table 1.3), but not NMDA receptors 
(Patneau et a l,  1994; Gallo et a l,  1994). Group I mGluRs have also been shown to 
be expressed in primary cortical OPC (Holtzclaw et a l,  1995).
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OPC in viti'o^ GalC^^/MBP^ 
cells in vitrc}^
White matter 
oligodendrocytes'^
GluRl -/+ - -
GluR2 + - -
GluRS + + +
GluR4 + + +
GluRS “ - nd
GluR6 + + +
GluR7 + + +
KAl + + +
KA2 + + +
Table 1.3. lonotropic glutamate receptor subunits in oligodendrocytes.
purified OPC cultures derived from rat cerebral cortex, purified cultures of 
differentiated oligodendrocytes obtained from rat optic nerve. % white matter tracts 
include corpus callosum, fornix, optic nerve and spinal cord, nd, not determined. 
Taken from Matute ei al. (2001).
Interestingly growth factors can also modulate expression of different 
glutamate channels. bFGF has been shown to up regulate levels of the AMPA 
receptor subunit GluR4 in OPCs (Gallo et at., 1994). Furthermore combined 
treatment of OPCs with bFGF and PDGF have resulted in an increase in the 
transcription levels of GluRl subunits (Chew et al., 1997).
The fact that oligodendrocytes present at many differentiated stages in the 
adult brain suggests other potential roles for these cells other than myelin synthesis 
and maintenance. Indeed Bergles et al. (2 0 0 0 ) reported the presence of OPC
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processes at the nodes of Ranvier and that vesicle-filled axon terminals make synaptic 
junctions with the processes of OPCs within the mammalian hippocampus and that 
stimulation of these excitatory axons elicited inward currents in OPCs that were 
mediated by AMPA receptors. These findings may link adult OPCs to influencing or 
responding to neuronal transmission and regulation of synaptic growth and plasticity. 
Activation of Ca^^-permeable AMPA receptors on OPCs could result in Ca^^ influx 
and regulate the motility of OPCs and their ability to extend and retract cellular 
processes. The retraction of OPC processes could allow for synaptic growth, whereas 
the extension of processes into the synaptic cleft might lead to synaptic silencing. 
Moreover expression of what was originally considered to be a surface antigen marker 
of OPCs, NG2 proteoglycan, has since been shown to have an inhibitory or repulsive 
role for neurite outgrowth (Dou & Levine, 1994).
1.1.5.1 Oligodendrocytes and CNS degeneration
Damage may occur to oligodendrocytes in a number of conditions including 
infections, exposure to toxins, injuiy, degeneration, or autoimmune disease and 
inflammation, some of which are outlined in Table 1.4.
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Autoimmune: Humoral or immune cell-mediated demyelination 
Multiple Sclerosis 
Neuromyelitis optica (Devices)
Parainfectious: Direct viral infection, viral-induced immune mechanism or
immunosuppression
Acute disseminated encephalomyelitis (ADEM)
Progressive multifocal leukoencephalopathy (PML)
Subacute sclerosing panencephalitis (SSPE)
Tropical spastic paraparesis 
Genetic Defects in Mvelin-Associated Proteins 
Pelizaeus-Merzbacher 
Vascular: Sequelae of hypoxia-ischemia and disturbances in cerebral vascular 
autoregulation
Periventricular Leukomalacia (PVL)
Metabolic: accumulation of toxic storage products in oligodendrocytes 
Adrenoleukodystrophy (ALD)
Metachromatic leukodystrophy 
Ki'abbe’s Disease 
Alexander’s Disease 
Canavan’s Disease
Table 1.4. White matter disorders associated with oligodendrocyte death (Back & 
Volpe, 1999)
Some of the most researched diseases are in multiple sclerosis (MS) and
Periventricular Leukomalacia. MS is an inflammatoiy relapsing or progressive
disease of the CNS that typically strikes young adults, and is characterised by focal
areas of myelin destruction associated with astroglial scar formation. These lesions
are scattered throughout the CNS with increased prevalence in optic nerves,
brainstem, spinal cord and periventricular white matter. Although it is considered that
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the immune system contributes mostly to the tissue damage, evidence is unclear 
whether this inflammatory response is a primary or secondary phenomenon 
contributing to lesion formation. Furthermore, which components of the immune 
response are mainly involved (e.g. CD4 cells, CDS cells, cytokines, adhesion 
molecules, chemokines, antibodies/complement, stress proteins, and 
macrophages/microglia), the target of the immune attack (myelin, oligodendrocyte or 
axon) and the specific pathogenetic mechanism responsible, autoimmune, viral or 
toxic, are still unknown. In vitro and in vivo data demonstrate that oligodendrocytes 
are liighly susceptible to damage by a variety of immune effector mechanisms, such 
as direct T-cell-mediated cytotoxicity, the Fas-Fas ligand pathway, T-cell products 
(perforin and lymphotoxin), products of activated macrophages (cytokines, reactive 
oxygen species and nitric oxide) serum components (antibodies, complement and 
plasmin), viral infection and heat shock proteins (Bo et a l, 1994; Tsuchida et al, 
1994; Cannella & Raine, 1995). Interestingly recent work using an animal-induced 
model of MS, experimental autoimmune encephalomyelitis (EAE), suggests that as a 
result of activation of the immune response, there is an alteration in glutamate 
homeostasis leading potentially to oligodendrocyte excitotoxicity and axonal damage 
(Werner e/a/., 2001).
Periventricular Leukomalacia, defined as hypoxic-ischaemic damage to 
cerebral white matter, occurs during brain development between 23 and 32 weeks 
gestation and is the most common foim of brain injuiy in premature infants and 
results in cerebral palsy in 5-15% of survivors. Periventricular Leukomalacia is 
characterised by an initial coagulating necrosis involving damage to axons and glia, 
especially ohgodendrocytes, whereby oligodendrocyte death is particularly marked 
and leads to hypomyelination. It is this loss that leads to the secondary loss of axonal
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connections and myelination in the white matter that is considered to result hi the 
motor deficits that characterise cerebral palsy (Volpe, 2000). Immaturity of the 
cerebral blood supply and a propensity for impaired autoregulation are the major 
vascular factors related to susceptibility of the periventricular region to ischaemia 
(Volpe, 1998). MS and Periventricular Leukomalacia and their relation to the aims of 
the proposed PhD research are discussed in more detail in section “oligodendrocytes 
and excitotoxicity: research aims”.
Presently research is striving to understand the basic functions of 
oligodendrocytes not only in development and CNS functioning, but also in 
diseased/stressed states and within this opens up therapeutic research for the 
prevention and treatment of oligodendrocyte damage such as pharmacological and 
stem cell intervention. An interesting point to note for future research is witliin the 
regeneration field and the problems of once the damage has occuiTed and how can it 
be repaired?
1.1.6 Oligodendrocytes and Excitotoxicitv; Chapter 1 Research Aims
Oligodendrocytes play an important role in certain diseases such as multiple 
sclerosis (MS) and Periventricular Leukomalacia, and also appear to be susceptible to 
damage under ischaemic or toxic conditions, such as stroke and spinal cord injury. In 
the case of CNS trauma, an emerging candidate to induce oligodendrocyte damage is 
excitotoxicity, an event already confirmed to occur in neurones during toxic insults. 
Recent data suggest that mature (GalC^) oligodendrocytes are susceptible to toxic 
insults via activation of AMPA/kainate receptors (McDonald ei al., 1998a) and optic
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nerve OPCs, also GalC^, appear to suffer the same vulnerability (Matute, 1997). 
Indeed with Periventricular Leukomalacia the mechanism of perinatal white matter 
injury involved is maturation dependent-vulnerability in the oligodendrocyte lineage, 
whereby OPCs (A2B5^ and 04^) are more susceptible to damage than mature 
oligodendrocytes (Miller, 1996; Fern and Moller 2000; Back et a l, 2002). Moreover 
in MS, recent evidence suggests that some of the pathological changes that occur may 
be the result of excitotoxicity. Glutamate concentrations in the cerebral spinal fluid of 
acute MS patients are reported to be elevated to approximately 3.3±0.3pM compared 
to 1.3+0. IpM  in control patients (Stover et a l, 1997). Furthermore in EAE, 
glutamate-metabolising eii2ymes, glutamine synthetase and glutamate dehydrogenase, 
are down regulated in astrocytes (Hardin-Pouzet et a l, 1997) and the glutamate 
transporters GLT-1 and GLAST (glial transporters) are also down regulated in the 
spinal cord at the peak of disease (Ohgoh et a l, 2002) and could therefore explain the 
increased glutamate levels obseiwed. Additionally it has also been demonstrated that 
amelioration of EAE occurs as a result of administration of AMPA-type glutamate 
receptor antagonists by either subcutaneous injections of 4.46mM NBQX over 7-10 
days in adult female mice or intraperitoneal injections of 30mg/kg NBQX for 7 days 
in adult rats (Pitt et a l, 2000; Smith et a l, 2000). The research undertaken in this 
chapter therefore, aims to determine whether primary rat cerebrocoitical OPCs are 
also vulnerable to excitotoxic insults.
Presently the role of mGluRs in neurodegenerative disorders are unclear as 
both mGluR agonists and antagonists have been found to be protective in models of 
excitotoxicity. Drugs which reduced damage in some models, actually increased 
neurodegeneration in other models of study (Henrich-Noack et a l, 2 0 0 1 ). These 
findings have probably been due in part to the lack of selective compounds for mGluR
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subtypes in earlier experiments. The role of mGluR activation during OPC 
excitotoxicity has not been established and therefore the present study aims to 
determine vyhether mGluR co-activation offers neuroprotection against kainate- 
induced OPC toxicity.
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1.2 Methods
1.2.1 Reagents 
Cell Culture
Cell culture reagents were purchased from Invitrogen (Gibco Life 
Technologies,XJK), except platelet-derived-growth factor-AA (PDGF-AA) and basic 
fibroblast growth factor (bFGF) which were purchased from Becton-Dickinson and 
Promega (UK). Papain and ovomucoid were obtained from Roche (East Sussex, UK). 
All other chemical constituents for cell culture were supplied by Sigma.
Indirect Immunofluorescence
Anti-A2B5 and anti-GalC monoclonal antibodies were obtained from Roche 
(East Sussex, UK). Mouse anti-oligodendrocyte marker 04  antibody was purchased 
from Chemicon International. Anti-mouse-FITC conjugated secondary antibody was 
from Amersham-Pharmacia (Buckinghamshire, UK) for anti-A2B5 and anti-GalC 
detection whereas for anti-04 antibody detection, anti-mouse-FITC conjugated rabbit 
secondary antibody was obtained from DakoCytomation Ltd (UK). Goat Semm and 
Vector-Shield mounting medium with DAPI were purchased from Vector 
Laboratories Inc. (Burlingame, CA).
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Cell Viability
(S)“AMPA (stock lOmM, dissolved in milliQ water), cyclothiazide (lOOmM 
stock in 100% DMSO), DCG-IV (lOmM stock in milliQ water), (S)-DHPG (lOOmM 
stock in milliQ water), L-glutamate (lOOmM stock in Ix PBS), (S)-5-iodowillardiine 
(25mM stock in equimolar NaOH), kainate (lOOmM stock in equimolar NaOH), L- 
AP4 (lOOmM stock in equimolar NaOH), (S)-MCPG (lOOniM stock in equimolar 
NaOH), (2S, 4R)-4-methylglutamate (SYM 2081)(100mM stock in equimolar NaOH) 
and NMDA (lOOmM stock in equimolar NaOH) were purchased from Tocris 
Cookson (Bristol, U.K.). GYKI 52466 (stock lOmM, dissolved in 100% DMSO) was 
from RBI (MA, USA). PBS was purchased from Oxoid (UK) and HEPES was 
supplied by Calbiochem (San Diego, CA ). Evans Blue (lOmM stock in MilliQ grade 
water), fluorescein diacetate (stock 5mg ml’  ^ in acetone), propidium iodide (stock 
Img 5ml'^) and all other reagents and chemicals were obtained flom Sigma.
1.2.2 Cell Culture
Primary Cell Culture
Primary cultures of mixed glial cells were prepared flom 2-3 day old Wistar 
rat cerebral cortices according to the method described by McCarthy & de Vellis 
(1980). Freshly dissected cortices were freed of the meninges in MEM supplemented 
with HEPES buffer (lOmM) and cross-chopped with a razor blade. Tissue was 
incubated in protease digest (MEM/HEPES buffer supplemented with papain (300U 
ml'^), deoxyribonuclease 1 (DNase 1, 0.004% ^ \)  and L-cysteine (83 pM)) for 75
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minutes at 37°C. Incubation was terminated by addition of 3ml papain inhibitor 
solution (L-15 Leibovitz medium containing ovomucoid (l,54mg mf^), BSA (0.77mg 
mf^) and DNase 1 (0.01% % ) . A single cell suspension was achieved by mechanical 
dissociation (21-, 23- and 25-gauge needles, 2-4 strokes each). Cells were then 
centrifuged (700rpm, 5mins) and re-suspended in DMEM (4.5g/litre 
glucose/1 lOmg/litre sodium pyruvate) supplemented with 10% fetal calf serum, L- 
glutamine (2mM) and gentamicin (2pg ml‘ )^. Cells were subsequently seeded into 
T80cm^ flasks and maintained for 10 days at 37°C/5% CO2/ 95% humidified air. 
Medium was changed every 3 days.
Oligodendrocyte progenitor cell culture
Secondary cultures of purified OPCs were prepared from the primary cell 
culture flasks after 9-11 days. Loosely attached microglia were removed by 
mechanical shaking of the culture flasks for 1 hour at 200rpm/37°C using a rotary 
shaker (New Brunswick Scientific). After this duration, supernatant was removed and 
replaced with fi esh primary culture medium, as described earlier. Flasks were shaken 
for a further 18 hours at 230rpm/37°C. Supernatant was removed, passed through a 
40pm nylon filter and plated onto a T80cm^ flask for 2 0  minutes at 37°C/5% CO2/ 
95% humidified air. Subsequently the supernatant was collected and passed through 
an 1 1 pm nylon mesh and centrifliged at 1 2 0 0 rpm for 5 minutes. Cells were re­
suspended in chemically-defined growth DMEM supplemented with L-glutamine 
(2mM); bovine pancreatic insulin (5pg ml'^); gentamicin (25pg mf^); BSA (lOOpg
ml‘ )^; human apo-transfenin (lOOpg ml'^); putrescine (16pg ml‘ )^; sodium selenite
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(62.5ng progesterone (40ng L-thyroxine (80ng 3,3’, 5-triiodo-L-
thyronine (80ng basic fibroblast growth factor (bFGF, lOng ml'^) and platelet- 
derived growth factor-AA (PDGF-AA, lOng mf^). Cells were seeded onto poly-D- 
lysine (lOpg mf^) coated Nunc culture plates or glass cover slips (for indirect 
immunofluorescence and Hoechst stain) at a density of 25,000 cells welf^ for 24-well 
plates or 15,000 cells welf^ for 96-well plates unless otherwise stated. Cultures were 
maintained at 37°C/ 5% COg/ 95% humidified air, fresh medium was added eveiy 2-3 
days. For all experiments cells were used at 14-16DIV.
Pofy-D-fysine coating
In order for OPCs to attach to culture plates, plates were pre-coated in poly-D- 
lysine. Poly-D-lysine (lOpg mf^) was added to each well of the culture plate for at 
least 40 minutes. After this duration plates were washed twice with PBS. Culture 
plates were stored overnight at 2-8°C. On day of use plates were at room temperature 
for cell seeding.
Coverslip preparation
13 mm cover slips (BDH) were prepared by incubating cover slips in 70% 
ethanol for at least 24-hours at room temperature. Coverslips were washed twice in 
sterile milliQ water, transfeiTed to 24-well tissue culture plates and pre-coated with 
poly-D-lysine as described above.
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1.2.3 Determination of cell lineage bv indirect immunofluorescence
OPC identity was confirmed via indirect immunofluorescence using the 
monoclonal anti-A2B5 antibody, anti-04 antibody and also anti-Gal-C antibody. 
Cells (on cover slips) were washed twice with PBS and fixed in 4% formaldehyde for 
1 0  minutes at room temperature. Cells were further washed with PBS and then 
blocked with 1 0 % goat semm for 1 hour. Cells were then incubated with anti-A2B5 
(lOpg ml'  ^ and Ipg ml" )^, anti-04 (lOpg ml'  ^ and 20pg ml'^) or anti-Gal C (lOpg ml'  ^
and Ipg ml'^) antibody for 1 hour at 37°C. Afi;er this duration cells were washed with 
PBS (3 times, 120pl) and exposed to an anti-mouse-FITC conjugated secondary 
antibody (1/20 or 1/50 dilution) for a further hour at 37°C. Following several PBS 
washes and a single milliQ wash, OPCs were mounted in Vectorshield ( 8  pi) and 
visualised with a Zeiss Axiovert 135 TV fluorescence microscope.
1.2.4 Determination of cell viability
In all experiments, cells were used between 14-16 days in vitro and all 
compound dilutions were in PBS. Cells were dosed for 6  or 24-hours in duplicate. 
Antagonists and/or modulators were added 5 minutes prior to excitatory amino acid 
exposure. Chemically defined media containing various agonists and/or antagonists 
was aspirated and replaced with BBSS (llOmM NaCl; 5.4mM KCl; 810pM 
MgS0 4 .7 H2 0 ; 44mM NaHCOs; 25mM glucose; 900pM NaH2P 0 4 .2 H2 0 ; lOmM 
HEPES and l.BmM CaCl2, pH 7.4). BBSS was aspirated from well and replaced with 
fluorescein diacetate (60pg/ml in PBS) propidium iodide (20pg/ml in PBS) mix and 
was incubated at room temperature for 3 minutes (Jones & Sneft, 1985). Cell counts
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(living vs. dead cells) were then taken using a 2 0 x objective on a Zeiss Axiovert 135 
TV fluorescence microscope from 2 random fields of view per well.
1.2.5 Statistical Analysis
Concentration-response cui*ves were generated by non-linear regression 
analysis (GraphPad Prism, v3.03) and data are expressed as the mean (± S.E.M.) of 
percentage control cell viability (GraphPad Prism, v3.03). Statistical significance was 
determined by comparing the raw data means versus raw data control means with 
either one-way analysis of variance (ANOVA, Dunnett or Tukey-Kramer post test) or 
Student’s two-tailed paired /-test, where appropriate (GraphPad Instat, v.3.01). * = 
p<0.05, ** = p<0.01, *** = p<0.001 versus respective controls. Values of p<0.05 
were considered statistically significant.
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1.3 Results
1.3.1 Confirmation of OPC identity with indirect immunofluorescence
Indirect immunofluorescence experiments resulted in A2B5 positive cells (Figure 
1.17a), which confirmed that the cell type used in all experiments were in fact OPCs. 
A small percentage (<5%) of cells were 04  positive (Figure 1.18). Control 
experiments, using secondary antibody only (anti-mouse-FITC conjugate), did not 
show any detectable staining (Figure 1.17b).
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Figure 1.17a. A2B5+ Oligodendrocyte Progenitor Cells at 15DIV.
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Figure 1.17b. Control picture of oligodendrocyte progenitors cells at 15DIV stained 
with anti-mouse FITC conjugated secondary antibody only.
Figure 1.18. 04+ Oligodendrocyte Progenitor Cells at 15 DIV.
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1.3.2 lonotropic glutamate receptor pharmacology
1.3.2,1 Effect o f excitatory amino acid exposure on OPC viability after 24-hour 
exposure
Primary oligodendrocyte progenitor ceils were treated for 24 hours with specific 
glutamate receptor agonists. As illustrated in Figure 1.19, two ionotropic glutamate 
receptor agonists were found to induce OPC death: kainate (pECso = 3.9 ± 0.3) and 
(S)-5-iodowillardiine (pECso = 4.9 ± 0.2) respectively.
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Figure 1.19. Concentration-response curves showing effects of glutamate receptor 
agonists on cultured rat OPC viability after 24-hour exposure. (O) kainate, ( ♦ )  (S)- 
AMPA, (V ) L-Glutamate, (■ ) ( S )-5 -iodowillardiine, (A) (2S,4R)-4-
methylglutamate (SYM 2081). Each data point (+S.E.M.) represents the mean of at 
least four experiments.
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The reportedly selective GluR5-6 subunit agonist, (2S, 4R)-4-methylglutamate, failed 
to elicit a sigmoidal dose-response curve. It did however decrease cell viability, at a 
dose of ImM, to 62.9+ 9.6% (n=3). (S)-AMPA and L-glutamate failed to 
significantly influence cell viability in OPCs (Table 1.5.). NMDA also failed to 
decrease cell viability (Table 1.5 and Figure 1.20).
Glutamate Receptor Agonist % Control Cell Viability at IniM 11 pECso
(S)-AMPA 86.0 + 3.1% 4 -
L-Glutamate 95.2 + 0.9% 4 -
(S)-5 -Iodowillardiine 40.7 + 4.5% 4 4.9+  0.2
Kainate 64.2 + 8.5% 5 3.9+  0.3
(2S, 4R)-4-methylglutamate 61.6 + 7.0% 3 -
NMDA 92.8+4.0% 3 -
Table 1.5. Percentage control OPC viability after 24-hour excitatory amino acid 
exposure. Data represents the mean +S.E.M.
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Figure 1.20. Lack of effect of NMDA on OPC viability after 24-hours exposure. 
Each data point (±S.E.M.) represents the mean of three experiments. One-way 
ANOVA (Dunnett post-test versus control).
1.3.2.2 Effect o f cyclothiazide on OPC viability after 24-hour exposure
Cyclothiazide (CTZ, a selective AMP A receptor desensitisation blocker) (Partin et a i, 
1993) was used to determine whether the inability of (S)-AMPA and L-glutamate to 
cause cell death was due to AMPA receptor desensitisation. Cells were exposed to 
CTZ in the presence of excitatory amino acids for 24 hours. As illustrated in Figure 
1.21, in the presence of lOOpM CTZ, both lOOpM (S)-AMPA and ImM L-glutamate 
elicited significant cell death (65.2+9.3%, n=4, p<0 01 and 57.8+6.4%, n=4, p<0.01.
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respectively). When tested alone, lOOpM CTZ failed to influence OPC viability 
(n=4) and this was also the case for the CTZ vehicle, DMSO (at 0.1% % final). 
Kainate (300pM), a non-desensitising agonist at the AMPA receptor, did not cause 
increased cell death in the presence of CTZ when compared to kainate alone.
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Figure 1.21. Effect of glutamate receptor agonists in the presence of cyclothiazide 
(CTZ) on OPC viability after 24-hour exposure. Data represent the mean (+S.E.M.) 
of four experiments. * P<0.05 versus respective controls (one-way ANOVA (Tukey- 
Kramer multiple comparisons test)).
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1.3.2.3 Potential inhibition o f OPC death by selective AMPA receptor antagonists
The aim of the following experiments was to determine if OPC death was due to 
AMPA receptor activation. OPCs were exposed to either the selective non­
competitive AMPA receptor antagonist GYKI 52466 or the putative AMPA receptor 
antagonist Evans Blue for 24 hours. GYKI 52466 (50pM) (Zorumski et al., 1993) 
significantly (p<0.001 and p<0.01) reversed both 300pM kainate and lOOpM (S)- 
AMPA/ 1 OOpM cyclothiazide-induced OPC death as illustrated in Figure 1.22a.
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Figure 1.22a. Effect of GYKI 52466 (50pM) on OPC viability after 24-hour 
excitatory amino acid exposure. Data represents the mean (±S.E.M.) of four 
experiments. ** P<0.01 and *** P<0.001 versus respective controls (one-way 
ANOVA (Tukey-Kramer multiple comparisons test)).
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0.5% DMSO (vehicle for SOjiM for GYKI 52466) failed to influence control cell 
viability, alone and in the presence of 300pM kainate. Also the putative AMPA 
receptor antagonist, Evans Blue at all concentrations tested (5, 10 and 30pM, Figure 
1.22b) significantly reversed 300pM kainate-induced OPC death.
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Figure 1.22b. Effect of Evans Blue on OPC viability after 24-hour kainate exposure. 
Data represents the mean (+S.E.M.) of at least four experiments. *** P<0.001 versus 
respective controls (one-way ANOVA (Tukey-Kramer multiple comparisons test)).
63
1.3.3 Potential metabotrooic glutamate receptor activity in cultured rat OPC
1.3.3.1 Effect of metabotropic glutamate receptor agonists on OPC viability
OPCs are reported to express group I metabotropic receptors (Holzwarth et a l, 1994), 
and in neuronal cell cultures they are considered to show neuroprotective properties 
(Pizzi et a l, 1993). The following experiments determined whether co-activation of 
group I niGluRs with kainate (300pM) influenced cell viability. As illustrated in 
Figures 1.23a and 1.23b, (S)-DHPG (ImM), DCGIV (lOpM) and L-AP4 (ImM) 
failed to significantly influence OPC viability after 24 hours alone or in the presence 
of 300pM kainate.
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Figure 1.23a. Lack of effect of metabotropic glutamate receptor agonists on OPC 
viability (24-hour exposure). Data represent the mean (+S.E.M.) o f six experiments. 
One-way ANOVA (Dunnett post-test versus control).
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Figure 1,23b. Lack of effect of metabotropic glutamate receptor agonists on OPC 
viability after 24-hour kainate exposure. Data represent the mean (+S.E.M.) of four 
experiments. One-way ANOVA (Dunnett post-test versus 300gM kainate).
However, in the presence of 300pM kainate, in a 6 hour study, lOOpM (S)-DHPG 
significantly (p<0.05) protected against kainate-induced toxicity by approximately 
18% (Figure 1.23c), as did ImM (S)-DHPG. DCGIV and L-AP4 did not protect OPC 
against kainate-induced death
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Figure 1.23c. Effect of metabotropic glutamate receptor agonists on OPC viability 
after 6-hour kainate exposure. Data represent the mean (±S.E.M.) of at least four 
experiments. * P<0.05 versus kainate (SOOpM) control (one-way ANOVA (Dunnett 
post-test)).
1.3,3,2 Determination o f group 1 mGluR involvement in kainate-induced toxicity 
in OPCs after 6-hour exposure
The involvement of group I mGlu receptor activation was confirmed in tliis 
experiment. (S)-MCPG, a selective mGluR antagonist, significantly (p<0.05) 
reversed the effects of (S)-DHPG protection on kainate-induced 6-hour toxicity in
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OPC cultures (Figure 1.24). (S)-DHPG and (S)-DHPG + (S)-MCPG failed to 
significantly influence cell viability.
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Figure 1.24. Effect of (S)-MCPG in presence of (S)-DHPG on OPC viability after 6- 
hour kainate exposure. Data represents the mean (+S.E.M.) of six experiments. * 
P<0.05 versus kainate (300pM) + lOOpM (S)-DHPG (Student’s paired /-test).
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1.4 Discussion
The aim of this study was to determine whether rat cultured oligodendrocyte 
progenitor cells were susceptible to excitotoxic insults.
Immunofluorescence staining with monoclonal anti-A2B5 antibody confirmed 
that the cell population consisted of predominantly oligodendrocyte progenitor cells 
(OPCs) with a small percentage of cells expressing the surface antigen 04.
Excitatory amino acid exposure for 24-hours resulted in the following rank 
order of toxin potency, (S)-5-iodowillardiine> kainate> (2S, 4R)-4-methylglutamate> 
(S)-AMPA. (S)-5-iodowillardiine is putatively selective for GluR5 (kainate receptor 
subunit, Jane et a l, 1997) with an E C 5 0  value of 83 pM in HEK 293 cells expressing 
homomeric GluRS subunits (Swanson et a l, 1998). In native mixed receptor 
populations however, (S)-5-iodowillardiine is considered to be a more useful tool in 
discriminating between AMPA and kainate receptor populations, even more so than 
between kainate receptor populations, with a reported E C 5 0  value of 0 .14pM in dorsal 
root ganglia (kainate receptor mediated (GluR5/KA2 receptor populations)) and 
19pM in liippocampal neurones (AMPA receptor mediated (Wong et a l, 1994)). 
Indeed Moldrich et at. (1999) also showed that cultured cortical neurones are subject 
to AMPA receptor-mediated death by (S)-5-iodowillardine ( E C 5 0  = 9pM). The 
present study generated an E C 5 0  value of 18.5pM in response to (S)-5-iodowillardiine, 
which suggested potential activation of AMPA receptors.
(2S,4R)-4-Methylglutamate (SYM2081) shows selectivity for the low-affinity 
kainate receptor subunits GluRS and GluR6 with a kainate-receptor mediated E C 5 0  
value of lln M  in dorsal root ganglia (Jones et a l, 1997). In the present study 
SYM2081 decreased OPC viability to 61% at a concentration of ImM. Zhou et a l
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(1997) reported in neocortical neurones activation of AMPA receptors with SYM2081 
with an EC50 value of 325pM. It is therefore unlikely that kainate receptors mediate 
OPC death in the present study.
Kainate also elicited OPC death in the current study (EC50 = 117pM). EC50 
values generated in native kainate receptor populations (dorsal root ganglia) are in the 
range of 6-22pM. Whereas EC50 values to kainate for native AMPA receptors 
(cortical and hippocampal neurons) are in the range of 64-1 ôOpM (Heuttner, 1990; 
Wilding & Heuttner, 1996; Clarke et al., 1997; Moldrich et a l, 1999). McDonald et 
a l  (1998a) using cerebrocortical oligodendrocyte-astrocyte co-cultures, showed that 
oligodendrocyte lineage cells were vulnerable to kainate-induced insults, with NG-2 
positive cells (0-2A progenitor cells) displaying an EC50 value of approximately 
lOOpM and whereas 04 positive cells (immature oligodendrocytes) displayed an EC50 
value of approximately 40pM. Interestingly, Sânchez-Gômez and Matute (1999) in 
rat optic nerve oligodendrocyte cultures (majority GalC^) reported that kainate- 
induced toxicity produced a bi-phasic concentration response curve, which indicated 
activation of low- and high-affinity kainate receptors with EC50 values of 0.6pM and 
590pM respectively as well as activation of AMPA receptors. Since no bi-phasic 
curve was observed in the present study, it is likely that the response observed is 
entirely due to AMPA receptor activation. In the presence of cyclothiazide (lOOpM, 
CTZ), which selectively prevents AMPA receptor desensitisation (Partin et a l, 1993), 
(S)-AMPA and L-glutamate significantly (p<0.01) decreased cell viability in this 
study, whereas alone, (S)-AMPA and L-glutamate failed to significantly induce cell 
death. In the present study CTZ (lOOpM) alone failed to influence cell viability, 
indicating that there was no glutamate (potentially released from contaminating 
astrocytes or indeed from the OPCs themselves) in the surrounding media.
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In order to prove AMPA receptor activation during excitotoxic insult the non­
competitive AMPA-receptor selective antagonist GYKI 52466 was employed 
(Zorumski et al., 1993). GYKI 52466 (50pM) attenuated kainate- (300pM) and 
lOOpM (S)-AMPA/100|nM CTZ-induced cell death. Therefore it could be concluded 
that the excitotoxic insult was via AMPA-receptor activation. The AMPA-receptor 
antagonist Evans Blue (lOpM) also indicated AMPA-receptor activation by inhibiting 
300pM kainate toxic insult. Sânchez-Gômez & Matute (1999) in optic nerve GalC^ 
oligodendrocytes have also described AMPA receptor-mediated excitotoxicity. In 
this study this group showed AMPA and kainate-induced cell death with was 
prevented by GYKI 53655 (lOOpM) and CNQX (30pM). Interestingly they also 
showed glutamate in the presence of Concanavalin A, to prevent kainate receptor 
desensitisation (Huettner, 1990), also caused approximately 30% cell death, wliich 
was attenuated in the presence of CNQX. These findings though not conclusive, 
indicate a possible role for kainate-receptor mediated excitotoxicity. Moreover 
AMPA-receptor mediated excitotoxicity has also been described by the following 
research groups, Yoshioka et al. (1996) and Yamaya et al. (2002) in the 
“oligodendroglial-like” cell line CG-4 cells, McDonald et al. (1998a) in rat forebrain 
GalC^ oligodendrocytes and Kavanaugh et al. (2000) in rat forebrain oligodendroglial 
lineage cells. A recent study by Deng et al. (2003) demonstrated that OPCs derived 
from rat forebrain during oxygen-glucose deprivation (in a model for studying 
Periventricular Leukomalacia) are more susceptible to AMPA/kainate receptor 
mediated cell death than mature oligodendrocytes. They suggested that this finding 
was due to the fact that immature oligodendrocytes are significantly more vulnerable 
to oxygen-glucose deprivation due in part to developmental lack o f antioxidant 
enzymes, over-expression of non-NMDA glutamate receptors and a transiently
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increased Ca^  ^ signalling during oligodendrocyte development. Moreover in an 
earlier study by the same research group, Follett et al. (2000), reported that 
developing rat oligodendrocytes in vivo show an up-regulation of glutamate receptors 
during the same time in which premature infants are susceptible to Periventricular 
Leukomalacia.
NMDA did not influence cell viability in OPC in the present study, which is in 
agreement with Patneau et al. (1994) and Gallo (1994), in which they reported that 
oligodendrocytes do not express functional NMDA receptors.
Therefore the next question to be asked is what is the physiological relevance 
of the above results, since L-glutamate, the native ligand to glutamate receptors, did 
not cause significant cell death in the OPC cultures. The levels of cystine found in the 
chemically defined media can possibly explain this finding. It is considered that there 
are glutamate/cystine transporters located on neuronal/glial cells, and that the normal 
function of these transporters is to take up cystine in exchange for intracellular 
glutamate. However with glutamate toxicity in immature neurones or OPCs, reversal 
of the transporter takes place and cystine is released. Intracellularly, cystine is 
reduced to cysteine, wliich in-tum acts as a precursor for glutathione and this protects 
cells from oxidative stress (Murphy et a l, 1989). Therefore glutamate toxicity may 
result in glutathione depletion and cellular vulnerability to toxic free radicals. Oka et 
a l  (1993) showed 200pM cystine fully protected oligodendrocytes (majority GalCQ 
from 2mM glutamate by inhibiting glutamate/cystine antiporter reversal. In vivo 
studies suggest that the concentrations of cystine located in the brain (specifically 
located witliin the synapse) were of the magnitude of l-SOpM respectively (Perry, 
1975). The culture media in these studies (standard DMEM) contains 200pM cystine 
and therefore it is improbable that glutamate alone would cause cell death.
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Another important question to ask is whether it is possible that the observed 
glutamate receptor expression and excitotoxic vulnerability of oligodendrocytes, 
shown in the present and other related studies, are features possibly unique to in vitro 
culture modules. McDonald et a l  (1998a), showed that in vivo stereotaxic co­
injection of (S)-AMPA (20nmol) in the presence of 5nmol MK-801 (to block 
secondary neuronal NMDA receptor activation) into adult rat brain resulted in 
substantial oligodendrocyte death (-60% reduction 24-hours after injection). 
Interestingly, a similar injection of 20nmol NMDA caused loss o f overlying cortical 
neurones, but little oligodendrocyte death, indicating that glutamate-induced 
oligodendrocyte excitotoxicity is not mediated via NMDA receptors. Moreover 
Follett et a l  (2000) in developing white matter of rat pups at postnatal day 7, and 
Tekkok & Goldberg (2001) in adult mice cerebral white matter demonstrated that 
excitotoxic injury, following oxygen and glucose deprivation, was prevented by the 
AMPA/kainate receptor selective antagonist NBQX.
The role of group I mGlu receptors in neurodegeneration/ neuroprotection 
remains confusing (Henrich-Noack et a l, 2001). Whilst some studies indicate that 
group I mGluR activation potentiates the neurodegenerative effects of NMDA- and 
AMPA-receptor mediated effects (Bruno et a l, 1995; Pisani et a l, 1997), emerging 
evidence now speculates that in different experimental models group I mGlu receptors 
may also offer neuroprotection (Orlando et a l, 1995; Strasser et a l, 1998; Bruno et 
al, 2001). For example in mixed murine cortical cultures, group I mGluRs enhanced 
neuronal cell death (Bruno et a l, 1995), whilst in cultured cerebellar granule cells, 
group I mGluR agonists protected against excitotoxic damage (Pizzi et a l, 1993), In 
the present study, mGluR agonists alone had no effect on cell viability after 24-hour 
exposure. Moreover, in the presence of kainate (300pM, 24-hour), mGluR agonists
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failed to influence on OPC viability. However (S)-DHPG at concentrations of lOOpM 
and ImM offered significant (p<0.05) protection from 300pM kainate toxicity over a 
6-hour exposure. This effect was due to group I mGlu receptor activation evidenced 
by inhibition by the selective metabotropic glutamate receptor antagonist (S)-MCPG. 
Holzwarth et al. (1994) in mixed glial cells cultures demonstrated that application of 
the mGluR agonist ACPD produced a [Ca^^]i response and indicated the presence of 
functional group I mGluRs. Moreover, recent work by Luyt et al. (2003) on the 
expression of functional metabotropic glutamate receptors in oligodendrocyte 
progenitor cells, demonstrated the expression of mGluRSa and mGluRS receptors in 
homogenous populations of 04^ and 01^ rat CG-4 OPCs. They also demonstrated 
via immunocytochemistry, the presence of mGluRS of receptor populations in the 
periventricular wliite matter of postnatal day 4 and 7 rat pups. In the same study they 
also observed the presence of functional Group 1 and Group IH mGluR receptors. 
Application of (S)-DHPG to fura-2 loaded CG-4 cells showed an increase in [Ca^']j, 
an event mediated by activation of mGluR5 and the subsequent Ca^’*' release from the 
endoplasmic reticulum. The present study is the first to show group I inGluR 
protection against excitotoxicity in cultured rat OPC, however the mechanisms for the 
protection offered by group I agonists in this study and the other studies mentioned 
above remains to be elucidated.
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Chapter 2
Excitotoxic OPC Death
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2.1 Excitotoxic OPC Death, a feature of Necrosis vs. Apoptosis
It is established that durmg excitotoxic cell death, rapid Ca^^ influx occurs via 
glutamate receptor activation and stimulates intracellular pathways and enzymes, 
ultimately resulting in cell death. The type of cell death incurred by glutamate 
receptor over-activation, i.e. necrosis vs. apoptosis in OPC cultures remains to be 
established. The characteristic features of these two methods of death are described in 
table 2.1.
Apoptosis is an important form of cell death characterised by a series of 
distinct morphological and biochemical alterations, as listed in table 2.1, suggesting 
the presence o f common execution machinery in different cells. Necrotic cell death 
also displays morphological and biochemical characteristics and are summarised in 
table 2.1. It should be noted that there is much overlap between these two forms of 
cell death and it has been reported that a cell committed to apoptosis can be pushed 
towards necrotic cell death when energy levels are depleted (Schwartz ef. a l, 1993). 
At present it seems that the main feature associated with necrotic death is that of 
energy depletion. Apoptotic cell death requires ATP for the activation of certain 
effector substrates, such as the formation of the apoptosome, a multi-protein complex 
wliich consists of cytochrome c, apoptosis activating factor-1 (Apaf-1), ATP and 
procaspase-9 and activates caspase 9, an upstream initiator of apoptosis (Kass et a i, 
1996; Li et a l, 1997; Nicotera et a l, 1999). Without this the cell cannot execute the 
apoptotic pathway
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Necrosis
Passive cell swelling 
Energy loss
Intense mitochondrial damage 
Cell lysis
Release of intracellular constituents 
Activation of inflammatory response 
Possibility of internucleosomal DNA 
fragmentation
TUNEL-negative (except some necrotic 
neurons -  which stain positive)
Apoptosis
Cell and nuclear shrinkage 
Condensation of cliromatin 
DNA fragmentation
Preservation of membrane & organelle 
stmcture
Cell auto-digested by proteases 
Cell debris cleared by phagocytosis 
No inflammatory response 
TUNEL-positive
Table 2.1. Common features associated with necrotic and apoptotic states. It should 
be noted that some over-lapping of characteristics can occur between the two modes 
of death. TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine 
triphosphate (dUTP) nick end-labelling.
2.1.1 Caspases
Apoptosis describes a form programmed cell death, and caspases are one of 
the main effectors of tliis process. Tliis family of cysteine aspartyl proteases, which 
numbers 14 (12 of which are expressed in human), and are named caspase-1 through 
to caspase-14, possess the ability to specifically cleave an aspartic acid residue 
located on the N-terminal side of the substrate cleavage site (Yuan et a l, 1993, Love, 
2003). Caspases are normally expressed as proenzymes that contain three domains, 
an N-terminal prodomain together with one large subunit of approximately 17-20kDa 
(p i7 to p20) and a small subunit C-terminal of approximately lOkDa (plO). The large 
subunit contains the active site cysteine within a conserved QACXG motif (X being R,
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Q or G). An aspartate cleavage site separates this subunit from the prodomain, and an 
interdomain linker containing one or two aspartate cleavage sites separates the large 
and small subunits (Schulz et a l, 1999;Wolf & Green, 1999). Activation of caspases, 
either as a result of autoactivation or by other activated caspases (Muzio et a l, 1998), 
results in cleavage of the prodomain leaving the large and small subunits to associate 
into a heteromer containing two small and two large subunits (Mittl et a l, 1997). 
Caspases can be roughly classified into two groups depending on their function, either 
those of the interleukin-1 converting enzyme family (caspases-1, -4, -5, -11, -12, and 
-14) that are in involved in the maturation of cytokines and the induction of 
inflammation and those caspases directly involved in apoptosis (-2, -3, -6, -7, -8, -9, 
and -10). The caspases in the later group can be further subdivided into the initiator 
caspases (-2, -8, -9, and -10) and the effector caspases, such as caspase-3, -6 and -7, 
and the stereotypical features of apoptotic cell death (table 2.1) are of the direct result 
of caspase cleavage of a number of critical cellular substrates (see table 2.2) (Love, 
2003). It is an essential requirement of all cells to have the ability to undergo this 
form of cell death for normal development, tissue homeostasis, regulation of the 
immune system and development of the nei*vous system (Ellis et a l, 1991).
2.1.2 Calpains
Calpains are also mediators of apoptotic cell death, however unlike caspases 
they do not have strict sequence requirements for substrate cleavage and are not only 
activated during an apoptotic event. Calpains are Ca^^-activated cysteine proteases 
and consist of a family of two isozymes, p- and m-calpain based upon their Ca^^
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requirements. Unlike caspases, calpains are expressed ubiquitously and p-calpain, or 
calpain 1, is activated by micromolar concentrations of Ca^  ^ whereas m-calpain 
(calpain 2) is only activated when Ca^^ levels reach millimolar concentrations 
(Vanderklish & Bahr, 2000).
Substrate Class Putative Function Example
Pro- and anti-apoptotic Signal amplification Procaspases, Bcl-2,
proteins Inhibitor inactivation Bid
Components of the Induction of the apoptotic ICAD, gelsolin, PAK2,
apoptotic machinery phenotype PKCÔ
Structural proteins and Dissolution of cell integrity Lamins, fodrin
associated molecules Cellular packaging (spectrin), keratins, 
actin
Homeostatic proteins Disruption of macromolecular 
synthesis and cellular repair 
mechanisms
Termination of survival signals
DNA-PKcs, PARP, 
Ul-70kDA, 
transcription factors
Other Unknown
? Apoptosis induction
Huntingtin 
Atrophin-1, ataxin-3, 
cPLAz
Table 2.2. Apoptotic substrates cleaved by activated caspases. Abbreviations are 
ICAD, inhibitor of caspase-activated DNase; PAK2, p21-activated kinase 2; DNA- 
PKcs, DNA protein kinase catalytic subunit; PARP, poly (ADP-ribose) polymerase; 
Ul-70kDA, Ul-specific 70-kDA protein; cPLAg, cytoplasmic phospholipase Aj. 
Adapted from Wolf & Green (1998).
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The activated protease acts on a host of endogenous proteins including the 
cytoskeletal element a-spectrin, which is also a substrate of caspase cleavage, 
(Vanderklish & Bahr, 2000) whereby calpain proteolysis leads to the immediate 
production of breakdown products of approximately 1501<Da in size. These 
breakdown products are unusually relatively stable and so have lead researchers to 
develop specific antibodies to these products enabling calpain activity to be measured 
(Siman et a l, 1984). It is considered that calpains are not only activated during a 
neuropathology, but are also activated during cell signalling cascades. For example, 
studies have shown that during synaptic plasticity, glutamate receptor activation leads 
to an increase in [Ca^^], and results in subtle levels of calpain mediated spectrin 
proteolysis (Lynch & Baudry, 1984; Vanderklish et a l, 1995).
2,L3 Mitochondrial &
Under normal physiological conditions, mitochondria are responsible for 
normal metabolic function of the cell such as ATP production and sequestration of 
Ca^ "^ . During normal synaptic transmission, for example, mitochondria serve as liigh 
capacity, low affinity buffering systems if the intracellular cytosolic Ca^ *^  
concentration ([Ca^’^ ji) exceeds SOOnM. In this situation mitochondria will remove 
Ca^^ from the cytosol via a uniporter whose structure at present is unknown (Nicholls 
et a l, 1999; Duchen, 2000). However during acute neuronal excitotoxic insults, 
activation of the NMDA receptor results in excessive cytosolic Ca^^ influx. 
Previously it was considered that this massive influx of Ca^^ or ‘overload’ resulted m 
cell death. Lately however experiments appear to suggest the possibility that the route
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of entry may play a crucial role in defining the outcome and that ‘overload’ is 
not as simple answer as it appears. This speculative theory stems from experimental 
data whereby it was observed that during excitotoxic insults high [Ca^^]i 
microdomains were established in certain regions of the cell and possibly resulted in 
activation of localised enzymes which may then play an important role in triggering 
neuronal death (Tymianski et a l, 1993; Sattler et a l, 1999). Excitotoxicity is the 
failure of cytoplasmic Ca^  ^ homeostasis, also known as delayed Ca^^ deregulation 
(DCD), and raised [Ca^^]i is established as the trigger for neuronal death as removal 
of extracellular Ca^^ prevents cell death. During these conditions mitochondria serve 
to buffer [Ca^^]i, which leads to a massive increase in mitochondrial Ca^  ^
concentration (~mM). When [Ca^’‘]i levels reach pM concentrations the 
mitochondrial membrane potential collapses and, at the same time, the opening of a 
high conductance pathway refened to as the mitochondrial permeability transition 
pore (MPTP) occurs (Figure 2.1). Tliis then results in cytochrome c release from the 
mitochondria possibly via the MPTP, as well as mitochondrial swelling, cessation of 
ATP production and possible oxygen free radical burst (Prass & Dirnagl, 1998; 
Nicholls et a l, 1999; Friberg & Wieloch, 2002; Krieger & Duchen, 2002).
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Cytoplasmic
membrane
Death ligand 
e.g. Fas ligand
Death receptor 
e.g. Fas
Lamms/Chromatin 
chondensation
Caspase-6
Caspase-8a-fodnn /  \ pro-caspase-8Structural
breakdown Caspase-3 Bid
(pro-apoptotic)
PARP 
(failure of DNA 
repair)
Bax, Bak
► Non-caspase 
mediated apoptosis
ICAD Formation of 
pore
Cytochrome c
+ APAF-1/
ATP/Pro-
caspase-9DNA cleavage 
(fragmentation of 
DNA)
Ca -activated 
enzymes (e.g. NOS, ^  calpains Caspase-9/
PARPi
DNA damage
Caspase-3
Figure 2.1. Schematic illustration of the likely major pathways of programmed 
neuronal death after brain ischaemia. Arrow keys; ^  activation; ^  substrate; ^  
result; ^  inhibition; release. Abbreviations: AIF, apoptosis inducing factor; Apaf- 
1, apoptosis activating factor-1; CAD, caspase-activated deoxyribonuclease; ICAD, 
inhibitor of caspase-activated deoxyribonuclease, PARP, poly (ADP-ribose) 
polymerase; A'Pm, mitochondrial membrane potential.
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2.1,4 Excitotoxicity: - Apoptosis vs. Necrosis?
The type of cell death observed depends largely on the size and duration of 
insult. A large excitotoxic insult, such as NMDA receptor activation, would severely 
inhibit mitochondrial function and shut down of ATP production. Therefore 
activation of apoptotic enzymes is unlikely. Also accompanying a large insult is 
cellular swelling, and with in vivo investigations, where a large ischaemic insult has 
been applied, brain studies often show that an inflammatory response has been 
activated (Prass & Dirnagl, 1998; Menil & Scolding, 1999; Kanellopoulos et aL, 
2000), all of which indicate early onset necrosis. Indeed, Moldrich et al. (2000) using 
cultured murine cortical neurones, showed 4hr acute exposure to liigh concentrations 
(100-1000|iiM) of the low affinity kainate receptor subtype agonist, (RS)-ATPA, 
induced cellular swelling and subsequent extracellular debris. This finding was 
considered to be due to AMP A and Kainate receptor activation resulting in an 
excessive and irreversible Na"^  and Cl" influx which caused rapid cell swelling (Choi, 
1988; Rego et aL, 2001) and labelling with propidium iodide (a membrane 
impeimeable DNA stain) revealed isolated nuclei consistent with the increased 
involvement of rapid necrosis (Moldrich et a l, 2000). Moreover excessive 
application of NMDA to cultured neurons results in DCD and mitochondrial 
dysfiinction leading to ROS production and subsequent necrotic death (Nicholls & 
Ward, 2000). Zhang et a l (2002) recently demonstrated that application of NMDA 
receptor and L-type voltage-gated Ca^^ channel antagonists in rat hippocampal 
neurones resulted in the suppressed release of cytochrome c and the expression of 
procaspase-3 after global brain ischaemia indicating a possible role of apoptotic death. 
Indeed with smaller excitotoxic insults, although damaging to mitochondria, as long
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as ATP levels remain sufficient, activation of apoptotic executioners such as caspase- 
3 can occur (Cebers et a l, 1998; Nicotera et a l, 1999). Oligodendrocytes expressed 
in culture are reported to express caspases -2, -3, -8 and -9 (Gu et a l, 1999; Osterhout 
et a l, 2002). Furthennore infusion of the selective caspase-3 inhibitor Z-DEVD-fink, 
decreased infarct size after transient focal ischaemia and reduced hippocampal CAl 
cell death in transient global ischaemia (Schulz et a l,  1999). Moldrich et a l  (2000) 
also showed in cultured murine cortical neurones, 24hr exposure to low 
concentrations (l-30pM) (RS)-ATPA produced cellular shrinkage and nuclear 
granulation consistent with slow, apoptotic-like neuronal death respectively. Indeed, 
Yoshioka et a l  (1996) demonstrated that the CG-4 oligodendrocyte cell line was 
susceptible to excitotoxic death with 2mM kainate and the type of cell death obseiwed 
displayed both apoptotic and necrotic like features.
2.1.5 Project aims
Previous studies have indicated that NMDA receptor activation leads to Ca^^ influx 
and subsequent mitochondrial failing resulting in apoptotic, necrotic, or both forms of 
cell death depending on the duration and size o f insult applied (Bonfoco et a l, 1995; 
Ward et a l, 2000; Krieger & Duchen, 2002). Data have suggested that activation of 
AMP A receptors in rat derived oligodendroglial-like CG-4 cells results in Ca^^ influx 
(Holtzclaw et al, 1995) and that this Ca^^ may be sufficient to initiate excitotoxicity 
(Yoshioka et a l, 1996). Current research investigating the mechanisms of 
oligodendrocyte death in cell lines and primary cultures give conflicting and often 
confusing results indicating that both forms of cell death are activated and are very
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much dependent on the type, size and duration of insult. The present study aims to 
determine the mechanisms of AMPA receptor mediated cell death in rat cultured 
OPC, by examining the possible involvement of factors associated with the apoptotic 
and necrotic pathways.
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2.2 Methods
2.2.1 Reagents 
Cell Cultures
As described in section 1.2.2 methods.
Cell Viability
iV-benzyloxycarbonyl-Vai-Ala-Asp-(0-methyl)fluoromethyi ketone (Z-VAD- 
fmk) (lOOmM stock in 100% DMSO) was purchased from Bachem (UK). 
Staurosporine (ImM stock in 100% DMSO) was obtained from Alexis Corp (UK). 
PD150606 (ISOmM stock in 100% DMSO) was purchased from Calbiochem. DPPD 
(lOmM stock in 100% ethanol), PBN (lOOmM stock in 100% DMSO), trolox 
(lOOmM stock in 100% DMSO), forskolin (lOmM stock in 100% DMSO), 
nicardipine (30mM Stock in 100% ethanol), L-NAME (lOmM stock in milHQ grade 
water) and all other reagents and chemicals were obtained from Sigma.
Western Blotting
Rabbit polyclonal anti-caspase-3 antibody was purchased from Calbiochem 
and mouse monoclonal anti-a-fodrin (all-spectrin) antibody was obtained from 
Affiniti Research Products Limited (Exeter, UK). The secondary horseradish 
peroxidase-conjugated antibodies were goat anti-rabbit immunoglobulin and goat 
anti-mouse immnunoglobulin both obtained from DakoCytomation (UK). 
Nitrocellulose membrane (Hybond-ECL) and ECU Western blotting detection 
reagents were obtained from Amersham Pharmacia Biotech (UK). Super RX (100
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NIF) medical X-ray film was from Fuji Film, CD 18 developer and CF40 fixative were 
from Photosol (Essex, UK). Acrylamide: Bis-Arcylamide (40% of 37.5:1 solution), 
ammonium persulphate, bromophenol blue, kaleidoscope prestained standards and 
TEMED were supplied by Bio-Rad (UK). Skimmed milk powder was manufactured 
by Marvel Foods (UK). All other reagents and chemicals were obtained by Sigma. 
Protease inhibitors, pepstatin (Img mf^ stock in 100% DMSO), leupeptin (Img mf^ 
stock in milliQ grade water), aprotinin (Img mf^ stock in milliQ grade water) and 
phenylmethylsulphonylfluoride (PMSF, IM stock in 100% DMSO) were obtained 
fi'om Roche.
2.2.2 Determination of cell viability
In all experiments cells were aged between 14-16 days in vitro. All compound 
dilutions were either in PBS or lOmM HEPES (pH 7.4) buffer. Generally, inhibitors 
were added 5 minutes prior to excitatory amino acid exposure. Z-VAD-fink and N- 
acetylcysteine was added 2 hours prior to and PD 150606, PBN, DPPD, and trolox 
were added 1 hour prior to, excitatory amino acid addition. Cell viability was 
determined by dual staining with fluorescein diacetate and propidium iodide as 
previously described in section 1.2.4 methods.
2.2.3 Reactive oxygen species production
Cellular oxidative stress was assessed via monitoring 2 \  T -  
dichlorofluorescein (2’,7’-DCF) accumulation (Wang & Joseph, 1999) whereby 2’,7’-
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dichlorodihydrofluorescin diacetate in the presence of ROS forms the fluorescent 
product DCF. Cells were seeded (50,000 cells well'^) onto poly-D-lysine-coated 
(lOpg mf^) FluoroNunc 96-well plates. At 14-16 DIV culture media was replaced 
with HBSS and cells incubated with 2 \  7’-dichlorodihydrofluorescin diacetate 
(lOOpM, 30 mins), washed, and then exposed to kainate (300pM) and H2O2 (200pM, 
positive control) for up to 4hrs. Fluorescence intensity (485nm excitation and 
emission 530nm) was then determined using a Denley Wellfluor fluorescence 
microplate reader and fluorescence intensity values transformed using DCF standards. 
Data were subsequently expressed pmoles mg protein^ whereby protein levels were 
quantified by Lowiy protein measurement (described below) using BSA standards.
2.2.3.1 Lowry Protein measurement
Protein content was determined using the Lowry method (Lowry et aL, 1951). 
Briefly supernatant was removed from well and replaced with 0.2M NaOH (200pl). 
Samples were left to solubilize overnight at room temperature, 1ml activated reagent 
A (250pl reagent A (lOmg mf^ Na2C0 3  0.5mg mf^ CUSO4 ; Img mf^ 
Na02CCH(0H)CH(0H)C02NA (sodium tartrate)); 500pl 5% %  SDS; 250pl 0.8M 
NaOH) was added to 200pi protein sample (in 0.2M NaOH), mixed and left for 
lOminutes at room temperature. Subsequently 0.5ml Reagent B (1 part 2N Folin- 
Ciocalteau Phenol reagent to 5 parts H2O) was added to sample followed by 
immediate mixing and a 30-minute incubation time at room temperature. Absorbance 
values (750nm) were then determined and protein levels quantified using a BSA 
standard cui*ve.
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2.2.4 Quantification of Chromatin Condensation
Nuclear morphology was assessed using the fluorescent nucleic acid stain, 
Hoechst 33342, as previously described (Johnson et a i, 2000). Cells on coverslips 
were exposed to either PBS, kainate (300pM) or staurosporine (SOOnM) for 6-hours at 
37°C 5%C02/ 95% humidified air. Cells were subsequently fixed (4% (w/v) 
formaldehyde, 30 minutes), washed twice with PBS and then exposed to Hoechst 
33342 (3pg m f\ 8 minutes). Following a further wash, cells were mounted (50 % 
glycerol: 50 % PBS) and viewed (365mu excitation and > 420nm emission) using a 
Zeiss Axiovert fluorescence microscope. Nuclei were scored as either normal 
(uncondensed cliromatin), or apoptotic (higlily condensed chromatin, yielding a high 
blue fluorescence or fragmented into discrete apoptotic bodies). Cell counts were 
taken from 2 random fields of view and expressed as percentage total pyknotic nuclei 
in a field of view.
2.2.5 Detection of caspase-3 involvement bv Western Blot analysis
Activation of caspase-3 involvement was also examined by Western Blot 
analysis using a rabbit polyclonal anti-caspase-3 antibody to detect the 34kDa caspase 
3 proform and the 17-20kDa processed forms caspase-3 (Kirsch et a l, 1999). A 
mouse monoclonal anti-a-fodrin (all-spectrin) antibody was also used to determine 
caspase-3 involvement. Anti-a-fodrin antibody reacts with the 240/280kDa a-fodrin 
molecule, a 150/145kDa sized doublet from calpain/caspase cleavage and the 120kDa 
caspase-3 specific cleaved product.
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2.2.5.1 Extraction of cytosolic protein for Western Blot analysis
Cells (2 X 10  ^ cells/T80cm^ flask) were exposed to kainate (300pM) and 
staurosporine (SOOnM) for 6hrs at 37°C 5% C02/95% humidified air. After this 
duration cytosolic protein was collected by media removal and addition of ice-cold 
PBS (4ml) supplemented with pepstatin (Ipg mf^), leupeptin (Ipg mf^), aprotinin 
(Ipg  mf^) and PMSF (ImM). Cells were then detached from flasks using cell 
scrapers and supernatant centrifuged at 16,000g (4°C, 10 minutes). The supernatant 
was subsequently removed and pellet re-suspended in lOOpl ice-cold PBS/protease 
inhibitor mix. Samples were then centrifuged at 16,000g (4°C, 5 minutes) and pellet 
then re-suspended in 50pl lysis buffer (1% SDS; ImM sodium ortho-vanadate; lOmM 
Tris-buffer, pH 7.4) supplemented with pepstatin (Ipg mf^), leupeptin (Ipg  mf^), 
aprotinin (Ipg mf^) and PMSF (ImM). Subsequently samples were sonicated (3 x 10 
second bursts), subjected to 3 ffeeze/thaw cycles and centrifuged at 16,000g (4°C, 10 
minutes). Supernatant and pellet were then stored at -80°C.
2.2.5.2 Protein quantification and preparation for SDS-PAGE
Cytosolic protein was determined BioRad protein assay based on the method 
described by Bradford (1976). Briefly samples were thawed and centrifuged at 
16,000g for 5 minutes and stored on ice until use. BioRad protein standard was 
prepared and used according to manufacture’s instructions (1:5 dilution). To lOpl of 
supernatant protein (diluted with 90pl lysis buffer) 5ml BioRad protein standard was 
added. Samples were then mixed and incubated for 10 minutes at room temperature.
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Absorbance was then determined at 595nm and absorbance intensity values 
transformed using appropriate BSA standards. Subsequently 12.5pi sample (6 or 8pg 
protein) and Kaleidoscope prestained markers were boiled for 5mins with 12.5pl 
loading buffer (0.25M Tris-buffer, pH 6.8; 20% SDS; 0.4g ml'  ^ glycerol; 5% %  p- 
mercaptoethanol; 1% bromophenol blue) and stored on ice until loading.
2.2.5,3 SDS-PAGE, transfer and immunoblot
For caspase-3 detection, protein and markers were run on a 7.5% gel (0.75M 
Tris-buffer, pH 8.8; 7.5% acrylamide: bis-arcylamide (37:1 of 40% solution); 2% 
SDS; 0.1% ammonium persulphate; 0.03% 7v TEMED), for anti-a-fodrin (8pg 
protein loading) or a 15% gel (0.75M Tris-buffer, pH 8.8; 15% acrylamide: bis- 
arcylamide (37:1 of 40% solution); 2% SDS; 0.1% ammonium persulphate; 0.03% 7v 
TEMED), for anti-caspase-3 detection (6pg protein loading). The 7.5% and 15% gel 
were completed with a 4% stacking gel (0.25M Tris-buffer, pH 6.8; 4% acrylamide: 
bis-arcylamide; 2% SDS; 0.1% ammonium persulphate; 0.15% 7v TEMED) and were 
run at 115volts for 2-hours using a Mini-Protean®-3 Gel Tank System (BioRad) 
according to manufacturers instructions. Protein was then transferred to nitrocellulose 
membrane at lOOvolts for lV2 -hours using a Mini Trans-Blot® Electrophoretic 
Transfer Cell. To ensure protein transfer and equal loading of protein sample the 
nitrocellulose membrane. Ponceau S staining was performed (on a shaker with 1% 
Ponceau S solution (0.2% %  Ponceau S; 3% '7v trichloroacetic acid; 3% '7v 
solphosalicylic acid) for 15 minutes at 200rpm and washed twice with milliQ grade 
water). The blot was subsequently transferred to centrifuge tube containing 5% milk
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in IX-Tris-Buffered-Saline-Tween Buffer, pH 7.6 (TBST) and blocked overnight at 
4°C. Blot was then exposed to either anti-capsase-3 or anti-a-fodrin (1:5000 dilution 
in 5% milk TBST buffer) for 2-hours on a roller at room temperature. After this 
duration, the blot was washed (30 seconds) twice with IX-TBST buffer and exposed 
to either goat anti-rabbit peroxidase-conjugated secondary antibody for caspase-3 
detection, or goat anti-mouse peroxidase-conjugated secondary antibody for a-fodrin 
detection (1:2000 dilution in 5% milk TBST buffer) for 1-hour, on roller, at room 
temperature. The blot was subsequently washed twice with IX-TBST and stored in 
5%-milk TBST at room temperature.
2.2.5.4 Enhanced Chemiluminescence detection
Detection of antibody (bound to blot) was determined by enzymatic reaction 
using the Enhanced Chemiluminescence (ECL) Western blotting detection system 
whereby luminol is oxidised by horse radish peroxidase/hydrogen peroxide in alkaline 
conditions (see Figure 2.2). Briefly the blot was removed from storage buffer and 
applied with 2ml active ECL (1ml solution A to 1ml solution B) for 3 minutes. After 
this duration the blot was wrapped in clingfilm and transferred to a hypercassette 
where it was exposed to film for appropriate duration. Film was then processed by 
incubation in developer (1 litre, diluted 1:5 with H2O) for 1 minute. Film was then 
transferred to stopper solution (1 litre H2O containing 500pi acetic acid) for 30 
seconds and subsequently transferred to fixative (1 litre, diluted 1:5 with H2O) for 2 
minutes. Film was then stored in milliQ grade water overnight and was subsequently 
air-dried.
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Figure 2.2. Principles of ECL Western Blotting. HRP, horse radish peroxidase.
2.2.6 Statistical Analysis
As described in section 1.2.5 methods.
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2.3 Results
2.3.1 Effect of nicardipine, forskolin and L-NAME on kainate-induced toxicity 
in rat cultured OPC
The selective L-type Ca^-channel blocker nicardipine (Thellung el al., 2000) was 
used to determine if AMPA receptor activation resulted in activation of L-type Ca^ 
channels and therefore enhanced kainate-induced toxicity. Nicardipine (IpM) and the 
compound vehicle 0.1% (7v) ethanol alone did not influence OPC viability 
(96.5+3.3% and 100.7+8.0% cell viability. Figure 2.3a). In the presence of kainate 
(38.4+6.2% cell viability), nicardipine failed to significantly reduce OPC death.
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Figure 2.3a. Lack of effect of nicardipine on OPC viability after 24-hour exposure. 
Data represents the mean of six (+S.E M ) experiments. One-way ANOVA (Tukey- 
Kramer multiple comparisons test).
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Yoshioka et al. (1998) in the oligodendroglial-like cell line CG4 have showed that 
forskolin, via the activation of adenylyl cyclase, is neuroprotective against 2mM 
kainate toxicity. As illustrated in Figure 2.3b, 300pM kainate decreased cell viability 
to 50.8+6.0%, but this effect was not reversed by the addition of forskolin. Forskolin 
had no effect alone on OPC viability.
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Figure 2.3b. Lack of effect of forskolin on OPC viability after 24-hour exposure 
Data represents the mean of four (±S.E.M.) experiments. One-way ANOVA (Tukey- 
Kramer multiple comparisons test).
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L-NAME, a nitric oxide synthase inhibitor (Pfeiffer et a l, 1996), was used to 
determine whether activation of AMPA receptors resulted in downstream activation
of a cytotoxic NOS pathway. As illustrated in Figure 2.3c L-NAME (SOOpM) alone
and in the presence of 300pM kainate (44.0±12.7% cell viability, p<0.01) did not
significantly influence cell viability over 24-hours.
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Figure 2.3c. Lack of effect of L-NAME on kainate-induced OPC toxicity after a 24-
hour insult. Data represents the mean of four (±S.E.M.) experiments. One-way
ANOVA (Tukey-Kramer multiple comparisons test).
2.3.2 Determination of potential ROS involvement during kainate-induced
toxicity in rat cultured OPCs
2.3.2.1 Effect o f free radical scavengers on kainate-induced toxicity in cultured rat 
OPC
The following experiments were undertaken to determine whether reactive oxygen 
species (ROS) were generated during kainate exposure and whether ROS production 
contributes to OPC death.
120n
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Figure 2.4. Lack of effect of the free radical scavengers, trolox, PBN, DPPD and N- 
acetylcysteine (NAC) on kainate-induced OPC toxicity after 24-hour exposure. Data 
represents the mean (±S.E.M.) of three to four experiments. One-way ANOVA 
(Tukey-Kramer multiple comparisons test).
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As illustrated in Figure 2.4, neither lOOjiM trolox, PBN (lOOgM), DPPD (l|iM ) nor 
5mM iV-acetylcysteine (NAC) influenced OPC viability. Additionally, they also 
failed to significantly reduce 300pM kainate-induced OPC death
23,2,2 Effect o f  kainate on rat cultured OPC RO S production over 4-hours insult
As illustrated in Figure 2.5, kainate (300gM) over a 4-hour insult, failed to elicit 
significant ROS production vs. control HEPES as determined by DCF monitoring. In 
control OPCs (HEPES-treated) a gradual increase in DCF occurred over 4-hours 
(t=Ohr, 245.02+51.0 pmol DCF mg'^ protein and t=4hrs, 835.80+121.77 pmol DCF 
mg'^ protein, p<0.01). As a positive control, H2O2 (200pM) significantly (p<0.01, vs. 
time-matched control) increased DCF levels after a 1-hour insult (945.21±59.79 pmol 
DCF mg'^ protein), which reached a maximum of 1642.81+141.84 pmol DCF mg“^ 
protein at 4-hour exposure.
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Figure 2.5. Effect of kainate (300pM) and H2O2 (200^iM) on DGF production over a 
4-hour insult in rat cultured OPCs. (A) 300pM kainate; (■ ) lOmM HEPES buffer; 
( • )  200pM H2O2 Data represents mean (±S.E.M.) of five experiments. ** P<0.01 
versus time-matched control (HEPES) (one-way ANOVA (Dunnett post-test)).
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2.3.3 Determination of potential apoptotic activation during kainate-induced
toxicity in rat cultured OPCs
2.3.3.1 Effect o f  Z-VAD-fmk on kainate-induced toxicity in OPCs
The broad-spectrum caspase inhibitor Z-VAD-fmk (Tenneti et a i, 1998) was 
employed to determine if 300pM kainate-induced OPC death involved activation of 
the caspase apoptotic cascade. 24-hour kainate (300pM) toxicity in the presence of 
Z-VAD-fmk resulted in a significant increase (18%, p<0.01) in OPC viability (Figure 
2.6a ). The known apoptotic inducer staurosporine (SOOnM) reduced cell viability to 
20.4 ± 1.1% an effect significantly (p<0.01) reversed by Z-VAD-fmk (lOOpM).
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Figure 2.6a. Effect of Z-VAD-fmk on kainate-induced toxicity in OPC after 24-hour 
exposure. Data represent the mean (±S.E.M) of at least four experiments. ** P<0.01 
versus respective controls (Students paired /-test).
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Since Z-VAD-fmk did not fully reverse kainate-induced toxicity over 24 
hours, 6 hours kainate toxicity was therefore also examined. As illustrated in Figure 
2.6b, kainate (300|iM) decreased cell viability to 59.8 ± 4.9% over a 6 hour exposure. 
In the presence of Z-VAD-fmk, cell viability was significantly (p<0.01) increased, 
however this was not a full reversal. Staurosporine also reduced cell viability to 63.7 
± 1.3%, and in the presence of Z-VAD-fmk cell viability was increased to 88.0 ± 
3.9% (p<0.05).
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Figure 2.6b, Effect of Z-VAD-fmk on kainate-induced toxicity in OPC after 6-hour 
exposure. Data represents the mean of four (±S.E.M.) experiments. * P<0.05 and ** 
P<0.01 versus respective controls (Students paired /-test).
1 0 0
2.3.3.2 Effect of calpain inhibitor PD150606 on kainate-induced OPC toxicity
The calpain inhibitor PD 150606 (Wang el a i, 1996) was examined to determine 
whether 24-hour kainate-induced OPC death involved calpain activity. PD 150606 at 
4pM and lOpM afforded no significant protection against 300pM kainate insult 
(Figure 2.7). PD 150606 (4pM and lOpM) alone did not affect cell viability.
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Figure 2.7. Lack of effect of calpain inhibitor PD 150606 on 300pM kainate-induced 
OPC toxicity after 24-hours exposure. Data represents the mean of four (+S.E.M.) 
experiments. One-way ANOVA (Tukey-Kramer multiple comparisons test).
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2.3.3.3 Morphological observations after 6-hour exposure to toxins
Images of OPCs exposed to kainate (300pM) and staurosporine (SOOnM) for 6 
hours were taken using a phase contrast microscope in order to examine cell 
morphology. Control (PBS) OPCs (Figure 2.8a) showed bright OPCs with intact- 
branched processes. 300pM kainate and SOOnM staurosporine (Figures 2.8b and 
2.8d) resulted in loss of cell processes, and with staurosporine virtually complete cell 
death. Addition of lOOpM Z-VAD-fmk (Figures 2.8c and 2.8e) to kainate and 
staurosporine incubations resulted in cell morphology resembling control (PBS) 
OPCs.
Figure 2.8a. Image of control (PBS) OPCs.
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Figure 2.8b. Image of 6-hour OPC exposure to 300fiM kainate.
Figure 2.8c. Image of 6-hour OPC exposure to 300pM kainate in presence of lOOpM 
Z-VAD-fmk.
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Figure 2.8d. Image of 6-hour OPC exposure to 500nM staurosporine.
Figure 2.8e. Image of 6-hour OPC exposure to SOOnM staurosporine in presence of 
lOOpM Z-VAD-fmk.
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2.3.3.4 Examination of cellular nuclear morphology after 6-hour toxin exposure
To further investigate the possible role of apoptotic activation caused by kainate, the 
fluorescent nuclear DNA stain Hoechst 33342 was examined. When examined at 
300pM, kainate caused increased appearance of pyknotic nuclei over time (Figure 
2.9), with significance (p<0.05) achieved at 4-hour toxin exposure (36.3±4.5% 
pyknotic nuclei).
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Figure 2.9. Time-course study for appearance of pyknotic nuclei exposed to toxin. 
(■) control (PBS), ( • )  300pM kainate and (O ) SOOnM staurosporine. Data 
represents the mean of four (+S.E.M.) experiments. * P<0.05 and ** P<0.01 versus 
time-matched control (PBS) (one-way ANOVA (Dunnett post-test)).
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The positive control staurosporine (SOOnM) also showed increasing appearance of 
pyknotic nuclei with time. Significant (p<0.01) pyknotic nuclei were also observed 
after 4-hour insult (42.6±8.2%). Morphological representative pictures are shown in 
Figures 2.10a-e.
Figure 2.10a. Hoechst 33342 stain o f control OPCs at time 0. Circled cell denotes 
cell displaying pyknotic nuclei.
Figure 2.10b. Hoechst 33342 stain o f control OPCs at 6 hours exposure.
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Figure 2.10c. Hoechst 33342 stain of an OPC exposed to 300pM kainate for 6-hours. 
Note that the nucleus appears more granular.
Figure 2.10d. Hoechst 33342 stain o f an OPC exposed to SOOnM staurosporine for 6- 
hours.
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Figure 2.10e. Hoechst 33342 stain of OPCs rescued from 6-hour staurosporine 
(SOOnM) toxicity using Z-VAD-frnk (lOOpM) (2-hour pre-incubation).
To confirm the reversal observed with kainate and staurosporine in the presence of Z- 
VAD-fink (lOOpM) was via inhibition o f apoptosis. Hoechst 33342 stain analysis 
was performed over a 6-hour insult. 2SmM was also examined as it has been 
suggested that high concentrations o f protect against kainate-induced toxicity 
(Gallo et al, 1987; Yu et al, 1999). 6-hour kainate (300pM) insult resulted in 
47.7+1.1% of the population showed pyknotic nuclei morphology (Figure 2.11). In 
the presence of lOOpM Z-VAD-fmk pyknotic nuclei expression decreased to 
39.6±1.0%, however this effect was not found to be significant. 25mM (19.8±2.1) 
did not significantly increase OPC nuclear condensation when compared to control 
PBS (17.3+2.2% pyknotic nuclei) and in the presence of kainate (300pM) failed to 
affect the percentage of cells committed to apoptosis. The positive control 500nM 
staurosporine caused 54.8+5.2% of cells to display pyknotic nuclear morphology and
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staurosporine caused 54.8±5.2% of cells to display pyknotic nuclear morphology and 
in the presence of Z-VAD-fmk this effect was significantly (p<0.001) reduced to 
24.6+4.8%. Z-VAD-fmk alone also failed to increase the percentage of pyknotic 
nuclei (20.9+1.3%) compared to PBS control.
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Figure 2.11. Hoechst 33342 stain analysis of effect kainate in presence of Z-VAD- 
fmk and K 6-hour exposures. Data represent the mean of four (+S.E.M.) 
experiments. *** P<0.001 versus respective control (one-way ANOVA (Tukey- 
Kramer multiple comparisons test)).
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2.3.3.5 Western blot analysis to caspase-3 activation 
Caspase-3 activation.
Western blotting was employed to determine if during a 6-hour kainate (300pM) 
insult, activation of capsase-3 occurred As illustrated in Figure 2.12 the Western blot 
to caspase-3 showed for HEPES the intact 34kDa procaspsase-3 form as well as an 
extremely weak 17-20kDa cleaved caspase-3 fragment. Kainate (300pM) and SOOnM 
staurosporine also expressed the procaspase-3 form (34kDa), with a denser band 
however observed for kainate. They also expressed a weak cleaved caspase-3 17- 
20kDa fragment. Also observed on all lanes was a weak unrelated 30kDa fragment.
MARKER HEPES KA STA
39.1 kDa
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17-20kDa
Figure 2.12. Western Blot analysis to anti-caspase-3. Representative picture of 
Western performed at least 3 times. (KA) 300pM kainate, (STA) SOOnM 
staurosporine and (MARKER) Kaleidoscope pre-stained marker.
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a-Fodrin Cleavage
The cytoskeletal protein a-fodrin (also known as non-erythroid -(all) spectrin) was 
also examined since detection of caspase activity using anti-caspase-3 failed to give a 
clear result when compared to control. Calpains and caspases share a-fodrin as a 
substrate and hence both cleave a-fodrin at 145-150kDa. Caspase-3 is reported to 
cleave a-fodrin at 120kDa. Kainate (300pM) 6-hour insult to OPC resulted in 
cleavage of a-fodrin and revealed intense bands (v5. control) at 145/1 SOkDa (doublet) 
which indicated activation of calpains/caspases and also appearance of the 120kDa 
fragment, but this did not appear different from control (Figure 2.13). Moreover the 
positive control staurosporine (500nM) showed an intense band (v& kainate) at 
120kDa fragment, indicative of a-fodrin cleavage by capsase-3.
145/1 SOkDa 
120kDa
Figure 2.13. Representative image of Western Blot to anti-a-fodrin. (M) 
Kaleidoscope pre-stained marker, (H) HEPES buffo: lOmM, (K) 300pM Kainate, (S) 
500nM staurosporine.
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2.4 Discussion
As reported in chapter 1, OPCs are susceptible to AMP A receptor-mediated 
cell death. The research in tliis section aimed to investigate the intracellular 
mechanisms leading to OPC death following kainate-induced excitotoxicity.
Preliminary experiments examined the possibility of second messenger 
activation following 24-hour kainate-induced toxicity. Previous findings of neuronal 
excitotoxicity indicate that cellular death is the result of Ca^  ^ overload mediated by 
NMDA and to an extent, AMP A and Kainate receptors. AMP A receptors allow the 
influx of Na^ and Ca^ "^  ions depending on subunit composition. Na^ influx, as well as 
causing cellular swelling, can in turn trigger a secondary increase in [Ca^^]i tlirough 
the activation of voltage-gated Ca^  ^ channels and reverse operation of Na"'/ Ca^^ 
exchange (Lee et a l, 2000). Oligodendrocytes, during AMPA receptor activation, 
also results in Ca^ "^  influx (McDonald et a l, 1998a; Fern & Moller, 2000), an effect 
which is totally abolished by non-NMDA receptor antagonists or by removing Ca^^ 
from the culture medium (Alberdi et a l, 2002). In the present study, nicardipine 
(IpM ), an L-type Ca^^ channel blocker (Thellung et a l, 2000) failed to decrease 
kainate-induced OPC death. Consistent with the present study, work by Deng et a l 
(2003) demonstrated that primary rat forebrain OPCs in paradigms of 2-hour oxygen- 
glucose deprivation (OGD) and 300pM kainate-induced toxicity, the L-type Ca^^ 
channel blockers nifedipine (50pM) and nimodipine (lOpM) failed to increase OPC 
survival. Deng et a l  (2003) also showed that OGD and 300pM kainate-induced 
excitotoxicity resulted in Ca^^ influx and concluded that this Ca^^ influx was mediated 
in part by Ca^  ^ permeable AMPA/Kainate receptors as IpM  loro Spider Toxin, a 
selective Ca^^-permeable AMPA/kainate receptor chamiel blocker, partially
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attenuated kainate evoked Ca^  ^ influx. An inhibitor of the Na^-Ca^^ exchanger, 
bepridil (lOOpM), also failed to protect OPCs against Ca^^ influx following kainate 
exposure in the study by Deng and co-workers. Oligodendrocytes have been shown 
to express functional AMPA receptor subunits. Primary rat whole brain OPCs are 
reported to express the AMPA receptor subunits GluR2 edited (Ca^^ impermeable), 
GluR3, GluR4 and to a small extent GluRl (Liu et a l, 2002). In rat optic nerve 
oligodendrocytes (GalC^) the AMPA receptor subunits GluRl and GluR3 are also 
expressed (Sanchez-Gomez & Matute, 1999). Deng et a l (2003) also showed that 
OPCs cultures preconditioned to OGD for 1-hour and assessed 24-hours later 
displayed a down-regulation of cell-surface GluR2 subunit expression and therefore 
increased AMPA receptor Ca^^ permeability. They concluded that these findings 
explained the enhanced vulnerability of preconditioned OPC cultures to subsequent 
excitotoxic Ca^ "^  influx and cell injury. The expression of these AMPA receptor 
subunits in primary cultures of oligodendrocytes provides additional evidence to 
suggest that AMPA receptor mediated excitotoxicity could result in Ca^^ influx via 
the direct activation of Ca^^-permeable AMPA receptors. Interestingly Alberdi et a l 
(2002) in rat cultured optic neiwe oligodendrocytes, showed that LaClg (lOOpM) and 
nifedipine (lOpM), both L-type Ca^^ channel blockers, decreased Ca^^ influx by 
approximately 65% and concluded that a substantial fi'action of the type of total Ca^  ^
entry elicited by (S)-AMPA occurs via L-type Ca^^ channels. In the same study they 
also demonstrated that application of KB-R7943 (lOpM), an inhibitor of the reverse 
mode of the NaV Ca^  ^ exchanger, only attenuated (S)-AMPA (lOOpM) with 
cyclothiazide (lOOpM) mediated Ca^^ influx by 22-25%. The group failed to examine 
whether there was direct Ca^ "^  influx via Ca^^-permeable AMPA/Kamate receptors. 
The differences observed with these studies could be due to cell type localisation (i.e.
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cerebral cortex optic nerve oligodendrocytes) and also cell lineage stage, as 
previous reports have shown differences in the susceptibility of oligodendrocytes to 
kainate, such that oligodendrocytes become less susceptible to 300pM and 500pM 
kainate with increasing lineage stage (McDonald et al., 1998b; Rosenberg et a l, 
2003).
The present study also examined the potential role of other second messenger 
systems. Yoshioka et al. (1998) showed cyclic-AMP elevating agents protected CG4 
cells from kainate excitotoxicity. Specifically they reported that lOpM forskolin 
protected against 2mM kainate (24-hour insult) by a PKA-dependent protein 
phosphoiylation mechanism that ultimately resulted in a reduction of Ca^^ influx 
caused by kainate. lOpM forskolin in our hands, failed in protecting OPC from 
kainate-induced cell death. Expression of iNOS and production of nitric oxide (NO) 
has been shown to occur in primary rat oligodendrocytes as well as in CG-4 cells 
upon stimulation with inflammatoiy cytokines (Merrill et a l, 1997; Boullerne et a l, 
2001). However alternate studies have indicated that iNOS expression is not 
increased in oligodendrocyte cultures following cytokine exposure (Hewett et a l, 
1999). The mechanisms of oligodendrocyte damage induced by NO are not well 
understood and a potential role for NO following a non-NMDA receptor mediated 
insult are unknown. The nitric oxide synthase inhibitor, L-NAME, in the present 
study failed to protect against 24-hour kainate induced toxicity indicating there was 
none or little involvement of NO signalling in OPC AMPA-receptor mediated cell 
death.
In neurones the rapid influx of Ca^  ^ through Ca^^-permeable AMPA/Kainate 
receptors resulted in mitochondrial Ca^ overload and consequent production of ROS 
(Carriedo et a l, 1998). The present study aimed to determine if kainate-induced
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toxicity resulted in ROS production. The antioxidants PEN (an electron spin trap 
reagent), trolox, DPPD (free radical scavengers) and V-acetylcysteine (NAC), a 
precursor to glutathione, did not attenuate 300pM kainate-mediated OPC death. 
McDonald et a l  (1998a) also found that 30pM trolox and lOOpM PEN also failed to 
protect mouse forebrain GalC^ oligodendrocytes from AMPA toxicity. Whereas 
Yoshioka et a l (1996), in CG-4 cells, and Liu et a l  (2002), in primary whole brain rat 
OPCs, showed that NAC prevented kainate-induced damage and therefore suggested 
that reactive oxygen species were involved in the pathophysiology of OLC toxicity. 
Moreover Liu et a l (2002) also reported that NAC not only functioned directly as an 
ROS-scavenging antioxidant, but it also prevented OPC death by increasing 
intracellular glutathione levels which were found to be decreased after kainate 
(lOOpM) with CTZ (SOpM) exposure for 24 hours. In order to confirm that 
significant ROS production was not involved in kainate-induced OPC death and also 
was not an early-mediated event in the present study, the production of 2’,7’- 
dichlorofluorescein fluorescence (2’,7’-DCF) was examined. The present study 
demonstrated that there was no significant 2’,7’-DCF production over a 4-hour insult 
in OPCs exposed to 300pM kainate compared to control cells. The positive control 
hydrogen peroxide (200pM) did however show significant (p<0.01) 2’,7’-DCF 
accumulation. Richter-Landsberg & Vollgraf (1998) demonstrated that primary rat 
cerebrocortical cultures of highly enriched populations of differentiated 
oligodendrocytes died as a result of oxidative stress following application of 200pM 
hydrogen peroxide for 30mins. The observation of no ROS involvement in the 
present study raised the possibility that these findings may have in fact been an 
artefact caused by the presence of 200pM cystme in the cell culture medium. 
However 2’,7’-DCF monitoring occurred in artificial medium that did not contain any
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cystine and ROS was observed, albeit with the positive control. Moreover, Liu et a l  
(2002) in primary rat whole brain OPCs demonstrated ROS production in OPC 
cultures bathing in 200pM cystine.
The potential role for apoptotic involvement following kainate toxicity in 
OPCs was also investigated. Initial experiments examined the effect of the broad- 
spectrum caspase inhibitor V-benzyloxycarbonyl-Val-Ala-Asp-(O-methyl)- 
fluoromethyl ketone (Z-VAD-fmk) to determine if activation of caspases occurred 
following kainate insult. Z-VAD-fmk acts as a pseudosubstrate and binds irreversibly 
to caspases to inhibit their activity (Tenneti et a l, 1998). Moreover, rat whole brain 
oligodendrocyte cultures (A2B5^ and Ol^) have been shown to express caspases -1 , - 
2, -3 -8  and -9  respectively (Gu et a l, 1999; Osterhout et a l, 2002). The bacterial 
alkaloid staurosporine is a general kinase inhibitor and has been shown to induce 
apoptosis (Bertrand et a l, 1994). Preliminary results at 6- and 24-hours suggest that 
OPC death can be mediated via apoptosis, as indicated by staurosporine insult and 
was partially attenuated with Z-VAD-fink which indicated caspase involvement. In 
the human oligodendroglial cell line, M03.13, Craighead et a l  (1999), showed that 
24-hour staurosporine toxicity could be prevented by Z-VAD-fmk in naïve (mimic 
progenitor cells) and differentiated cells (resembling mature early oligodendrocytes). 
They also showed that naive cells were more susceptible to staurosporine. However 
Z-VAD-fmk did not provide a complete increase in cell viability, correlating with the 
present study. 24-hour kainate (300pM) exposure in the presence of Z-VAD-fmk 
(lOOpM) prevented OPC death by -18%  (p<0.01), therefore the possibility that OPCs 
are committed to apoptosis early after kainate exposure was investigated. 6-hour 
kainate exposure resulted m 40% OPC death as determined by fluorescein diacetate 
propidium iodide staining. In the presence of Z-VAD-fmk, cell viability was again
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only partially increased (p<0.01) and this indicated potential caspase involvement. 
Tenneti et al. (1998) also demonstrated in rat cerebrocortical neuronal cultures that Z- 
VAD-fmk (50pM) only partially prevented 300pM NMDA insult. Using the caspase- 
3 inhibitor acetyl-aspartyl-glutamyl-valyl-aspart-1-aldehyde (DEVD-CHO) (lOOpM, 
1-hour pre-incubation), cerebrocortical OPCs were fully protected against lOOpM 
kainate with 50pM cyclothiazide (3-hour exposure, assessed 24-hours following 
insult) induced excitotoxicity (Liu et al., 2002). Hoechst 33342 fluorescent staining 
was used to complement OPC apoptosis following 6-hour kainate and staurosporine 
exposure. Pyknotic nuclei, a hallmark of apoptotic cell death (see chapter 2 
introduction), were identified by round, smaller, clumped nuclei and condensed 
chromatin with bright blue fluorescent nuclei compared to normal cells (Tekkok & 
Goldberg, 2001) and are illustrated in chapter 2 results, figures 2.10a-e. 
Staurosporine (500nM) over a 6-hour insult confirmed OPC death involved apoptosis 
and this effect was again prevented by Z-VAD-fmk (lOOpM). Moreover 6-hour 
kainate (300pM) exposure resulted in -40%  of the population of OPCs displaying 
pyknotic nuclei (p<0.05), however using Hoechst 33342 staining, Z-VAD-fmlc 
(lOOpM) did not prevent kamate toxicity contraiy to the fluorescein diacetate -  
propidium iodide cell viability findings. Hoechst 33342 staining can be speculative in 
terms of the obsei*vers’ judgement, and hence why this assay alone cannot be used to 
define whether or not a process occurs. However it does serve as a useflil guide and 
can complement alternate methods for studying cellular death. As to why kainate 
toxicity did not appear to be prevented (even partially) by Z-VAD-fmk using Hoechst 
staining can possibly be explained using the very interesting research of Johnson et al. 
(2000). This group used Hoechst 33358 stahiing to examine the nuclear 
morphological changes that occur during apoptosis of Jurkat T cells (a human T-cell
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leukaemic cell line). Jurkat cells were exposed to SOOnM staurosporine alone and in 
the presence of Z-VAD-fmk (50pM) for 3-hours. Untreated cells displayed nuclear 
morphology reminiscent to that of OPC control cultures. Staurosporine treatment 
resulted in the appearance of pyknotic nuclei, again similar to the observations seen 
with OPC cultures. However, staurosporine in the presence of Z-VAD-fmk revealed 
nuclear morphology that was unlike control and staurosporine only treated cells. The 
nuclear morphology did not display the typical condensed nuclei, but rather a 
strikingly "creased’ or partially condensed nuclei was observed. The group concluded 
that these findings were of pre-apoptotic cells, that caspase activation is a down 
stream event in the process of apoptotic cell death and that these cells, by using 
caspase inhibitors, were halted in the apoptotic cascade. Johnson et <7/.’s (2000) 
research therefore indicates as to why OPCs exposed to staurosporine and in the 
presence of Z-VAD-fink were mistaken for displaying pyknotic nuclei during Hoechst 
analysis, when in fact the morphology was that of a pre-apoptotic state. As kainate- 
induced OPC toxicity appeared to indicate caspase activation, western blotting was 
used to determine caspase-3 activation. OPC cultures treated for 6-hours with either 
kainate (300pM) or the positive control staurosporine (SOOnM) were probed with the 
antibody anti-caspase-3, which detects the 34kDa procaspase form as well as the 
cleaved 17-20kDa forms of caspase-3. The control revealed the presence of the intact 
34kDa fi*agment and is in agreement with the findings of Gu et ah (1999) and 
Osterhout et a l  (2002) who reported that oligodendrocyte cultures express procaspase 
-3. Caspase-3 western blots to staurosporine insult showed a very weak band at 17- 
20kDa and a strong 34kDa procaspase band and therefore indicated weak caspase-3 
activation. Gu et a l  (1999) found that cerebrocortical oligodendrocytes exposed to 
IpM  staurosporine did not result in caspase-3 activation, but did however result in
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activation of caspase-8. In contrast, Craighead et a l  (1999) reported caspase-3 
activation in naïve M03.13 cells treated with 30nM staurosporine. OPC death 
following kainate insult in the present study only showed a very weak 17-20kDa 
fragment compared to control, providing inconclusive results. In contrast to this, Liu 
et a l  (2002) in whole brain OPCs treated with lOOpM kainate and 25 pM 
cyclothiazide for 6-hours, resulted in caspase-3 activation assessed by Western 
Blotting with an antibody against cleaved caspase-3 (17kDa).
The fluorescein diacetate -  propidium iodide cell viability assay revealed that 
300pM kainate exposure for 6-hours decreased cell viability to -60% , whereas the 
same insult, but assessed by Hoechst stain analysis, showed only 40% of cells 
displayed pyknotic nuclei. The present findings therefore suggest that caspases are 
possibly not the only processes activated following AMPA receptor-mediated over­
activation. Since previous studies have indicated that kainate-induced excitotoxicity 
in cultured oligodendrocytes results in Ca^^ influx, we next examined the role of the 
Ca^^-activated proteases, calpains, by using the calpain inhibitor PD 150606 (3-(4- 
iodophenyl)-2-mercapto-(Z)-2-propenoic acid). PD 150606 interacts with a 
molecular domain distinct from the active site of calpain, possibly the Ca^^ binding 
site of the enzyme and prevents its activation (Wang et a l, 1996). In the present 
study 4pM and lOpM PD 150606 did not prevent 24-hour kainate-induced OPC 
toxicity. Studies have reported that even though calpain activation may result 
following excitotoxin-induced cell death in cerebrocortical neurones, calpain 
inhibition is ineffective against this insult (Faddis et a l, 1997; Moore et a l, 2002). 
Indeed Faddis et a l  (1997) in neocortical neurons, claimed that following NMDA 
receptor-mediated excitotoxicity, the calpain activation that ensued fiom this insult 
was involved in neurite regeneration. Cleavage of a-fodrin was also examined by
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Western blotting to determine calpain/caspase activation following OPC death. The 
cytoskeletal protein a-fodrin is a substrate cleaved by both caspases and calpains 
during apoptosis. The 240-280kDa intact a-fodrin protein is cleaved by both caspases 
and calpains to a 145-lSOkDa doublet. Caspase-3 is reported to cleave a-fodrin to a 
120kDa fragment. The positive control staurosporine (SOOnM) 6-hour insult resulted 
in cleavage of a-fodrin to the 145-1 SOkDa doublet and also the 120kDa fragment, 
both bands were more intense than the control lane. These findings indicate that 
staurosporine insult results in caspase-3 activation. Moreover kainate-induced 
toxicity (300pM) 6-hour insult also resulted in cleavage of a-fodrin to the 145- 
1 SOkDa fragments compared with control, a-fodrin analysis following kainate-insult 
also resulted in the presence of the caspase-3 cleaved 120kDa a-fodrin fragment, 
however it was not overtly obvious whether this band was different to control. Liu et 
a l  (2002) also examined a-fodrin cleavage in rat OPCs and found the presence of the 
145-1 SOkDa doublet and also the 120kDa fragment following 6-hour kainate 
(lOOpM) and cyclothiazide (25 pM) treatment. In the same study Liu et a l also 
prevented kainate/cyclotliiazide-induced OPC death with 2pM PD 150606.
The findings from the present study suggest that kainate-induced toxicity 
results in activation of the apoptotic cascade that includes caspase involvement and 
possibly a caspase-3 component. A hypothetical mechanism for the intracellular' 
events that occur following kainate-induced toxicity in rat cultured OPCs could be 
that kainate exposure results in Ca^^ influx leading to Ca^ "^  overload and loss of 
mitochondrial homeostasis. This could then lead to the formation of a mitochondrial 
permeability transition pore and release of cytochrome c. Osterhout et a l  (2002) have 
demonstrated rat OPCs express Apaf-1 and procaspase-9, as well as the pro-apoptotic 
molecule Bad in culture. Therefore the presence of Apaf-1, pro-caspase-9.
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cytochrome c and ATP would lead to the formation of an apoptosome and subsequent 
activation of capsase-9. Caspase-9 is a substrate for the activation of caspase-3. 
Caspase-3 will then go on to cleave structural proteins (e.g. lamins) resulting in 
chromatin condensation and nuclear fragmentation; inhibitor of caspase activated 
DNase (ICAD) (so releasing CAD), which leads to fragmentation of DNA into 
nucleosomal units; and inhibition of the enzyme poly (ADP-ribose) polymerase. Z- 
VAD-ftnk partially attenuated 300pM kainate toxicity at 6- or 24-hour exposures and 
therefore indicated involvement of an alternate process, which did not appear to 
involve calpain activation. If  indeed the formation of a mitochondrial permeability 
transition pore resulted with release of cytochrome c, it may be plausible to consider 
the release of apoptosis-inducing factor (ABF) also occurred. This flavoprotein is a 
mediator of non-caspase-mediated apoptosis and can cause chromatin condensation 
and fragmentation of nuclear DNA (Love 2003).
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Chapter 3
its role in the brain and in exdtotoxicitY
1 2 2
3.1 it’s role in the brain and in excitotoxicity
Zn , an essential nutrient, is one of the most abundant trace elements in the 
body. Humans contain approximately 2-4g of Zn^^ (Rink & Gabriel, 2000), and since 
there is no specialised Zn^ "^  storage system in the body, it has to be obtained from 
dietary intake on a regular basis. In microorganisms, plants and animals, over 300 
enzymes require Zn^^ such that this element can serve three functions in Zn^ "^ - 
requiring enzymes: catalytic, coactive and structural (e.g. table 3.1). Zrf^ has two 
properties; firstly unlike other metals it is virtually non-toxic by excessive ingestion, 
in contrast to iron, copper and mercury. Secondly the physical and chemical 
properties of Zn^\ including its generally stable association with macromolecules, 
make it highly adaptable to meeting the needs o f proteins and enzymes that cairy out 
diverse biological functions (Vallee & Falchuk, 1993).
Enzyme Number of ions and 
their function
Enzyme class
Alcohol dehydrogenase 1 for stability Oxidoreductase
1 for enzyme activity
RNA polymerase 2 for catalytic activity Transferase
Alkaline phosphatase 2 for catalytic activity and Hydrolase
co-activity
Carbonic anhydrase 1 for catalytic activity Lyase
Aldolase II (fungi) 1 for catalytic activity Isomerase
t-RNA synthetase 1 or 2 for catalytic activity Ligase
Table 3.1. Enzymes with Zif^ as a co-factor (examples in each enzyme class) (Rink 
& Gabriel, 2000).
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Zn is essential for cell proliferation and differentiation. For example it is a 
structural ion of biological membranes and is also important in protein synthesis. 
Moreover the concept of Zn^’*' fingers explains the role of Zn^^ in gene expression, 
DNA synthesis, RNA synthesis, cell division and endocrine function. Zn^^ also 
interacts with important hormones involved in bone growth such as somatomedin-c, 
oesteocalcin, testosterone, thyroid hormones and insulin. It is linked to bone 
metabolism, whereby its concentration is very high compared with other organs and 
tissues (see table 3.2) and is considered to be an essential component of the calcified 
matrix. Zn^  ^ also stimulates DNA synthesis of bone cells through the enhancement of 
vitamin D.
Zn^^ content
Organ/tissue pg/g organ dry weight % whole-body Zif^
Muscle 51 57.0
Bone 100 29.0
Skin 32 6.0
Liver 58 5.0
Brain 11 1.5
Kidneys 55 0.7
Heart 23 0.4
Hair 150 0.1
Plasma 1 0.1
Table 3.2. Zn^^ content of human organs (Rink & Gabriel, 2000).
Zn^  ^ deficiencies lead to impairment of growth; which can be fatal if the 
foetus is deprived, and also if the mother is deficient, milk production during lactation
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is hindered, suppression if the immune response and retardation o f the central nervous 
system; such that a Zn^^ deficiency in children impairs long term intellectual 
development (Vallee & Falchuk, 1993; Rink & Gabriel, 2000, Salgueiro et a l, 2002).
In addition, there is also increasing evidence for a direct signalling function 
for Zn^^ on all levels of signal transduction (i.e. either as a structural element or 
regulatory factor or both), such as hormone receptors (e.g. oestrogen receptor), 
intracellular second messenger metabolism (e.g. Ca^  ^ signalling and cyclic nucleotide 
metabolism), cascades of protein kinases (e.g. receptor tyrosine kinases and mitogen- 
activated protein kinases), protein phosphorylation and dephosphorlyation, and 
activity of transcription factors (e.g. metal response element-binding transcription 
factor-1 (MTF-1)) (Beyersmann & Haase, 2001).
Zn^ "^  is present in particularly liigh levels in the brain with an overall Zn^^ 
content of about 150pM (Frederickson, 1989) and Zn^^ homeostasis is very closely 
regulated. The highest levels of Zn^^ are found in the hippocampus, amygdala and 
cortex, 30-40% of the cellular Zn^^ is localized in the nucleus, 50% in the cytosol and 
cytosolic organelles and the remainder is associated with membranes (Vallee & 
Falchuk, 1993). 90% of the cellular Zif^ is bound or at least associated with protein 
or complexed by anions and this therefore maintains very low (nM) concentrations of 
intracellular Zn^  ^ (Frederickson, 1989). Regulation of Zif^ homeostasis is controlled 
either by Zn^^ binding proteins or via Zn^^ transporters. The major Zn^^ binding 
protein is metallothionein (MT) which donates Zn^^ to enzymes and transcription 
factors with zinc finger domains, whereas the apoprotein tliionein accepts Zn^^ from 
binding sites in proteins with moderate affinity for Zif^ (Maret, 2001). In the CNS 
three isoforms of the cysteine rich MTs are considered to be expressed (MTl-3), with 
MT-3 expression occurring exclusively in the brain and is considered to function by
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buffering intracellular (Coyle et a l, 2002). At present there are two putative 
families of mammalian Zn^^ transporters, ZnT and ZIP. ZnT are considered to 
maintain Zn^^ efflux from the cell (e.g. ZnT-1, ZnT-2 and ZnT-4) (McMahon & 
Cousins, 1998; Harris, 2002). The ZIP family of transporters (e.g. human transporters 
hZIPl, hZIP2 and hZIP3) have been identified and are considered to take part in Zn^^ 
influx (Gaither & Eide, 2001; Harris, 2002). The mechanism by which Zn^ "^  is taken 
up by neurones and glial cells is poorly understood, DMTl, a divalent metal 
transporter, as well as the ZIP family of transporters may be likely candidates for Zn^^ 
uptake into neuronal and glial cells (Colvin et a l, 2000; Colvin, 2002).
The remainder of total brain Zn^ ^  (-10%) is concentrated in a chelatable pool 
localised to synaptic vesicles (Frederickson, 1989), whereby it may be released upon 
excitation and may play a role in modulation of synaptic transmission. Indeed Zn^ "^ , 
in neuronal cultures has been shown to alter the function of several membrane 
receptors and channels such as inhibition of NMDA- and GABAA-receptor mediated 
currents (Dingledine et a l, 1999), potentiation of AMPA, glycine, P^x- and ATP- 
receptor mediated responses (Weiss et a l, 1993; Smart et a l, 1994) and blockade of 
voltage-gated Na^ and Ca^^ channels (Harrison & Gibbons, 1994).
The chelatable pool of Zn^^ which has been extensively studied 
immunohistochemically, is localised in the pre-synaptic vesicles of excitatoiy 
(glutamatergic) nerve terminals (Frederickson, 1989) in up to millimolar 
concentrations (Assaf & Chung, 1984), however it should be noted that not all 
glutamatergic neurones contain these Zn^ "^  vesicles. The Zif^ transporter ZnT-3 is 
found in synaptic vesicles of Zn^^-containing pathways and appears to be necessary 
for loading Zn^^ into vesicles (Palmiter et a l, 1996). Strong activation of Zn^^- 
containing presynaptic terminals results in transient local synaptic Zn^^ concentrations
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in the range of 100-300pM (Assaf & Chung, 1984). Moreover Zn^^ release is 
considered to be in even larger quantities during high excitatory synaptic activity, 
such as epilepsy, transient global ischaemia and brain trauma, and under these 
conditions Zn^^ has been show to be neurotoxic (Frederickson, 1989; Koh et al., 
1996; Suh et a l ,  2000). Toxic translocation of presynaptic Zn^^ into postsynaptic 
neurones has also been implicated in the pathogenesis of selective neuronal death 
following transient global ischaemia, prolonged seizures, and trauma (Koh et a l, 
1996; Suh et a l, 2000). The link between Zn^^ toxicity and excitotoxicity comes 
from the fact that Zn^ "^  is co-released with glutamate, and since glutamate is also 
released in large quantities during CNS injury, then it is probable that Zn^^ may be a 
key component in excitotoxicity. Indeed recent evidence suggests that Zn^^ is co­
released with glutamate and that this contributes to excitotoxic neuronal cell death 
(Choi et a l, 1988; Koh et a l, 1996; Marin et a l, 2000; Suh et a l, 2000; Weiss et a l,  
2000; Manzerra et a l, 2001). The routes of Zn^^ entry into the cell, during high 
synaptic Zn^^ concentrations, are most likely to be through divalent Ca^^-permeable 
channels and have been classified into four main pathways wliich are: 1) activation of 
NMDA receptors by glutamate, 2) via voltage-dependent Ca^^ channels (VDCC), 3) 
via activation of Ca^^-impermeable AMPA/kainate receptors, therefore depolarising 
the cell and activating VDCC and 4) via activation of Ca^^-permeable AMPA/kainate 
receptors (Choi et a l, 1988; Weiss et a l, 1993; Kercher et a l, 2000; Kim et a l, 2000; 
Weiss & Sensi, 2000). Recent data in vitro suggest a trend in favour of Zn^ "^  
translocation through activation of Ca^^-permeable AMPA/kainate receptors (Sensi et 
a l,  1999) as AMPA-receptor activation was shown to potentiate Zn^^ toxicity in 
neuronal cultures (Weiss et a l,  1993, Sensi et a l ,  2000).
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The intracellular events leading to cell degeneration due to zinc toxicity 
remain largely unknown. Emerging evidence suggests a role for mitochondrial 
alteration leading to free radical production. In cultured cortical neurones and 
cerebellar granule neurones, Zn^^ entry through Ca^^-dependent AMPA/kainate 
channels or L-type Ca^ "^  channels causes a loss of mitochondrial membrane 
polarization, ATP depletion and increased reactive oxygen species generation and 
ultimately results in cellular death (Manev et a l, 1997; Sensi et al., 1999; Sheline et 
al, 2000). Indeed, Sensi and co-workers suggested that Zn^^ is directly taken up into 
mitochondria of intact neurones, and during excess Zn^^ toxicity the buffering 
capacity of mitochondria is lost and subsequent ROS production ensues. Moreover 
Zn^ "^  actions may be more potent then those of Ca^^, in that most often Zn^ '*' influx 
may lead to unrecoverable loss of mitochondrial function (Sensi et a l,  2000). The 
type of death as a result o f Zn^^-insult is at present unclear with both apoptotic and 
necrotic cell death pathways arising depending on severity, duration, cell and nature 
of insult applied (Kim et a l, 1999b; Lobner et a l, 2000). As to the effects of Zn^^ 
toxicity on glial cells, research is very limited since most studies have used neuronal 
paradigms. Koh & Choi (1994) and Dineley et a l  (2000) both found that astrocytes 
were more resistant to Zn^^ toxicity than neurones. There are no studies at present 
determining the cellular effects of Zn^^ in microglia and oligodendrocytes.
The aim of the present study therefore was to determine whether OPCs were 
also susceptible to Zn^^-mediated toxicity and whether this included AMP A receptor- 
mediated potentiation ofZ if^ toxicity. Moreover if OPCs were susceptible to Zif^ 
toxicity then the cellular events leading to CPC death would also be examined.
1 2 8
3.2 Methods
3.2.1 Reagents
ATP Bioluminescence Assay Kit CLS II was supplied from Roche Molecular 
Biochemicals (Germany). Sodium pyruvate (lOOmM stock in lOmM HEPES buffer) 
was purchased from BDH. "^ ^Zinc chloride (2.26 mCi mg’ )^ was purchased from NEN 
Life Sciences Ltd, UK. Zinc sulphate (lOOmM stock in lOmM HEPES buffer), 
cycloheximide (2mg ml'  ^ stock in 100% ethanol), gadolinium chloride (lOmM stock 
in milliQ grade water) and all other reagents and chemicals were purchased from 
Sigma (UK).
3.2.2 Determination of cell viability
In all experiments cells were aged between 13-18 days in vitro. All dilutions 
were in lOmM HEPES buffer. Cells were dosed for 6 or 24-hours (or as stated) in 
duplicate or quadruplicate for MTT-assay. Z-VAD-frnk was added 2 hours prior to, 
PBN, trolox, DPPD and PD150606 were added 1 hour prior to Zn^^ exposure. Other 
modulators were added 5 minutes prior to Zn^^ exposure. Cell viability was 
determined either by dual staining with fluorescein diacetate and propidium iodide or 
MTT-reduction.
3.2.2.1 Dual staining with fluorescein diacetate and propidium iodide 
As described in section 1.2.4 methods.
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3,2.2,2 MTT-Based cytotoxicity assay
Cell viability could also be determined using the MTT-based cytotoxicity 
assay originally described by Mossmann (1983). MTT (3-(4,5-dimethylthiazol-2-yl)- 
2,5-diphenyltetrazolium bromide) is a yellow water-soluble tétrazolium dye which is 
reduced by live cells via mitochondrial dehydrogenase activity to a purple formazan 
product for which the absorbance can be measured on a 96-well plate reader. Briefly, 
after 24-hour drug exposure (or as specified) lOpl MTT (5mg ml'^) was added to each 
well. The plate was incubated at 37°C/5% 002/95% humidified air for 30 minutes 
(Figure 3.1).
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Figure 3.1. Time-course of increasing absorbance with reduction of MTT in OPCs. 
OPCs were incubated with lOpl MTT (5mg ml'^) for specified time point. Incubation 
was terminated and MTT-reduction quantified as described in section 3.2.2.2. 30- 
minute OPC incubation with MTT produced a submaximal response. Data are 
expressed as mean (± S.E.M.) optical density (OD) at 540nm per mg protein of tliree 
experiments.
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After this duration media was removed and the formazan ciystals formed were 
solubilized with DMSO (150|il) and Sorensen's glycine buffer (25pi; O.IM glycine; 
O.IM NaCl, pH 10.5). Subsequently the plate was shaken at 200rpm for 15 minutes 
and absorbance (at 540nm) measured using a multiplate reader (Lab Systems 
Multiscan® Bichi'omatic). Data were normalised by removing background (MTT, no 
cells) absorbance values from test values. Data were then expressed as percentage 
100% control cell viability (HEPES buffer).
3.2.3 uptake
Cellular uptake was examined using based on a previously
described neuronal methodology (Snider et a l, 2000). In a 96 well plate format, cells 
(and cell-fi'ee well plastic controls) were washed and pre-incubated with HBSS (10 
min, 37°C). HBSS was then replenished with HBSS containing ^^ZnCl2 (1 pCi ml'^) 
together with appropriate drug of interest and incubated for 15 min at 37°C. 
Subsequently, HBSS was removed and cells washed four times with modified ice- 
cold HBSS (supplemented with ImM ZnS0 4  and lOraM EDTA). Following cell 
solubilization (0.2M NaOH, overnight), ^^Zn^  ^ uptake was quantified by liquid 
scintillation spectrometry and protein content determined by the Lowry method, using 
BSA standards as previously described in section 2.2.3.1 methods.
131
3.2.4 Reactive oxygen species production
Cellular oxidative stress was assessed via monitoring 2’, T -  
dichlorofluorescein (2%7'-DCF) accumulation. Cells were seeded (50,000 cells well" 
onto poly-D-lysine-coated (10 pg ml" )^ FluoroNunc 96-well plates. At 14-16 DIV 
culture media was replaced with HBSS and cells incubated with 2% T -  
dichlorodihydrofluorescin diacetate (100 pM, 30 minutes), washed, and then exposed 
to Zn^ "^  (lOOpM and 300pM) and H2O2 (200pM) for up to 4hrs. Fluorescence 
intensity (485 mn excitation and emission 530 nm) was then determined using a 
Denley Wellfluor fluorescence microplate reader and fluorescence intensity values 
transformed using 2’,7’-DCF standards. Data subsequently expressed per mg protein 
whereby protein per well was quantified by the Lowry protein measurement, using 
BSA standards as described in section 2.2.3.1.
3.2.5 Quantification of Chromatin Condensation
Nuclear morphology was assessed using the nucleic acid fluorescent probe, 
Hoechst 33342. Cells, on coverslips, were exposed to either HEPES control Zn^ "^  
(lOOpM and 300pM) or staurosporine (500nM) for 6-hours at 37°C 5%C02/ 95% 
humidified air and were subsequently fixed in 4% (w/v) foimaldehyde (30 minutes), 
washed twice with PBS and then exposed to Hoechst 33342 (3pg m l'\ 8 minutes). 
Following a further wash, cells were mounted (50 % glycerol; 50 % PBS) and viewed 
(365nm excitation and > 420nm emission) using a Zeiss Axiovert fluorescence
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microscope. Nuclei were scored as either normal (uncondensed chromatin), or 
apoptotic (highly condensed chromatin, yielding a high blue fluorescence or 
fi-agmented into discrete apoptotic bodies). Cell counts were taken from 2 random 
fields of view and expressed as percentage total condensed nuclei in a field of view.
3.2.6 Detection of caspase-3 and calpain involvement bv Western Blot analysis
Activation of caspase-3 and calpain involvement was examined by Western 
Blot analysis using the mouse monoclonal anti-a-fodrin (all-spectrin, as described in 
chapter 2 methods) antibody. Cells (2 x 10  ^ cells/12ml T80cm^ flask) were exposed 
to toxins Zn^ "*" (300pM) and staurosporine (500nM) for 6-hours at 37°C 5% C02/95% 
humidified air. Then as described in section 2.2.5 methods except only probed with 
the monoclonal antibody to anti-a-fodrin.
3.2.7 Measurement of cellular ATP levels.
Determination of cellular ATP was examined using an ATP Bioluminescence 
Assay kit whereby ATP concentration is directly proportional to light output 
according to the following equation: -
ATP + D-luciferin + O2 ----- ► oxyluciferin + PPi + AMP + CO2 + light
Cells (seeded at a density of 25,000 cells well'^ in 96-well plates) were exposed to 
Zn^^ (lOOpM and 300pM) for up to 24-hours alone or in the presence of pyruvate
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(5mM). The mitochondrial protonopliore carbonyl cyanide-;w-chlorophenylhydrazone 
(CCCP) (lOOinM stock in 100% DMSO and used at a final concentration of lOOpM) 
was used as a positive control to ensure assay was functioning correctly. After toxin 
exposure for appropriate time, media was aspirated from each well, cells were lysed 
(lOOpl) with IM HCIO4 : 50mM EDTA (except protein deteraiinant wells (200pl, 
0.2M NaOH)) and immediately stored at -20°C overnight. The following day plates 
were defrosted at room temperature and 100pi of media fi’om each well was 
transferred to a 0.5ml microtube and stored on ice. Samples were subsequently 
centrifuged for 1 minute at 13,000rpm and pH then adjusted to pH 7.4 using 3M 
KOH: 1.5M Tris (0°C, 28pl). Following centrifugation at 13,000rpm for 1 minute, 
50 pi each sample (performed in quadruplicate) and 50 pi of each ATP standard in 
triplicate (16.5M stock in milliQ grade water, diluted in neutralised buffer to give 
final range [lOOpM-lpM]) was transferred to a white microassay plate (Opti plate 96- 
well, Packard Bioscience) and was followed by addition of 50pl luciferase reagent, 
prepared according to manufacture's instructions (10ml milliQ grade water to 1 bottle 
luciferase reagent, lyophilised). Relative light units (RLU) were determined using a 
Packard Lumicount Microplate luminometer set with a gain of 32 and PMT 1100, 10 
second read time. RLU were subsequently transformed using the ATP standards and 
expressed as ATP mg‘^  protein, where protein was quantified using the Lowry method 
as described in section 2.2.3.1 methods.
3.2.7 Statistical Analysis
As describe in section 1.2.5 methods.
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3.3. Results
3.3.1 Potential of Zn^ '^  toxicity in rat cultured OPC
OPC viability decreased with increasing concentrations of zinc sulphate 
(pECso value of 4.1 ± 0.1). As outlined in Figure 3.2, toxicity experiments were 
repeated so that the cell viability methods MTT-reduction (open squares) or FDA-PI 
dual staining (open circles) could be compared. Statistical analysis between the two 
methods showed there was there was no significant difference in cell viability 
between the two.
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Figure 3.2. Zv^^ induces OPC death in a concentration-dependent mamier afl;er 24- 
hour exposure. (□ )  MTT-reduction cell viability assay; (O) Fluorescein diacetate -  
propidium iodide staining cell viability assay. Data represents the mean (± S.E.M.) of 
at least four experiments.
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3,3,2 Time-course study o f toxicity
OPCs were exposed to lOOpM and 300pM Zn^^ over 24-hours in order to 
examine the rate of OPC death with different concentrations of Zn^ "^ . As illustrated in 
Figure 3.3 lOOpM Zn^^ caused significant (p<0.01) death (47.4+8.5% cell viability) at 
24-hour Zn^^-insult. 300pM Zn^^ insult showed rapid cell death compared to lOOpM 
Zn^\ whereby cell viability significantly (p<0.01) decreased to 26.4+1.0% after 6- 
hour exposure. Cell viability decreased to 11.3+1.7% (p<0.01) at 9-hour Zn^^-insult 
and virtual total cell death was observed at 24-hour exposure (5.1+3.5% cell viability,
p<0.01).
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Figure 3.3. Time-course of Zn^^-induced toxicity in rat cultured OPC. Normalised 
data represents the mean (+ S.E.M.) of four experiments. (■ ) lOOpM Zn^^ and (O ) 
300pM Zn^ .^ ** P<0.01 versus 24-hour control (HEPES) (one-way ANOVA
(Dumiett post-test)). Cell viability determined by MTT-reduction.
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3.3.3 Potential involvement of glutamate receptors
As has been suggested to be co-released with L-glutamate and Weiss et 
al. (1993) showed Zn^^ toxicity was potentiated by activation of AMP A receptors, the 
AMP A receptor antagonist Evans Blue was utilised to help determine AMP A receptor 
involvement in the mechanism of Zn^^ toxicity. lOOpM Zn^  ^ significantly (p<0.001) 
decreased cell viability to 37.2+8.5% over 24-hours insult (Figure 3.4). Evans Blue 
(lOpM) alone, failed to influence cell viability (101.1 ±3.9%) and in the presence of 
Zn^  ^(lOOpM) failed to attenuate cell death.
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Figure 3.4. Lack of effect of lOpM Evans Blue on Zn^^-induced OPC toxicity after 
24-hour exposure. Data represents the mean (+S.E.M) of four experiments. One-way 
ANOVA (Tukey-Kramer multiple comparisons test). Cell viability determined by 
FDA-PI dual staining.
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To test for AMP A receptor activation using an AMP A receptor selective 
antagonist the first choice compound would be GYKl 52466, however solubility 
issues concerning this compound meant it was unable to be used with Zn^ .^ Initial 
studies using GYKI 52466 with Zn^  ^ (data not shown, n=2) showed increased 
susceptibility to OPC mediated death compared to Zn^  ^ alone. The control vehicle 
DMSO (0.1-0.5% 7v) had an identical effect. As illustrated in Figure 3.5, Zn^  ^
(lOOpM and 300pM) alone caused significant cell death after 24-hours exposure 
(lOOpM; 49.8+7.0% cell viability, p<0.001; 300pM; 15.3+6.3% cell viability, 
p<0.001). In the presence of 0.1% DMSO, lOOpM Zn^  ^ significantly decreased cell 
viability to 23.5+6.3% (p<0.05). DMSO in the presence of 300pM Zn^^ and alone 
failed to influence cell viability (101.4+2.5%).
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Figure 3.5. Effect of DMSO in Zn^  ^ -induced OPC toxicity after 24-hour exposure. 
Data represents the mean (+S.E.M.) of at least four experiments. * P<0.05 versus 
lOOpM Zn^^ (one-way ANOVA (Tukey-Kramer multiple comparisons test)). Cell 
viability determined by FDA-PI staining.
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In order to determine whether there was an indirect relationship between Zn^' 
and AMP A receptor activation, that is, could kainate potentiate Zn^  ^ toxicity, kainate 
(lOOpM) was examined in the presence of Zn^ .^ As illustrated in Figure 3.6 lOOpM 
Zn^  ^ alone decreased (p<0.001) cell viability to 30.5+3.1% and this effect was not 
significantly enhanced by lOOpM kainate. 30pM Zn^^ alone did not affect cell 
viability (66.4+2.3%) and in the presence of lOOpM kainate, Zn^  ^ (30pM) cell death 
was not increased (v& kainate). Kainate alone (lOOpM) decreased (p<0.01) cell 
viability to 50.9+8.7%.
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Figure 3.6. Lack of effect of kainate on Zn^^-induced OPC toxicity after 24-hour 
exposure. Data represents the mean (+S.E.M.) of three to eight experiments. *** 
P<0 001 versus control (HEPES) (one-way ANOVA (Tukey-Kramer multiple 
comparisons test). Cell viability determined by FDA-PI staining.
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To ensure that the sulphate group of the bound form of Zn^^ (i.e. zinc 
sulphate) did not affect cell viability sodium sulphate was examined. As illustrated in 
Figure 3.6 sodium sulphate did not affect OPC viability after 24-hours exposure 
(93.8+2.8%).
Recent data suggest (Weiss & Sensi, 2000) cellular Zn^^ accumulation may 
occur also via L-type Ca^ "^  channels. Therefore nicardipine, an L-type Ca^ "^  channel 
blocker, and gadolinium chloride (GdCls), a broad spectrum Ca^^ channel blocker, 
were used to investigate this statement. lOOpM Zn^^ significantly (p<0.01) decreased 
OPC viability to 49.8+7.2% after 24-hour insult (Figure 3.7). Nicardipine (IpM) and 
its compound veliicle ethanol (0.1% 7v) failed to influence cell viability and in the 
presence of Zn^^ nicardipine afforded no protection. Interestingly GdClg (lOpM) 
alone resulted in OPC death (29.7+10.3%, p<0.001) after 24-hour exposure.
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Figure 3.7. Lack of effect of IpM nicardipine and lOpM gadolinium chloride on 
Zn^^-induced OPC toxicity after 24-hour exposure. Data represents mean (±S.E.M) 
of at least four experiments. *** P<0.001 versus control (HEPES) (one-way ANOVA 
(Tukey-Kramer multiple comparisons test). Cell viability determined by FDA-PI dual 
staining.
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Confirmation of the previous results was achieved by measuring ^^Zn^  ^ influx 
into OPCs upon exposure to toxins (Figure 3.8). Kainate (300pM) and IpM 
nicardipine failed to significantly influence ^^Zn^  ^ influx compared to control. 
Whereas the positive control pyrithione (20pM), a Zn^^ ionophore (Dineley et a i, 
2000), caused a significant (p<0.01) increase in ^^Zn^' accumulation when compared 
to control.
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Figure 3.8. ^^Zn^  ^ accumulation study on rat cultured OPC exposed to pyrithione, 
kainate and nicardipine. Data are expressed as mean (S.E.M) of three experiments. 
** P<0.01 versus control (one-way ANOVA (Dunnett post-test)).
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3.3,4 Determination of potential ROS involvement during Zn^-induced toxicity
in rat cultured OPCs.
3.3.4.1 Effect o f free radical scavengers on Zn^^-induced toxicity.
A broad-range of anti-oxidants were used to investigate whether reactive 
oxygen species were generated during a 24-hour Zn^-insult. lOOpM Zn^  ^ decreased 
cell viability to 44.0 ± 4.9% (Figure 3.9a), however neither the spin-trap reagent PBN 
(lOOpM) (Fuchs et a l, 1998) or lOOpM trolox (a vitamin E analogue) (McDonald et 
ai, 1998a) failed to influence zinc toxicity. Alone trolox and PBN had no significant 
effect on OPC viability.
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Figure 3.9a. Lack of effect of free radical scavengers’ lOOpM trolox and lOOpM 
PBN on Zn^-induced OPC toxicity after 24-hour exposure. Data represents the mean 
(+S.E.M.) of at least five experiments. One-way ANOVA (Tukey-Kramer multiple 
comparisons test). Cell viability determined by MTT-reduction.
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As illustrated in Figure 3.9b lOOpM Zn^  ^ decreased OPC viability to 43.4+3.1% 
(p<0.001). DPPD (IpM ) alone failed to affect OPC viability (99.7+2.0%) and in the 
presence of Zn^  ^ did not rescue OPCs from cell death. 5mM A-Acetylcysteine 
attenuated (p<0.001) lOOpM Zn^-induced OPC toxicity.
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Figure 3.9b. Effect of DPPD and A-acetylcysteine (NAC) on Zn^-induced OPC 
toxicity after 24-hour exposure. Data represents mean (+S.E.M.) of at least four 
experiments. *** P<0.001 versus lOOpM Zn^  ^ (one-way ANOVA (Tukey-Kramer 
multiple comparisons test)). Cell viability determined by FDA-PI dual staining.
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3.3.4.2 Effect of on rat cultured OPC ROS production over 4-hours insult
As illustrated in Figure 3.10, HEPES control produced a gradual increase in 
2 , 7 -DCF over time, with starting 2%7-DCF concentration of 199.47+48.80 pmols 
mg'  ^ protein and after 4-hours this increased to 847.83+90.33 pmols mg'  ^ protein 
(p<0.01). Zn^  ^ (lOOpM and 300pM) over a 4-hour insult, failed to elicit significant 
ROS production compared to control HEPES. However the positive control hydrogen 
peroxide (200pM) showed significant (p<0.01, vs. control) ROS levels (945.21+59.79 
nmol DCF mg’* protein) after a 1-hour insult, which reached a maximum at 4-hours 
exposure of 1642+141.84 nmol DCF mg’* protein.
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Figure 3,10. Effect of Zn^^ (lOOpM and 300pM) and hydrogen peroxide (200pM) on 
2%7-DCF production over a 4-hour insult in rat cultured OPCs. (▼) lOmM HEPES 
buffer; ( • )  lOOpM Zn^ ; (■ ) 300pM Zn^ ; ( ^ )  200pM H2O2 . Data represents the 
mean (±S.E.M.) of five experiments. ** P<0.01 versus time-matched control 
(HEPES) (one-way ANOVA (Dunnett post-test)).
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3.3.4.3 Effect of L-NAME on Zn^^-induced OPC toxicity.
L-NAME, a nitric oxide synthase inhibitor, was examined to determine if 
activation of the NO pathway occurred during Zn^^-induced OPC insult. As 
illustrated in Figure 3.11, Zn^^ (lOOpM) decreased cell viability to 39.7+7.8% 
(p<0.001) after 24-hours exposure. L-NAME (500pM) alone failed to influence OPC 
toxicity (96.7+5.7%) and in the presence of Zn^  ^ afforded no significant protection.
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Figure 3.11. Lack of effect of 500pM L-NAME on Zn^^-induced OPC toxicity. Data 
represents mean (±S.E.M.) of four experiments. One-way ANOVA (Tukey-Kramer 
multiple comparisons test). Cell viability determined by FDA-PI dual staining.
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3.3.5 Determination of potential aooptotic or necrotic involvement during Zn^ -^
induced toxicity in rat cultured OPCs.
3.3.5.1 Effect ofZ-VAD-fmk on Zn^^-induced toxicity in OPCs.
The broad-spectmm caspase inhibitor Z-VAD-fmk was examined in this 
experiment to determine if cell death observed with varying concentrations of Zn^^ 
involved activation of the apoptotic cascade. 30pM Zn^^ failed to cause significant 
cell death over a 24-hour insult (101.4+4.6%) and cell viability was not enhanced or 
decreased in presence of Z-VAD-fink (50pM) and 0.05% DMSO (Figure 3.12). 
lOOpM Zn^^ however, significantly deceased cell viability to 63.8+5.8% (p<0.05). In 
the presence of 0.05% DMSO cell viability decreased by -27% , however, this effect 
was not significant. Z-VAD-fmk also failed to attenuate OPC death in presence of 
lOOpM Zn^‘*‘. Moreover 300pM Zn^^ significantly decreased cell viability 
(22.2+4.6%, p<0.001) and this effect was also not rescued by Z-VAD-fink. 50pM Z- 
VAD-fmk and the compound vehicle control 0.05% DMSO alone both failed to 
influence OPC viability.
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Figure 3.12. Lack of effect of Z-VAD-fmk in presence of varying concentrations of 
Zn^  ^ on OPC viability after 24-hours exposure. Data represents the mean (+S.E.M.) 
of four experiments. * P<0.05 and *** P<0.001 versus respective controls (one-way 
ANOVA (Tukey-Kramer multiple comparisons test). Cell Viability determined by 
FDA-PI dual staining.
3.3.5.2 Examination of cellular nuclear morphology after 6-hour Zn^^  exposure.
To further investigate the possibility of apoptotic activation caused by Zn^ "- 
induced OPC toxicity, cellular nuclear morphology was examined over a 6-hour insult 
using the fluorescent nuclear DNA stain Hoechst 33342. The positive control 
staurosporine showed increasing appearance of pyknotic nuclei over the 6-hour insult
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with significant (p<0.05) OPC pyknosis observed after 2-hour staurosporine exposure 
(Figure 3.13). Appearance of pyknotic nuclei can be regarded as a good indication of 
apoptotic activation, however the morphology observed with 300pM Zn^^ over a 6- 
hour insult did not show pyknotic nuclei, however the nuclei had become condensed 
and were different to control (Figure 3.14e) and therefore data had been expressed as 
% condensed nuclei, with the exception of staurosporine (expressed as % pyknotic 
nuclei). Control (HEPES) demonstrated that ~11% of OPC possess condensed nuclei 
(Figures 3.13 and 3.14a).
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Figure 3.13. Time-course study for appearance of condensed nuclei exposed to Zn^\ 
(■)HEPES control, (O) lOOpM Zn^% ( ♦ )  300pM Zn^\ (‘-'A---) 500nM 
staurosporine presented as % pyknotic nuclei vs. time (hours). Data represents the 
mean of four (±S.E.M.) experiments. * P<0.05 and ** P<0.01 versus time-matched 
control (HEPES) using one-way ANOVA (Dunnett post-test).
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lOOfiM failed to cause an increase in nuclear condensation compared to control. 
300pm Zn^  ^ however caused appearance of condensed nuclei after 2-hour insult 
(p<0.05) (Figures 3.13 and 3.14c) with 54.0+8.0% of OPCs demonstrating condensed 
nuclei at 6-hours exposure (p<0.01).
Figure 3.14a. Hoechst 33342 stain o f control OPCs at time = 0.
Figure 3.14b. Hoechst 33342 stain of OPCs exposed to lOOpM Zn^  ^for 6-hours.
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Figure 3.14c. Hoechst 33342 stain o f OPCs exposed to 300pM Zn^^ for 2-hours.
Figure 3.14d. Hoechst 33342 stain of OPCs exposed to 300pM Zn^  ^for 4-hours
Figure 3.14e. Hoechst 33342 stain o f OPCs exposed to 300pM Zn^^ for 6-hours.
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3.3.5.3 Effect of cycloheximide on zinc-induced toxicity on rat cultured OPCs.
Cycloheximide (CHX), a protein synthesis inhibitor, has been reported to 
inhibit neuronal apoptosis (Kim et a i, 1999a). As illustrated in Figure 3.15, CHX 
(Ipg/ml) alone was toxic to OPC cultures (55.5 ± 10.7%, p<0.01).
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Figure 3.15. Effect of cycloheximide (CHX) on rat cultured OPC viability after 24hr 
exposure. Data represents the mean (±S.E.M.) of four experiments. * P<0.05, ** 
P<0.01 and *** P<0.001 versus respective controls (one-way ANOVA (Tukey- 
Kramer multiple comparisons test). Cell viability determined by MTT-reduction.
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3.3.5.4 Effect of calpain inhibitor PD150606 on Zn^^-induced OPC toxicity.
The calpain inhibitor PD 150606 was examined to determine whether 24-hour 
Zn^-induced OPC death involved calpain processing. As illustrated in Figure 3.16 
lOOpM and 300pM Zn^-insult over 24-hours caused significant OPC death, 
50.7+3.6% p<0 001 and 3.6+1.6%, p<0.001 respectively. In the presence of 
PD 150606 (4pM and lOpM), Zn^^-induced cell death at the concentrations tested, 
was not attenuated. PD 150606 (4pM and lOpM) however, in the presence of lOOpM 
Zn^^ significantly (p<0.05 and p<0.001) decreased OPC viability by 29% and 26%. 
PD 150606 (4pM and lOpM) alone did not affect cell viability.
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Figure 3.16. Effect of PD 150606 on Zn^^-induced OPC toxicity after 24-hours insult. 
Data represents mean (±S.E.M.) of four experiments. * P<0.05 and *** P<0.001 
versus lOOpM Zn^^ (one-way ANOVA (Tukey-Kramer multiple comparisons test)). 
Cell viability determined by FDA-Pl dual staining.
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3.3.5.5 Western Blot detection o f a-fodrin cleavage.
The sub-membranous cytoskeletal fibrous protein fodrin was examined in 
order to detect activation of caspase and calpains following 300pM Zn^^ 6-hour acute 
insult. 6-hour Zn^^ insult resulted in what appeared to be little or no activation of 
caspases and calpains compared to control HEPES lane. Moreover as illustrated in 
Figure 3.17 the 240kDa fragment was present with 6-hour acute Zn^-insult, therefore 
confirming presence of intact a-fodrin. The positive control staurosporine (500nM) 
resulted in cleavage of the intact 240kDa a-fodrin fragment and presence of strong 
bands for the 145/150kDa doublet and 120kDa fragments compared to control 
HEPES indicating activation of caspase-3.
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Figure 3.17. Representative image of Western Blot to anti-a-fodrin. (H) HEPES 
buffer lOmM, (Zn^ ) 300pM Zn^^, (STS) 500nM staurosporine.
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3.3,6 Determination of ATP depletion during toxic OPC insult
3.3.6.1 Effect o f pyruvate during Zn^  ^toxic OPC insult
Recent data by Sheline et al. (2000) suggested neuronal cultures were 
susceptible to Zn^  ^ toxic insults via ATP depletion and that this effect could be 
attenuated by pyruvate. As illustrated in Figure 3.18a lOOpM Zn^  ^ decreased cell 
viability to 65.6+6.7% (p<0.001) after 24-hours exposure. 5mM and lOmM pyruvate 
afforded significant protection against Zn^^ (lOOpM) OPC insult. Alone 5mM and 
lOmM pyruvate had no effect on OPC viability.
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Figure 3.18a. Effect of pyruvate on Zn^-induced OPC toxicity after 24-hour 
exposure. Data represent the mean (+S.E.M) of at least five experiments. ** P<0.01 
and *** P<0.001 versus lOOpM Zn^^ (one-way ANOVA (Tukey-Kramer multiple 
comparisons test). Cell viability determined by FDA-PI dual staining.
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300pM 6-hour acute exposure resulted in 39.5+4.0% cell viability (p<0.001. 
Figure 3.18b) and in the presence of 5mM pyruvate cell viability was significantly 
(p<0.001) increased to 58.6+2.9%, however this increase of 19.1% was not a full 
reversal. A similar result was observed with lOmM pyruvate in the presence of 
300pM Zn^^, such that OPC viability was significantly (p<0.001) rescued to 
79.2+1.9%, again this was not a full reversal. 5mM and lOmM pyruvate alone did not 
influence cell viability.
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Figure 3.18b. Effect of pyruvate on Zn^-induced OPC toxicity after 6-hour 
exposure. Data represents mean (+S.E.M.) of four experiments. *** P<0.001 versus 
300pM Zn^  ^ (one-way ANOVA (Tukey-Kramer multiple comparisons test). Cell 
viability determined by FDA-Pl dual staining.
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33.6.2 Time-course study of cellular ATP depletion during Zn^^-induced OPC
toxicity.
Depletion of cellular ATP was examined over 24-hours in the presence of 
lOOpM and 300pM Zn^ .^ As illustrated in Figure 3.19, lOOpM Zn^  ^ only caused 
significant ATP depletion at 24-hours insult, decreasing cellular ATP to 55.6±12.7% 
(p<0.01) versus HEPES control. 300pM Zn^  ^ however caused significant ATP 
depletion at 6-hours insult (17.1±10.0%, p<0.05) with total depletion of cellular ATP 
at 9-hour (5.3+5.2%, p<0.01) and 24-hour (0.1+0.1%, p<0.01) exposures.
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Figure 3.19. Cellular ATP depletion over 24-hours in presence of Zn^ .^ Data 
representative of % mean control ATP levels (+S.E.M.) of at least three experiments. 
HEPES Control 24-hour = 3.35+0.43 nmol/mg protein. (■ ) HEPES control, ( # )  
lOOpM Z n^\ ( ♦ )  300pM Zn^^ and (□ ) lOOpM CCCP * P<0.05 and ** P<0.01 
versus respective time-matched controls (one-way ANOVA (Dunnett post test)).
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The positive control CCCP (lOOpM), a mitochondrial protonophore (Peng, 1998), 
decreased cellular ATP to 53.1+5.3% after 30 minutes exposure, and decreased to 
37.1+5.6% (p<0.05) after 3-hours insult. The vehicle control for this compound 0.5% 
DMSO failed to influence cellular ATP levels. The control HEPES also failed to 
significantly alter percentage cellular ATP over 24-hours exposure.
3.3.63 Effect o f  pyruvate on cellular A T P  levels.
Pyruvate was investigated in order to determine whether the depletion of ATP 
caused by Zn^ "^  insult as previously observed could be reversed by the presence of 
5mM pyruvate. As illustrated in Figure 3.20 lOOpM Zn^  ^decreased cellular ATP to 
87.0+4.6%, however this effect was not significant. Nine-hour Zn^^ (300pM) 
exposure significantly (p<0.001) depleted cellular ATP levels to 39.7+6.2%, but this 
effect was not attenuated by 5mM pyruvate. Six-hour Zn^^ (300pM) insult also 
significantly (p<0.001) decreased cellular ATP to 45.3+7.1% and 5mM pyruvate 
afforded significant (p<0.05) protection against this insult, increasing cellular ATP 
levels to 68.8+5.4% (23.5% increase). 5mM pyruvate alone did not influence cellular 
ATP levels.
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Figure 3.20. Effect of pyruvate on Zn^-induced cellular ATP depletion after 6-, 9- 
and 24-hour exposures. Data represents % mean control ATP levels (+S.E.M.) of at 
least five experiments, where HEPES control 24-hour = 2.8+0.3 nmol ATP/mg 
protein. * P<0.05 versus 6-hour 300pM Zn^^ (Student’s paired /-test).
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3.4 Discussion
Previous studies examining the toxic potential of have mainly focused on 
neuronal cortical cultures, and only recently have data started to examine the effects of 
Z iL  on mixed neuronal and glial cultures (Dineley et a l, 2000; Sheline et a l, 2002). 
This study is the first to report on the toxic effects of Zn^  ^ in a population of rat 
cultured OPCs. OPCs were susceptible to patho-physiologically (i.e. 100-300pM 
Zn^ ,^ Assaf & Chung, 1984) relevant Zn^^ toxic insults, with an ECso value of 70pM 
after 24-hours exposure time. High concentrations ofZn^^ (100-300pM) exposure led 
to OPC death whereas lower concentrations of Zn^  ^(30pM) did not significantly affect 
cell viability. Kim et a l  (1999b) using murine cultures of cortical neurones reported 
that concentrations of 35pM Zn^  ^resulted in over 50% cell death, and that 40pM Zn^  ^
induced complete cell death to both neurones and glia with 24-hour exposure. In 
contrast Marin et a l  (2000) also in mouse cortical neurones reported concentrations of 
300pM Zn^  ^ induced 50% neuronal death after 30-minute exposure and assessed 24- 
hours later. Interestingly with some other neuronal studies, Zn^^-induced toxicity and 
Zif^-infiux could only be achieved when the cell was depolarised such as in the 
presence of 60-90mM (Kim et a l, 2000, Sheline et a l, 2002). This is also in 
contrast to the present study as Zn^  ^alone was toxic to OPCs. lOOpM Zn^  ^exposure 
over a 24-hour insult resulted in significant (p<0.01) OPC death at 24-hours, whereas 
with 300pM toxic insult over 50% of the population of OPCs had died after a 3-hour 
insult (p<0.01) with virtually complete cell death occurring after 9-hours insult 
(p<0.01). Manev et a l  (1996), in rat cerebellar granule cells found that 500pM Zn^^
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applied for 30-minutes and assessed 4-hours later resulted in 30% cell death (p<0.05) 
whereas 24-hours following initial toxic insult resulted in ~50% cell death (p<0.05).
The present study demonstrated that OPC cultures are susceptible to Zn^  ^
toxicity, which is concentration and duration dependent. As lOOpM Zn^^-induced 
-50%  OPC death after 24-hour exposure, findings similar to other paradigms, this 
concentration of Zn^  ^ and exposure time was studied. The next question to answer 
was through which routes did ZiL^ mediate OPC toxicity. As discussed in the 
introduction to this chapter, Zn^  ^ influx is reported to occur via divalent cation 
channels specifically: 1) via activation of NMD A receptors by glutamate; 2) VDCC; 3) 
via activation of Ca^^-impermeable AMPA/kainate receptors, therefore depolarising 
the cell and activating VDCC and 4) via activation of Ca^^-permeable AMPA/kainate 
receptors (Choi et ah, 1988; Weiss et a i, 1993; Kercher et a l, 2000; Kim et a l, 2000; 
Weiss & Sensi, 2000). As OPC cultures do not express NMDA receptors (Patneau et 
al, 1994) and also in the present study NMDA, at concentrations of lOOpM and 
ImM, failed to significantly affect cell viability, Zn^^ influx via functional NMDA 
receptors was extremely unlikely. Moreover, Zn^  ^ has been suggested to be co­
released with glutamate during trauma, therefore the possibility of AMP A receptor 
involvement was investigated. In the presence of lOpM Evans Blue, an AMPA 
receptor antagonist (Keller et a l, 1993), Zif^ toxicity was not prevented. In section 
3.3 results, it was reported that concentrations of 0.1% (%) DMSO significantly 
(p<0.05) enhanced lOOpM Zif^ induced OPC death. The selective AMPA receptor 
antagonist GYKI 52466, the preferred choice to investigate AMPA receptor 
involvement, is soluble to lOmM in 100% DMSO, therefore a working concentration 
of 50pm GYKI 52466, diluted in lOmM HEPES buffer, had a final DMSO 
concentration of 0.5% (%), which although not toxic to OPC cultures alone, in the
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presence of Zn^  ^ was found to enhance Zn^^ toxicity. The increased Zn^  ^ toxicity 
accompanying concentrations of 0.1% (%) DMSO or above could be due to the fact 
that DMSO has a high affinity to transition metals (Meek et a l, 1960). In the present 
study it is plausible to consider that DMSO forms a complex with Zn^ ,^ and since 
DMSO is lipophilic it has the ability to pass through cell membranes, therefore directly 
transporting Zn^  ^ into the cell and thus explains the enhanced toxicity. Therefore the 
solvent of choice for compound solubility in subsequent experiments was to use 
ethanol if possible. GYKI 52466 was unfortunately insoluble in ethanol at the desired 
concentration, and hence why Evans Blue was used instead.
The possibility of AMPA receptor involvement via indirect activation of 
voltage-dependent Ca^ "^  channels was also investigated. Cell viability assays 
demonstrated kainate (lOOpM) in the presence of 30pM and lOOpM Zn^^ failed to 
potentiate Zn^ *^  toxicity. Moreover ^^ Zn^  ^ uptake studies also demonstrated ^^ Zn^  ^
influx which was not influenced by SOOpM kainate, whereas the positive control 
pyrithione significantly (p<0.01) increased ^^Zn^  ^uptake. The Ca^^-channel blockers 
nicardipine (IpM), an L-type channel blocker (Thellung et a l, 2000), and lOpM 
gadolinium chloride (GdCls), a broad-spectmm voltage-gated Ca^  ^ channel blocker 
(Kim et a l, 2000), failed to influence cell viability. Moreover GdCls alone resulted in 
significant OPC death. Kim et a l (2000) demonstrated GdCb in PC 12 cells (a 
neuronal cell line) alone had no effect on cell viability and in the presence of 90mM 
KCl and 500pM Zif^ completely attenuated cell death (p<0.01). Kim et a l  (2000) 
went on to show that Zn^^-induced toxicity in depolarised PC 12 cells was mediated via 
L-type Ca^  ^channels, as Zif^ toxicity was also reduced by nimodipine, an L-type Ca^  ^
channel blocker, and the L-type Ca^  ^ channel opener Bay K 8644 increased Zn^  ^
toxicity. Also in contrast to the present findings, Weiss et a l (1993) using mixed
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cortical cell cultures, demonstrated that kainate (300pM) and (90mM) applied with 
300pM Zn^  ^ for 5 minutes and cell death assessed 24-hours later, potentiated Zn^  ^
toxicity, and in depolarised cells Zn^^ toxicity was again attenuated by L-type Ca^  ^
channel blockers. Weiss later went on to describe that Zn^  ^ influx was preferentially 
through Ca^^-permeable AMPA/kainate receptors (Sensi et a l, 1999). Recently 
Shelme et a l  (2002) also demonstrated ^^Zn^  ^ influx in depolarised cultured cortical 
neurones was also via L-type Ca^  ^ channels. The present observations are not in 
agreement with the above neuronal data as Zn^  ^entiy does not appear to be facilitated 
by activation of NMDA receptors, Ca^^-permeable AMPA/kainate receptors or by 
voltage sensitive L-type Ca^^-channels. Therefore Zn^  ^ influx in OPCs is via an 
alternate route which may be via a Zn^  ^ transporter, Marin et a l  (2000) studied the 
routes of Zn^  ^entry in mouse cortical neurons and speculated that Zn^  ^influx could be 
via a specific Zn^  ^ transporter, either unidentified or alternatively they could not rule 
out the possibility of ZnTl and ZnT4 fiinctioning in reverse mode. At present no data 
is available on Zn^  ^ transporter expression in rat OPCs and also there are no 
pharmacologically selective ZnT blockers or modulators to explore this avenue.
The mechanisms of Zn^^-induced OPC death were also were examined in this 
study. Previous studies suggest a trend in favour of the type of cell death caused by 
Zn^^ depends largely on the concentration of Zif^ and the duration of exposure. Such 
that lower doses of Zn^  ^ (<30pM) may commit neuronal cells to apoptosis whereas 
with larger insults cell death may follow a necrotic route with mediation o f ROS (Kim 
et a l, 1999a; Lobner et a l, 2000; Marin et a l, 2000). Necrotic death is often 
associated with mitochondrial dysfunction, subsequent production of ROS and 
activation of the inflammatory response. Using two different methods to assess ROS 
production following acute and chronic lOOpM and 300pM Zn^  ^exposure, the present
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study failed to show involvement of ROS in Zn^^-induced OPC toxicity. 
Dichlorofluorescin has a high affinity for peroxynitrite but will favour superoxide 
anions and also hydroxy radicals (Possel et a l, 1997). 2’,7’-DCF monitoring failed to 
show an increase in ROS production over a 4-hour acute lOOpM and 300pM Zn^  ^
insult. Moreover following chronic (24-hours) Zn^^ (lOOpM) exposure the spectrum 
of fi'ee radical scavengers trolox (lOOpM), PBN (lOOpM), DPPD (IpM ) and L- 
NAME (500pM) failed to protect against Zn^  ^ toxicity indicating lack of ROS 
production following acute and chronic Zn^  ^ exposure. These data are again in 
contrast to neuronal studies which suggest ROS generation following Zn^  ^exposure as 
trolox and PBN, at the same concentrations and pre-incubations used in the OPC 
study, attenuated neuronal death (Manev et a l, 1997; Kim et a l, 1999a; Kim et a l, 
1999b; Sensi et a l, 1999; Marin et a l, 2000). The lack of ROS may not be too 
surprising since Truong-Tran et a l  (2001) described Zn^  ^ as a well known 
cytoprotectant, and in this role it has the capacity to minimise (directly or indirectly) 
oxidative damage to cells. Directly as Zn^  ^ is a well-known stabilizer of lipids and 
proteins it may therefore protect membranes and macromolecules. Indirectly, Zn^  ^
may act via effects on glutathione, the main intracellular antioxidant, as Zn^^ deficiency 
resulted in glutathione depletion, however further studies are required on this as results 
appear veiy vague as to Zn^^ actions on glutatliione levels especially in the context of 
high concentrations of Zn^ .^ The present study demonstrated that 5mM N- 
acetylcysteine attenuated lOOpM Zn^  ^ OPC death. iV-acetylcysteine is a precursor for 
the antioxidant glutatliione, which may then suggest that the effect of JV-acetylcysteine 
protection against Zn^  ^ toxicity was via an increase in glutathione levels. However 
Ryu et a l (2002) have shown that A-acetylcysteine at the concentrations used in the 
present study chelates extracellular Zif^.
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Studies have demonstrated that sustainable levels of Zn^^ can inhibit activation 
of the apoptotic cascade, but can not however prevent cell death as it is pushed 
towards the necrotic route, whereas Zn^^ deficiency is reported to result in apoptotic 
cellular death (Truong-Tran et a l, 2001). The broad-spectrum caspase inhibitor Z- 
VAD-fmk in the present study failed to improve cell viability during a 30-300pM Zif^- 
insult over 24-hours. Kim et a l  (2000) in PC 12 cells showed significant, though not 
complete reversal of up to 500pM Zif^ toxicity with lOOpM Z-VAD-fmk over 24 
hours. In the present study cycloheximide, a protein synthesis inhibitor reported to 
prevent neuronal apoptosis (Kim et a l, 1999a), also failed to attenuate Zn^^-induced 
cell death, and in fact caused OPC death. McDonald et a l  (1996) using murine mixed 
cortical cultures also observed that oligodendrocytes exposed to 0.5jig/ml 
cycloheximide actually enhanced oligodendrocyte injury. Moreover nuclear
morphology following 6-hour acute and chronic Zn^  ^ exposure, as determined using 
Hoechst 33342 staining revealed no significant change in OPC nuclear morphology 
following lOOpM Zn^  ^ exposure. This finding is not surprising since 6-hour lOOpM 
Zn^  ^did not result in OPC death. 300pM Zn^  ^toxicity at 6-hours however resulted in 
-70%  OPC death, nuclear morphology staining revealed lack of pyknotic nuclei 
compared to the positive control staurosporine (500nM). However nuclear
morphology displayed condensed nuclei that were "‘kidney-bean”-like with a granular 
appearance. Correlating with these findings are from the suggestions that Zn^  ^
cytoprotective functions may enable it to suppress major pathways leading to 
apoptosis, specifically in the regulation of the caspase family of enzymes (Stennicke & 
Salvesen, 1997). For example caspase-3 has been established as a target for Zn^ ,^ 
however it is not clear whether Zn^  ^ blocks caspase-3 enzyme activity or the steps 
leading to its activation (Faleiro et a l, 1997). Indeed Perry et a l  (1997) reported that
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inhibits PARP-proteolysis by caspase-3 in the low pM range. Western blotting in 
the present study to detect a-fodrin fragmentation following 6-hour exposure to 
300pM Zn^  ^ did not reveal caspase-3 activation. Moreover caspase-6 and caspase-9 
are also suggested to be sensitive to inliibition by Zn^  ^and caspase inhibitors often fail 
to prevent cell death, rather shifting the mechanism of death from apoptosis to necrosis 
(Truong-Tran et a l, 2001). High concentrations of Zn^  ^ have been shown to inliibit 
the activation of calcium-dependent nucleases, such as calpains (Sundennan, 1995). 
Consistent with the previous statement, in the present study the calpain inhibitor PD 
150606 failed to protect against Zn^  ^toxicity. Moreover 4pM and lOpM PD 150606 
significantly decreased 24-hour lOOpM Zn^^-induced OPC death. Kim et a l  (1999b) 
in neuronal cultures indicated that following Zif^ insult, neuronal death displayed 
features of both apoptosis and necrosis. Initial findings revealed DNA fragmentation 
and chromatin condensation suggestive of apoptosis, however electron-microscope 
examinations revealed ultrastructural changes clearly indicative of necrosis, such as 
mar ked swelling of intracellular organelles and disruption of intact membranes amid 
relatively intact nuclear membranes. It has been suggested that the actions of Zn^  ^are 
not only limited to caspases inhibition, that it may have a role upstream of caspase 
activation, possibly at the mitochondrial level resulting in loss mitochondrial 
homeostasis. Studies on isolated non-neuronal and neuronal mitochondria have 
demonstrated direct uptake of Zn^ *^  and consequent loss of mitochondrial function 
(Saris & Niva, 1994; Sensi et a l, 2000; Jiang et a l, 2001; Sensi et a l, 2003). Indeed 
Jiang et a l (2001) reported that Zn^  ^induced permeability transition pore opening and 
release of pro-apoptotic peptides from neuronal mitochondria. Moreover Jiang et a l 
went on to show that these pro-apoptotic peptides were cytochrome c and apoptosis- 
inducing factor. It may plausible to consider therefore that Zn^^-induced OPC death
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may result in activation of non-caspase mediated apoptosis, with the release of 
apoptosis-inducing factor. Apoptosis-inducing factor can also be released as a 
consequence of ATP depletion (Daugas et a l, 2000) and causes chromatin 
condensation as well as large-scale (~50kb), but not mtemucleosomal, fragmentation 
of nuclear DNA (Susin et a l, 2000), and may therefore explain why chromatin 
condensation was observed in the present study.
Recent studies by Sheline et a l  (2000), Marin et a l (2000) and Lee et a l 
(2001) have reported Zn^^-induced cortical neuronal death to be attributable to a 
failure of mitochondrial respiration. Indeed Sheline et a l  (2000) in cortical neurones 
found 40pM Zn^^-induced neurotoxicity over 22-hours resulted in ATP depletion that 
was attenuated by 4mM pyruvate and suggested that Zn^  ^ inhibited elements of the 
glycolytic cascade. Specifically, high concentrations of Zn^ "^  were sufficient to inhibit 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) directly or indirectly, by 
causing the loss of nitcotinamide-adenine dinucleotide (NAD^). GAPDH catalyses the 
reaction of glyceraldehyde 3-phosphate to 1,3-biphosphoglycerate during glycolysis, 
whereby the aldehyde group of glyceraldehyde 3-phosphate is oxidised to a carboxylic 
acid to form 1,3-biphosphoglycerate, and the hydrogen (as a hydride ion) is transferred 
to NAD^ to form NADH + H^. Sheline et a l  (2000) observed that Zn^  ^exposure led 
to a decrease in NAD^ and this loss was considered to be attributable to inhibition of 
an unknown NAD^ catabolising enzyme by Zn^ .^ In agreement to these findings, 
lOOpM Zn^^-induced OPC death over 24-hours was attenuated by 4mM and lOmM 
pyruvate. Moreover 300pM Zn^^-induced toxicity over a 6-hour insult was also 
partially rescued by pyruvate. Lee et a l  (2001) in cortical cultures also attenuated 
35pM Zn^^-induced death over 24-hours with 5mM pyruvate. Moreover, in the same 
study they demonstrated that pyruvate afforded significant protection against rat
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transient forebrain ischaemia. Due to these findings we next investigated whether Zn^  ^
toxicity was the result of cellular ATP depletion. lOOpM Zn^  ^ over a 24-hour insult 
resulted in significant, although not total, depletion of cellular ATP levels. 300pM 
Zn^  ^ toxicity also resulted in ATP depletion after 6-hours insult. Moreover total 
cellular ATP was depleted after 9-hours 300pM Zn^  ^ exposure and the decrease in 
ATP appeared to follow the same time-trend as Zn^^-induced OPC death. The next 
natural progression was to determine whether cellular ATP depletion could also be 
reversed by pyruvate. Interestingly unlike the death studies 24-hour lOOpM Zn^^- 
induced ATP depletion was not attenuated by 5mM pymvate, whereas 6-hour 300pM 
Zn^ *^  ATP depletion was again partially rescued. Marin and co-workers (2000) also 
showed depleted ATP levels following 30 minute exposure to lOOpM-lmM Zn^  ^and 
assessed 24-hours later in mouse cortical neurones, however 2mM pyruvate did not 
protect against Zn^^-induced impairment of mitochondrial function (i.e. ATP 
depletion). They suggested Zn^^ interacted with mitochondria and not with enzymes 
of the glycolytic cascade. The present study however did show a partial reversal with 
pymvate and could therefore indicate possible inhibition of the glycolytic cascade 
either directly or indirectly by Zn^  ^ toxicity. As to why pymvate did not attenuate 
cellular ATP depletion following 24-hour lOOpM Zn^^-insult when it attenuated 
lOOpM Zn^Mnduced OPC death remains unclear. It may be that lOOpM and 300pM 
Zn^  ^ in the present model system evoked two distinct phases of response. Research 
into the field of Zn^^-induced neurotoxicity is very recent and has many unanswered 
questions especially around the intracellular events following Zn^  ^induced cell death as 
they appear to be concentration and duration dependent. Zn^^-induced toxicity in rat 
cultured OPCs has not been reported before and the present study is the first and so it 
is therefore difficult to make conclusions without further investigation. As we have
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discussed earlier oligodendrocyte cultures do not respond the same way as neuronal 
cultures following a toxic insult. Comparisons to neuronal data folloMng Zn^^-insult 
are merely a guide to determine if indeed these two distinct cell types may share a 
common response.
Therefore to summarise the findings of the present study in this chapter, OPC 
cultures were susceptible to a concentration and duration dependent Zn^  ^toxic insult. 
The routes of Zn^^ entiy did not appear to be via AMPA receptors or indeed L-type 
Ca^  ^ channels following kainate-induced cell depolarisation. Moreover Zn^  ^ toxicity 
did not appear to involve activation of caspase nor was an ROS evoked response 
obseiwed. Zn^  ^ toxicity did however result in cellular ATP depletion which could be 
partially rescued by addition of pyruvate to the culture medium. These data therefore 
suggest the mechanisms of Zn^  ^ toxicity may involve dismption of the glycolytic 
cascade.
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4.0 General Discussion and future work
The research undertaken throughout my training in order to obtain a Doctorate 
of Pliilosophy was novel at the time and often research findings sprang up many new 
routes of investigation. This was hardly surprising for a subject area that has not been 
extensively researched, especially within the field of excitotoxicity, and therefore 
made it difficult to compare and draw conclusions without further studies. The 
culturing of primary rat oligodendrocyte cells is a relatively difficult procedure to 
master and took the first 6 months of my Ph. D to establish an effective way of both 
culturing these cells and establishing a way in which these cells could then be co­
cultured into a format suitable for testing. This method for culturing oligodendrocytes 
has been utilised since McCarthy & de Vellis first described it in 1980. Since then it 
has been extensively used as a suitable model in which to study oligodendrocytes in 
vitro (McMorris & Dubois-Dalcq, 1988; Hardy & Reynolds, 1991; Oka et ah, 1993; 
Pende et a l, 1993; Gallo et a l, 1994; Gallo et a l, 1996; Liu et a l, 2002; Deng et a l, 
2003; Rosenberg et a l, 2003;).
The study of glutamate receptor-mediated excitotoxicity in rat cultured OPCs 
demonstrated that these cells were susceptible to AMPA-receptor mediated cell death 
following a 24-hour excitotoxin insult, an event which was prevented by application 
of the selective AMPA-receptor antagonists GYKI 52466 and Evans’ Blue. Previous 
studies (Fern & Moller, 2000; Alberdi et a l, 2002) demonstrated that application of 
300pM kainate resulted in Na^ and Ca^^ entry which was suggested to triggered the 
cascade of responses that lead to cell death. In the present study Na"^  and Ca^^ influx 
was not established. Ca^  ^ imaging studies using either fura-2-AM or ftuo-3-AM 
loading would confirm whether application of 300pM kainate resulted in Ca^^influx.
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A preliminary study (n=l, data not shown) demonstrated that OPCs pre-loaded with 
fura-2 showed increased fluorescence immediately following application of 300pM 
kainate and indicated Ca^^ influx. However as stated this was a preliminaiy finding 
and may have been an artefact of toxin loading. Additionally, the use o f Joro-Spider 
toxin (a selective Ca^^-peimeable AMPA/kainate receptor channel blocker) would 
indicate if the population of OPCs used in the present study expressed Ca^^-permeable 
AMPA/kainate receptors. It would also be interesting to examine the expression of 
AMPA subunits in a control situation and also following 24-hour kainate exposure to 
deteimine if there was an up- or down-regulation of AMPA receptor subunits. The 
role of the NaV Ca^ "^  exchanger working in reverse mode following kainate exposure 
could also be investigated using KB-R7943 (an inhibitor of the Na^/ Ca^^ exchanger) 
as Alberdi et a l  (2002) in rat cultured optic nerve oligodendrocytes speculated that 
-25%  of Ca^  ^ accumulation was via this exchanger and this may therefore contribute 
to OPC death in the present study.
Previous studies have shown that 200pM cystine protects cells against 2mM 
L-glutamate by inhibiting glutamate/cystine antiporter reversal (Oka et a l, 1993). 
The culture media in the present study contained 200pM cystine, therefore glutamate- 
induced OPC toxicity may have been prevented. Future work would aim to determine 
the extent of glutamate toxicity in culture medium containing physiological 
concentrations of 50pM cystine for example.
The mechanisms of cell death following kainate toxicity were also examined. 
300pM kainate-induced OPC death over a 24-hour insult was not attenuated by a 
broad spectrum of anti-oxidants, moreover during a 4-hour kainate insult ROS 
production was not observed. The broad-spectrum caspase inhibitor Z-VAD-fmk 
partially attenuated kainate-induced toxicity at 6- and 24-hour paradigms and Hoechst
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33342 staining also revealed the presence of pyknotic nuclei after 6-hour kainate 
(300pM) exposure. Western blot analysis using anti-caspase-3 antibody and anti-a- 
fodrin antibody indicated potential capsase-3 cleavage. Gu et al. (1999) and 
Osterhout et al. (2002) have reported the expression of caspases -1, -3, -8  and -9  , 
Apaf-1 and also Bad in rat cultured oligodendrocytes. The present study speculated 
that the reason Z-VAD-fmk did not provide a full reversal may have been due to the 
activation of an alternate death mechanism, possibly through the release of apoptosis- 
inducing factor. Future work examining the mechanisms of OPC cell death following 
kainate exposure could attempt to determine activation of caspase-9, release of 
cytochrome c and apoptosis-inducing factor, or PARP cleavage. Techniques such as 
terminal deoxynucleotide transferase mediated deoxyuridine triphosphate (dUTP) 
nick end-labelling (TUNEL) assay, to determine if strand breaks occur following 
kainate toxicity, and detennination of DNA laddering, features considered to be the 
result of apoptotic involvement, could be used to contribute to the above findings. 
These future studies could also be used to further investigate the mechanisms of OPC 
toxicity following lOOpM Zn^ "^  exposure for 24-hours and 300pM Zn^ "^  exposure for 
6-hours. Future work could also investigate the role of mitochondria following 
kainate-induced toxicity, such as is mitochondrial membrane potential altered? The 
mitochondrial membrane potential dye tetramethylrhodamine ethyl ester (TMRE) 
(Nicholls & Ward, 2000) using fluorescence microscopy could help elucidate this 
question. If mitochondrial membrane potential was altered would this then affect 
mitochondrial respiration, therefore ATP depletion could also be examined following 
kainate toxicity.
Zif^ has been shown to be co-released with glutamate and neuronal studies 
have demonstrated that Zn^^ toxicity results in cell death, an event in which AMPA
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receptor activation contributes to Zn^”^ entry. The present study is the first to 
demonstrate concentration- and time-dependent OPC death following Zn^^ exposure. 
Contraiy to neuronal findings Zn^^ toxicity was not potentiated via AMPA receptors, 
nor did L-type Ca^^ channels facilitate Zn^^ entry. The mechanism for Zn '^  ^ influx 
into OPCs was not determined; chapter 3 discussion speculated that Zn^ "^  entry may 
be the result of Zn^^transporters. Future experiments could determine if OPCs 
express Zn^ **" transporters in culture. Continuing with the type of OPC death that 
results following Zn^^ toxicity, Zif^ appears to possibly mediate two-distinct 
pathways of OPC death at concentrations of lOOpM and SOOpM Zn^”^, it would be 
interesting to determine if a-fodrin cleavage resulted following lOOpM Zif^ exposure 
for 24-hours or if the calpain inhibitor, PD 150606 reduced 300pM Zn^ "^  toxicity after 
6-hours exposure. Zn^^toxicity resulted in ATP depletion and results suggested that 
the mechanisms of Zn^^ toxicity may involve a disruption of the glycolytic cascade. 
Future experiments could examine this hypothesis in more detail; such as does Zn^^ 
inhibit the activity of glyceraldehyde-3-phosphate dehydrogenase or determine if 
NAD^ is affected as suggested by Sheline et a l  (2000) in cortical neurones.
As has been discussed within this thesis, written as part of the requirement for 
the degree of Doctor of Philosophy, the research undertaken generated many future 
directions for investigation following kainate and Zn^^-induced OPC toxicity.
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